false2022FY0001600033http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligationsCurrenthttp://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligationsCurrenthttp://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligationshttp://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations00016000332021-04-012022-03-3100016000332021-09-30iso4217:USD00016000332022-05-18xbrli:shares00016000332022-03-3100016000332021-03-31iso4217:USDxbrli:shares00016000332020-04-012021-03-3100016000332019-04-012020-03-310001600033us-gaap:CommonStockMember2019-03-310001600033us-gaap:AdditionalPaidInCapitalMember2019-03-310001600033us-gaap:RetainedEarningsMember2019-03-3100016000332019-03-310001600033us-gaap:RetainedEarningsMember2019-04-012020-03-310001600033us-gaap:AdditionalPaidInCapitalMember2019-04-012020-03-310001600033us-gaap:CommonStockMember2019-04-012020-03-310001600033us-gaap:CommonStockMember2020-03-310001600033us-gaap:AdditionalPaidInCapitalMember2020-03-310001600033us-gaap:RetainedEarningsMember2020-03-3100016000332020-03-310001600033us-gaap:RetainedEarningsMember2020-04-012021-03-310001600033us-gaap:AdditionalPaidInCapitalMember2020-04-012021-03-310001600033us-gaap:CommonStockMember2020-04-012021-03-310001600033us-gaap:CommonStockMember2021-03-310001600033us-gaap:AdditionalPaidInCapitalMember2021-03-310001600033us-gaap:RetainedEarningsMember2021-03-310001600033us-gaap:RetainedEarningsMember2021-04-012022-03-310001600033us-gaap:AdditionalPaidInCapitalMember2021-04-012022-03-310001600033us-gaap:CommonStockMember2021-04-012022-03-310001600033us-gaap:CommonStockMember2022-03-310001600033us-gaap:AdditionalPaidInCapitalMember2022-03-310001600033us-gaap:RetainedEarningsMember2022-03-310001600033us-gaap:CustomerConcentrationRiskMemberelf:CustomerAMemberus-gaap:SalesRevenueNetMember2021-04-012022-03-31xbrli:pure0001600033us-gaap:CustomerConcentrationRiskMemberelf:CustomerAMemberus-gaap:SalesRevenueNetMember2020-04-012021-03-310001600033us-gaap:CustomerConcentrationRiskMemberelf:CustomerAMemberus-gaap:SalesRevenueNetMember2019-04-012020-03-310001600033us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMemberelf:CustomerBMember2021-04-012022-03-310001600033us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMemberelf:CustomerBMember2020-04-012021-03-310001600033us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMemberelf:CustomerBMember2019-04-012020-03-310001600033us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMemberelf:CustomerCMember2021-04-012022-03-310001600033us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberelf:CustomerAMember2021-04-012022-03-310001600033us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberelf:CustomerAMember2020-04-012021-03-310001600033us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberelf:CustomerBMember2021-04-012022-03-310001600033us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberelf:CustomerBMember2020-04-012021-03-310001600033us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberelf:CustomerCMember2020-04-012021-03-310001600033srt:MinimumMemberelf:MachineryEquipmentAndSoftwareMember2021-04-012022-03-310001600033srt:MaximumMemberelf:MachineryEquipmentAndSoftwareMember2021-04-012022-03-310001600033us-gaap:LeaseholdImprovementsMember2021-04-012022-03-310001600033us-gaap:FurnitureAndFixturesMembersrt:MinimumMember2021-04-012022-03-310001600033srt:MaximumMemberus-gaap:FurnitureAndFixturesMember2021-04-012022-03-310001600033elf:StoreFixturesMembersrt:MinimumMember2021-04-012022-03-310001600033srt:MaximumMemberelf:StoreFixturesMember2021-04-012022-03-310001600033elf:RetailProductDisplaysMember2022-03-310001600033elf:RetailProductDisplaysMember2021-03-310001600033elf:RetailProductDisplaysMember2021-04-012022-03-310001600033elf:RetailProductDisplaysMember2020-04-012021-03-310001600033elf:RetailProductDisplaysMember2019-04-012020-03-310001600033srt:MinimumMember2021-04-012022-03-310001600033srt:MaximumMember2021-04-012022-03-31elf:segment0001600033country:US2021-04-012022-03-310001600033country:US2020-04-012021-03-310001600033country:US2019-04-012020-03-310001600033us-gaap:NonUsMember2021-04-012022-03-310001600033us-gaap:NonUsMember2020-04-012021-03-310001600033us-gaap:NonUsMember2019-04-012020-03-310001600033country:US2022-03-310001600033country:US2021-03-310001600033us-gaap:NonUsMember2022-03-310001600033us-gaap:NonUsMember2021-03-31elf:distribution_channel0001600033us-gaap:SalesReturnsAndAllowancesMember2019-03-310001600033us-gaap:SalesReturnsAndAllowancesMember2019-04-012020-03-310001600033us-gaap:SalesReturnsAndAllowancesMember2020-03-310001600033us-gaap:SalesReturnsAndAllowancesMember2020-04-012021-03-310001600033us-gaap:SalesReturnsAndAllowancesMember2021-03-310001600033us-gaap:SalesReturnsAndAllowancesMember2021-04-012022-03-310001600033us-gaap:SalesReturnsAndAllowancesMember2022-03-310001600033us-gaap:ShippingAndHandlingMember2021-04-012022-03-310001600033us-gaap:ShippingAndHandlingMember2020-04-012021-03-310001600033us-gaap:ShippingAndHandlingMember2019-04-012020-03-310001600033elf:SocialMediaAnalyticsCompanyMember2017-04-140001600033elf:CustomerRelationshipsRetailersMember2021-04-012022-03-310001600033elf:CustomerRelationshipsRetailersMember2022-03-310001600033elf:CustomerRelationshipsECommerceMember2021-04-012022-03-310001600033elf:CustomerRelationshipsECommerceMember2022-03-310001600033us-gaap:TrademarksMember2021-04-012022-03-310001600033us-gaap:TrademarksMember2022-03-310001600033us-gaap:TrademarksMember2022-03-310001600033elf:CustomerRelationshipsRetailersMember2020-04-012021-03-310001600033elf:CustomerRelationshipsRetailersMember2021-03-310001600033elf:CustomerRelationshipsECommerceMember2020-04-012021-03-310001600033elf:CustomerRelationshipsECommerceMember2021-03-310001600033us-gaap:TrademarksMember2020-04-012021-03-310001600033us-gaap:TrademarksMember2021-03-310001600033us-gaap:TrademarksMember2021-03-310001600033elf:MachineryEquipmentAndSoftwareMember2022-03-310001600033elf:MachineryEquipmentAndSoftwareMember2021-03-310001600033us-gaap:LeaseholdImprovementsMember2022-03-310001600033us-gaap:LeaseholdImprovementsMember2021-03-310001600033us-gaap:FurnitureAndFixturesMember2022-03-310001600033us-gaap:FurnitureAndFixturesMember2021-03-310001600033elf:StoreFixturesMember2022-03-310001600033elf:StoreFixturesMember2021-03-310001600033us-gaap:FairValueMeasurementsRecurringMember2022-03-310001600033us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-03-310001600033us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-03-310001600033us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-03-310001600033us-gaap:FairValueMeasurementsRecurringMember2021-03-310001600033us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-03-310001600033us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-03-310001600033us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-03-310001600033elf:A2016SeniorSecuredCreditFacilityMember2016-12-232016-12-230001600033elf:A2016SeniorSecuredCreditFacilityMember2016-12-230001600033elf:A2016SeniorSecuredCreditFacilityMember2017-08-250001600033us-gaap:RevolvingCreditFacilityMemberelf:A2016SeniorSecuredCreditFacilityMember2017-08-250001600033us-gaap:RevolvingCreditFacilityMemberelf:AmendedCreditAgreementMember2021-04-302021-04-300001600033us-gaap:RevolvingCreditFacilityMemberelf:AmendedCreditAgreementMember2021-04-300001600033elf:TermLoanMember2022-03-310001600033elf:TermLoanMember2021-03-310001600033elf:AmendedCreditAgreementMember2021-04-302021-04-300001600033us-gaap:RevolvingCreditFacilityMemberelf:AmendedRevolvingCreditFacilityMember2021-04-300001600033us-gaap:RevolvingCreditFacilityMemberelf:AmendedTermLoanFacilityMember2021-04-300001600033elf:PriorCreditAgreementMemberelf:TermLoanMember2021-04-290001600033us-gaap:RevolvingCreditFacilityMemberelf:PriorCreditAgreementMember2021-04-290001600033us-gaap:RevolvingCreditFacilityMemberelf:AmendedCreditAgreementMembersrt:MinimumMember2021-04-302021-04-300001600033srt:MaximumMemberus-gaap:RevolvingCreditFacilityMemberelf:AmendedCreditAgreementMember2021-04-302021-04-300001600033us-gaap:LetterOfCreditMemberelf:AmendedCreditAgreementMember2021-04-300001600033elf:AmendedCreditAgreementMemberus-gaap:LineOfCreditMember2021-04-300001600033us-gaap:RevolvingCreditFacilityMemberelf:AmendedCreditAgreementMember2022-03-310001600033elf:MinimumFloorMemberelf:AmendedCreditAgreementMemberelf:TermLoanMember2021-04-302021-04-300001600033us-gaap:RevolvingCreditFacilityMemberelf:MinimumFloorMemberelf:AmendedCreditAgreementMember2021-04-302021-04-300001600033elf:AmendedCreditAgreementMemberelf:TermLoanMembersrt:MinimumMemberus-gaap:LondonInterbankOfferedRateLIBORMember2021-04-302021-04-300001600033us-gaap:RevolvingCreditFacilityMemberelf:AmendedCreditAgreementMembersrt:MinimumMemberus-gaap:LondonInterbankOfferedRateLIBORMember2021-04-302021-04-300001600033srt:MaximumMemberelf:AmendedCreditAgreementMemberelf:TermLoanMemberus-gaap:LondonInterbankOfferedRateLIBORMember2021-04-302021-04-300001600033srt:MaximumMemberus-gaap:RevolvingCreditFacilityMemberelf:AmendedCreditAgreementMemberus-gaap:LondonInterbankOfferedRateLIBORMember2021-04-302021-04-300001600033us-gaap:BaseRateMemberus-gaap:RevolvingCreditFacilityMemberelf:AmendedCreditAgreementMembersrt:MinimumMember2021-04-302021-04-300001600033us-gaap:BaseRateMemberelf:AmendedCreditAgreementMemberelf:TermLoanMembersrt:MinimumMember2021-04-302021-04-300001600033us-gaap:BaseRateMembersrt:MaximumMemberelf:AmendedCreditAgreementMemberelf:TermLoanMember2021-04-302021-04-300001600033us-gaap:BaseRateMembersrt:MaximumMemberus-gaap:RevolvingCreditFacilityMemberelf:AmendedCreditAgreementMember2021-04-302021-04-300001600033elf:TermLoanMemberelf:A2016SeniorSecuredCreditFacilityMember2022-03-310001600033elf:PriorCreditAgreementMember2021-04-012022-03-310001600033elf:AmendedCreditAgreementMember2021-04-300001600033elf:TermLoanMember2021-04-012022-03-310001600033elf:TermLoanMember2020-04-012021-03-310001600033elf:TermLoanMember2019-04-012020-03-310001600033us-gaap:RevolvingCreditFacilityMember2021-04-012022-03-310001600033us-gaap:RevolvingCreditFacilityMember2020-04-012021-03-310001600033us-gaap:RevolvingCreditFacilityMember2019-04-012020-03-310001600033elf:FinanceLeasesMember2021-04-012022-03-310001600033elf:FinanceLeasesMember2020-04-012021-03-310001600033elf:FinanceLeasesMember2019-04-012020-03-310001600033us-gaap:DomesticCountryMember2021-04-012022-03-310001600033us-gaap:ForeignCountryMember2021-04-012022-03-310001600033elf:TwoThousandAndSixteenEquityIncentiveAwardPlanMember2022-03-310001600033elf:TwoThousandAndFourteenEquityIncentiveAwardPlanMember2022-03-310001600033elf:ServiceBasedStockOptionsMember2019-03-310001600033elf:ServiceBasedStockOptionsMember2018-04-012019-03-310001600033elf:ServiceBasedStockOptionsMember2019-04-012020-03-310001600033elf:ServiceBasedStockOptionsMember2020-03-310001600033elf:ServiceBasedStockOptionsMember2020-01-012020-03-310001600033elf:ServiceBasedStockOptionsMember2020-04-012021-03-310001600033elf:ServiceBasedStockOptionsMember2021-03-310001600033elf:ServiceBasedStockOptionsMember2021-04-012022-03-310001600033elf:ServiceBasedStockOptionsMember2022-03-310001600033elf:PerformanceBasedAndMarketBasedVestingOptionsMember2019-03-310001600033elf:PerformanceBasedAndMarketBasedVestingOptionsMember2018-04-012019-03-310001600033elf:PerformanceBasedAndMarketBasedVestingOptionsMember2019-04-012020-03-310001600033elf:PerformanceBasedAndMarketBasedVestingOptionsMember2020-03-310001600033elf:PerformanceBasedAndMarketBasedVestingOptionsMember2020-04-012021-03-310001600033elf:PerformanceBasedAndMarketBasedVestingOptionsMember2021-03-310001600033elf:PerformanceBasedAndMarketBasedVestingOptionsMember2021-04-012022-03-310001600033elf:PerformanceBasedAndMarketBasedVestingOptionsMember2022-03-310001600033elf:RestrictedStockUnitsandRestrictedStockMember2019-03-310001600033elf:RestrictedStockUnitsandRestrictedStockMember2019-04-012020-03-310001600033elf:RestrictedStockUnitsandRestrictedStockMember2020-03-310001600033elf:RestrictedStockUnitsandRestrictedStockMember2020-04-012021-03-310001600033elf:RestrictedStockUnitsandRestrictedStockMember2021-03-310001600033elf:RestrictedStockUnitsandRestrictedStockMember2021-04-012022-03-310001600033elf:RestrictedStockUnitsandRestrictedStockMember2022-03-310001600033us-gaap:RestrictedStockMember2022-03-310001600033us-gaap:RestrictedStockUnitsRSUMember2021-04-012022-03-310001600033us-gaap:RestrictedStockUnitsRSUMember2020-04-012021-03-310001600033us-gaap:RestrictedStockUnitsRSUMember2019-04-012020-03-310001600033elf:RestrictedStockUnitsandRestrictedStockMemberus-gaap:CostOfSalesMember2021-04-012022-03-310001600033elf:RestrictedStockUnitsandRestrictedStockMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2021-04-012022-03-310001600033elf:RestrictedStockUnitsandRestrictedStockMemberus-gaap:CostOfSalesMember2020-04-012021-03-310001600033elf:RestrictedStockUnitsandRestrictedStockMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2020-04-012021-03-3100016000332019-05-0800016000332022-01-012022-03-3100016000332020-01-012020-03-3100016000332021-04-012021-06-3000016000332021-07-012021-09-3000016000332021-10-012021-12-3100016000332020-04-012020-06-3000016000332020-07-012020-09-3000016000332020-10-012020-12-3100016000332021-01-012021-03-3100016000332019-04-012019-06-3000016000332019-07-012019-09-3000016000332019-10-012019-12-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________________________
FORM 10-K
___________________________________________________
|
|
|
|
|
|
☒ |
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 |
For the fiscal year ended March 31, 2022
OR
|
|
|
|
|
|
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from
to
Commission File Number 001-37873
___________________________________________________
e.l.f. Beauty, Inc.
(Exact name of registrant as specified in its charter)
___________________________________________________
|
|
|
|
|
|
Delaware |
46-4464131 |
(State or other jurisdiction of
incorporation or organization) |
(I.R.S. Employer
Identification No.) |
|
|
|
|
|
|
|
|
|
570 10th Street
|
Oakland,
|
CA |
94607 |
(Address of principal executive offices, including zip
code)
_______________________________________________________________
(Registrant’s telephone number, including area code)
_______________________________________________________________
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange
on which registered |
Common Stock, $0.01 par value |
|
ELF |
|
New York Stock Exchange |
Securities registered pursuant to Section 12(g) of the
Act:
None
___________________________________________________
Indicate by check mark if the registrant is a well-known seasoned
issuer, as defined in Rule 405 of the Securities
Act. Yes ☒ No ☐
Indicate by check mark if the registrant is not required to file
reports pursuant to Section 13 or 15(d) of the
Act. Yes ☐ No ☒
Indicate by check mark whether the registrant: (1) has filed
all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to
file such reports), and (2) has been subject to such filing
requirements for the past
90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted
electronically every Interactive Data File required to be submitted
pursuant to Rule 405 of Regulation S-T (§232.405 of this
chapter) during the preceding 12 months (or for such shorter
period that the registrant was required to submit such
files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated filer, a
smaller reporting company, or an emerging growth company. See the
definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company,” and “emerging growth company” in Rule
12b-2 of the Exchange Act.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Large accelerated filer |
☒ |
|
Accelerated filer |
☐ |
Non-accelerated filer |
☐ |
|
Smaller reporting company |
☐ |
|
|
|
Emerging growth company |
☐ |
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act.
☐
Indicate by check mark whether the registrant has filed a report on
and attestation to its management’s assessment of the effectiveness
of its internal control over financial reporting under Section
404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the
registered public accounting firm that prepared or issued its audit
report.
☒
Indicate by check mark whether the registrant is a shell company
(as defined in Rule 12b-2 of the Exchange
Act). Yes ☐ No ☒
As of September 30, 2021, the last business day of the registrant’s
most recently completed second fiscal quarter, the aggregate market
value of the voting and non-voting stock held by non-affiliates of
the registrant was $1.4 billion.
The number of shares of registrant’s common stock outstanding as of
May 18, 2022 was 52,272,764 shares.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the registrant’s Definitive Proxy Statement relating to
the registrant’s 2022 annual meeting of stockholders are
incorporated by reference into Part III of this Annual Report on
Form 10-K. Such Definitive Proxy Statement will be filed with the
Securities and Exchange Commission within 120 days of the
registrant's fiscal year ended March 31, 2022.
e.l.f. Beauty, Inc.
Table of Contents
CAUTIONARY NOTE ABOUT FORWARD-LOOKING STATEMENTS
This Annual Report on Form 10-K (“Annual Report”) contains
forward-looking statements within the meaning of the federal
securities laws concerning our business, operations and financial
performance and condition, as well as our plans, objectives and
expectations for our business operations and financial performance
and condition. Any statements contained herein that are not
statements of historical facts may be deemed to be forward-looking
statements. In some cases, you can identify forward-looking
statements by terminology such as “aim,” “anticipate,” “assume,”
”believe,” “contemplate,” “continue,” "could,” “due,” “estimate,”
“expect,” “goal,” “intend,” “may,” “objective,” “plan,” “predict,”
“potential,” “positioned,” “seek,” “should,” “target,” “will,”
“would” and other similar expressions that are predictions of or
indicate future events and future trends, or the negative of these
terms or other comparable terminology. These forward-looking
statements are based on management's current expectations,
estimates, forecasts and projections about our business and the
industry in which we operate and management’s beliefs and
assumptions and are not guarantees of future performance or
development and involve known and unknown risks, uncertainties and
other factors that are in some cases beyond our control. Although
we believe that the expectations reflected in the forward-looking
statements contained herein are reasonable, our actual results and
the timing of selected events may differ materially. Factors that
may cause actual results to differ materially from current
expectations include, among other things, those listed under Part
I, Item 1A. “Risk factors” and elsewhere in this Annual Report.
Potential investors are urged to consider these factors carefully
in evaluating the forward-looking statements. These forward-looking
statements speak only as of the date of this Annual Report. Except
as required by law, we assume no obligation to update or revise
these forward-looking statements for any reason, even if new
information becomes available in the future.
SUMMARY OF MATERIAL RISKS ASSOCIATED WITH OUR BUSINESS
The principal risks and uncertainties affecting our business
include the following:
•The
beauty industry is highly competitive, and if we are unable to
compete effectively our results will suffer.
•Our
new product introductions may not be as successful as we
anticipate.
•Any
damage to our reputation or brands may materially and adversely
affect our business, financial condition and results of
operations.
•Our
success depends, in part, on the quality, performance and safety of
our products.
•We
may not be able to successfully implement our growth
strategy.
•Our
growth and profitability are dependent on a number of factors, and
our historical growth may not be indicative of our future
growth.
•We
may be unable to grow our business effectively or efficiently,
which would harm our business, financial condition and results of
operations.
•A
disruption in our operations, including a disruption in the supply
chains for our products, could materially and adversely affect our
business.
•We
rely on a number of third-party suppliers, manufacturers,
distributors and other vendors, and they may not continue to
produce products or provide services that are consistent with our
standards or applicable regulatory requirements, which could harm
our brands, cause consumer dissatisfaction, and require us to find
alternative suppliers of our products or services.
•We
depend on a limited number of retailers for a large portion of our
net sales, and the loss of one or more of these retailers, or
business challenges at one or more of these retailers, could
adversely affect our results of operations.
•We
have significant operations in China, which exposes us to risks
inherent in doing business in that country.
•If
we are unable to protect our intellectual property, the value of
our brands and other intangible assets may be diminished, and our
business may be adversely affected.
•Our
success depends on our ability to operate our business without
infringing, misappropriating or otherwise violating the trademarks,
patents, copyrights and other proprietary rights of third
parties.
The summary risk factors described above should be read together
with the text of the full risk factors below in the section
entitled “Risk factors” and the other information set forth in this
Annual Report, including our consolidated financial statements and
the related notes, as well as in other documents that we file with
the U.S. Securities and Exchange Commission (the "SEC"). The risks
summarized above or described in full below are not the only risks
that we face. Additional risks and uncertainties not precisely
known to us or that we currently deem to be immaterial may also
materially adversely affect our business, financial condition,
results of operations, and future growth prospects.
PART I
Item 1. Business.
Overview
e.l.f. Beauty, Inc. (“e.l.f. Beauty” and together with our
subsidiaries, the “Company,” or “we”) is a multi-brand beauty
company that offers inclusive, accessible, clean and cruelty-free
cosmetics and skincare products.
•WHO
WE ARE.
We are bold disruptors with a kind heart. We’re disrupting
traditional beauty boundaries while leading with empathy, intention
and an innate desire to empower people.
•OUR
MISSION.
We build brands that disrupt industry norms, shape culture and
connect communities through positivity, inclusivity and
accessibility.
•OUR
PURPOSE.
We stand with every eye, lip, face and paw.
We believe our ability to deliver 100% cruelty-free, clean,
premium-quality products at accessible prices with broad appeal
differentiates us in the beauty industry. We believe the
combination of our innovation engine, core value proposition,
digitally-led strategy, as well as our world-class team’s ability
to execute with speed has positioned us well to navigate a rapidly
changing landscape in beauty.
Our Brands
Our family of brands includes e.l.f. Cosmetics, e.l.f. SKIN, Well
People and Keys Soulcare. Our brands are available online and
across leading beauty, mass-market and clean-beauty specialty
retailers. We have strong relationships with our retail partners
such as Walmart, Target, Ulta Beauty and other leading retailers
that have enabled us to expand distribution both domestically and
internationally.
Each of our brands is positioned to touch diverse consumer cohorts
at different price points. Each brand has accessible pricing
relative to its competitive set and furthers our mission of leading
with positivity, inclusivity and accessibility.
|
|
|
|
|
|
e.l.f. Cosmetics |
Since 2004, e.l.f. Cosmetics has made the best of beauty accessible
to every eye, lip and face. e.l.f. makes high-quality,
prestige-inspired cosmetics at an extraordinary value and is proud
to be 100% vegan, clean and cruelty-free.
|
|
|
e.l.f. SKIN |
Winning in skin the clean + kind way. Ingredient focused skincare
for every eye, lip, face and skin type. e.l.f. SKIN makes
innovative formulas at an extraordinary value, always 100% vegan,
clean and cruelty-free.
|
|
|
Well People |
A clean beauty pioneer with 40 EWG VERIFIED™ products, Well People
has raised the standard for high-performing, plant-powered and
cruelty-free beauty and skincare since 2008. Founded on the
principles of being derm-developed, super-clean, and planet minded,
Well People is committed to inspiring wellness and mindful
living.
|
|
|
Keys Soulcare |
Created by Alicia Keys and inspired by her own skincare journey and
love of ancient beauty rituals, Keys Soulcare goes beyond skincare
to truly care for the whole self - body, mind, and spirit. With an
inclusive point of view, Keys Soulcare brings a new meaning to
beauty and honors rituals through its line of
dermatologist-developed, clean and cruelty-free
offerings.
|
100% cruelty-free:
We do not conduct or tolerate any tests on animals, nor do we use
any ingredients that are tested on animals in any of our products.
Each of our brands is certified by People for the Ethical Treatment
of Animals (PETA) as “Global Animal Test-Free”, a credential given
to companies and brands who have verified that their own facilities
and their suppliers do not conduct, commission, pay for, or allow
any tests on animals for their ingredients, formulations, or
finished products. e.l.f. Cosmetics is also certified by PETA as
“Global Animal Test-Free and Vegan”, which recognizes companies and
brands that not only ban animal tests but also refuse to use any
animal-derived ingredients, such as honey, beeswax, or carmine in
products.
Clean ingredients:
Our products are formulated with ingredients that have the health
and safety of our consumers in mind. All products are formulated to
comply with Food and Drug Administration (the "FDA") and European
Union Cosmetic Regulation restrictions covering over 1,600
ingredients including parabens, phthalates, sulfates, formaldehyde,
nonylphenol ethoxylates, triclosan, triclocarban, toluene, coal
tar, lead, mercury, acrylamide and hydroquinone as well as other
substances. Additionally, Well People's product-line includes 40
EWG VERIFIED™ products, a leading standard of “clean and healthy”
in the beauty space.
Marketing & Digital
We deploy a consumer-centric marketing model. We build brand equity
and drive traffic to our national retailer partners and to our own
e-commerce websites and mobile applications primarily through
digital and social media, as compared to legacy beauty brands that
often seek to engage consumers through traditional media such as
magazines, newspapers and television. Total expenses for marketing
and digital in the year ended March 31, 2022 were $63.2 million,
approximately 16% of our net sales.
Our consumers have been our best advocates through strong word of
mouth. Many of our consumers are active in social media, write
reviews of our products online and generate content on Instagram,
Facebook, Twitter, TikTok, YouTube and other social media
platforms.
Innovation
We believe innovation is key to our success and that we are a
leader in the industry in speed and first to mass product
introductions. We have built an innovation capability that can
progress a new, high-quality product from concept to online launch
in as few as 13 weeks and approximately 20 weeks on average. We
leverage multiple sources of inspiration to develop our new product
ideas, including global trend assessments, supplier and industry
research, strategic customer input and consumer feedback and
insights.
Our innovation strategy is underpinned by four key
pillars:
•Holy
Grails.
“Holy grails” are beauty products that deliver premium quality at
unbelievable prices with broad appeal. As consumers are
increasingly savvy and knowledgeable about trends in the prestige
market, they look for ways to get the best of beauty at an
accessible price. Examples of our “holy grails” include the e.l.f.
Cosmetics Poreless Putty Primer at $10 versus a comparable prestige
primer at $52, the e.l.f. Cosmetics 16HR Camo Concealer at $7
versus a comparable prestige concealer at $30, and the Well People
Expressionist Pro Mascara at $20 versus a comparable clean prestige
mascara at $28.
•Core
Improvement.
We consistently evaluate our core offerings to develop new products
or improve quality based on category trends, consumer feedback, and
other market intelligence. We launch trend-inspired, core expansion
products that augment our assortment and deliver extraordinary
value across price points. We also evaluate quality improvement
opportunities within our product assortment, such as reformulating
existing products with cleaner ingredients.
•Adjacencies.
We believe that we can reapply our model to continue to launch
products into adjacent product categories outside of cosmetics. For
example, in October 2021, Well People launched its first product
collection in the skincare category, featuring five products with
dermatologist-developed formulas that support skin health and are
infused with plant-powered ingredients. In May 2021, Keys Soulcare
launched three product offerings in the body care category, adding
to the brand's dermatologist-developed, clean and cruelty free
skincare offerings.
•Collaborations
& Collections.
We utilize collaborations and collections to build brand awareness
and showcase our brands’ abilities to connect with, surprise and
delight consumers while creating buzz-generating moments. For
example, in March 2022, e.l.f. Cosmetics launched a collaboration
with Dunkin' on a limited edition makeup collection. We also
utilize exclusive collections with our national retailers. For
example, in January 2022, e.l.f. Cosmetics launched a limited
edition Cookies ‘N’ Dreams collection exclusively at Walmart in the
United States, at Superdrug in the United Kingdom, and at Douglas
in Italy and the Netherlands.
Markets and Competition
We operate across beauty categories including face makeup, eye
makeup, lip products, nail products, cosmetics sets/kits, beauty
tools and accessories, facial skincare, and eye skincare products.
Color cosmetics and skincare products are broadly sold through
food, drug and mass channels, as well as through department stores
and direct and specialty channels.
The beauty industry is relatively concentrated, with a significant
portion of retail sales in the United States generated by brands
owned by a few large multinational companies, such as L’Oreal,
Estee Lauder, Coty, Revlon, Shiseido, Johnson & Johnson, and
Procter & Gamble. These large multinational companies typically
own multiple brands. In addition to the traditional brands against
which we compete, small independent companies continue to enter the
market with new brands and customized product
offerings.
Distribution
We employ an omni-channel
distribution strategy and sell our products online through our own
direct e-commerce channels, and with national retailers in the
United States, as well as internationally. Our main channels of
distribution are described below.
•National
retailers. We
sell our products in the United States primarily in the mass, drug
store, food and specialty retail channels.
•e-commerce.
Our e-commerce platforms are an important component of our
engagement and innovation model. Our roots as an e-commerce company
and our digital engagement model drive conversion on our e-commerce
websites and our mobile applications, where we sell our full
product offerings.
•International. Our
products are also sold in a number of international markets,
including the United Kingdom, Canada, Australia and
Germany.
Customers
Along with our direct e-commerce channels, we have strong
relationships with our retail partners such as Walmart, Target,
Ulta Beauty and other leading retailers that have enabled us to
expand distribution both domestically and
internationally.
Walmart, Target and Ulta Beauty accounted for 26%, 23% and 12%,
respectively, of our net sales in the year ended March 31, 2022. No
other individual customer accounted for 10% or more of our net
sales in the year ended March 31, 2022. We expect that Walmart,
Target and Ulta Beauty along with small number of other customers
will, in the aggregate, continue to account for a large portion of
our net sales in the future.
As is customary in the industry, none of our customers is under any
obligation to continue purchasing products from us in the
future.
For more information regarding customer concentration, see Part II,
Item 7 “Management’s discussion and analysis of financial condition
and results of operations” of this report under the heading
“Overview.”
Supply Chain
We have developed a scalable, asset-light supply chain centered on
speed to market and high-quality at low cost. Substantially all of
our products are sourced and manufactured in China through close
collaboration with a network of third-party manufacturers. We have
ample manufacturing capacity as well as redundant capabilities in
the event that one or more suppliers cannot meet our needs. Our
broad supply base gives us the ability to fulfill our product
requirements and remain cost competitive.
We work closely with our suppliers on new product innovation and
quality. Our China-based sourcing, quality and innovation teams
work with their U.S.-based counterparts to deliver ongoing product
quality, innovation and cost savings. We are not overly dependent
on any single raw material. The raw materials used in our products
are broadly available and have regular quality testing for
ingredient integrity.
We operate two main distribution centers: one in Ontario,
California, which mainly serves our national retail customers, and
one in Columbus, Ohio, which mainly services our e-commerce
consumers. We have invested capital in picking, packaging,
scanning, and conveying technology to more fully automate our
processes. Our Ontario and Columbus distribution centers are both
operated by a leading third-party logistics provider. For our
international operations, we utilize third-party logistics
providers in Canada and the United Kingdom to distribute to certain
international customers and distributors.
Employees and Human Capital Management
We are led by our purpose—we stand with every eye, lip, face and
paw—and our employees are at the core of our business strategy. As
of March 31, 2022, we had 303 full-time employees (224 in the
United States, United Kingdom and Canada, and 79 in
China).
Culture and Commitments
By standing with every eye, lip, face and paw, we are committed to
creating a culture internally—and in the world around us—where all
individuals are encouraged to express their truest selves, are
empowered to succeed, and where we strive to do the right thing for
people, the planet and our furry friends. We are committed
to:
•
Encourage Self Expression.
We celebrate diversity and make the best of beauty
accessible.
•
Empower Others.
We provide equal opportunities for growth and success.
•
Embody Our Ethics.
We strive to do the right thing for all people, the planet and our
furry friends.
Encourage Self Expression: Promoting a Culture of Diversity,
Equity, and Inclusion
We are committed to diversity, equity and inclusion and believe it
is important that our team reflects the diverse consumers we serve.
Our commitment to diversity, equity and inclusion starts at the top
with a highly skilled and diverse Board of Directors. We are proud
to be one of only seven public companies in the U.S. with a Board
of Directors that has over 55% women and over 20% Black or African
American representation (out of over 4,800 public
companies).
We are proud of our workforce demographics and are committed to
ensuring that appropriate levels of diversity – including but not
limited to gender, race, sexual orientation, national origin,
ability, and age – are represented across our entire team. We
promote diversity, equity and inclusion at all levels of our
workforce, and our senior leadership team owns and is responsible
for our diversity, equity and inclusion initiatives and programs.
We are committed to increasing the representation of women and
minorities in our workforce.
The following table provides certain statistics of our team as of
April 2022:
|
|
|
|
|
|
|
|
|
|
|
|
|
Board of Directors |
Senior Leadership(1)
|
All Employees(2)
|
Gender |
|
|
|
Female |
56% |
43% |
81% |
Male |
44% |
57% |
19% |
Age |
|
|
|
Gen Z and Millennial |
—% |
—% |
65% |
All Other |
100% |
100% |
35% |
Race / Ethnicity |
|
|
|
Black or African American |
22% |
14% |
6% |
Hispanic or LatinX |
—% |
—% |
13% |
Asian |
11% |
29% |
18% |
Native American |
—% |
—% |
—% |
Two or More Races |
—% |
—% |
6% |
White |
67% |
57% |
57% |
|
|
|
|
|
|
(1)
|
Senior Leadership includes our Executive Officers and the Vice
President, General Manager of our China operations.
|
(2)
|
Includes our employees in the United States, United Kingdom and
Canada, where over 70% of our workforce is located. |
We believe that to drive change there must be continuous education,
learning and sharing. We offer Unconscious Bias Training and a
Behaviors of Inclusion Course to all of our employees, so that our
employees learn the psychology of unconscious bias and its impact
at work and practice behaviors of inclusion. We host open forums
with our senior leadership to share and encourage uncomfortable
conversations. Additionally, we regularly host education events for
our employees to lean into cultural moments, such as Black History
Month; International Women’s Month; Asian American and Pacific
Islander (AAPI) Heritage Month; Lesbian, Gay, Bisexual, Transgender
and Queer (LGBTQ) Pride Month; and LatinX Heritage
Month.
Empower Others: Supporting the Full Potential of Our
Employees
Our talented employees are at the core of our business strategy. We
place a high priority on attracting, recruiting, developing and
retaining diverse global talent. Our benefits and programs are
designed to support the total well-being and promote the full
potential of our employees.
With regards to compensation, we take a “one-team” approach. All
full-time employees receive a base salary, are bonus eligible under
the same bonus plan tied to our financial performance, and receive
an equity award. We believe this approach – which applies across
all employee levels and geographies – is unique in the beauty
industry and contributes to our success in hiring and retaining top
talent and driving business results.
In the United States, where over 70% of our workforce is located,
the benefits for our full-time employees include, among other
things:
•Financial
benefits, including competitive compensation as well as retirement
savings plans and commuter benefits;
•Healthcare
benefits including flexible spending accounts, disability and life
insurance;
•Family
support and flexibility benefits including up to 20 weeks of
parental leave for the birth or adoption of a child as well as the
placement of a foster child, as well as fertility and adoption
support;
•Wellness
and time off programs including an employee assistance program,
access to wellness coaches and paid time off;
•Community
impact programs including volunteer time off and donation matching
programs;
•Education
and career development programs including tuition reimbursement,
high performance teamwork coaching, as well as ongoing learning and
training opportunities; and
•Other
benefits, such as “Pawternity Leave” for the adoption of a shelter
animal.
Outside of the United States, we provide similarly competitive
benefit packages to those offered to our United States employees
and tailored to market-specific practices.
Embody Our Ethics: Doing the Right Thing for All People, the Planet
and Our Furry Friends
All People
We proudly support human rights and individual expression and
freedom. As such, we treat all employees with respect, regardless
of age, gender, ethnicity, religion, abilities or sexual
orientation. We also expect our suppliers and partners to observe
these principles when providing products and services to
us.
The Planet
We are committed to minimizing our environmental impact while
providing our consumers with premium-quality beauty products. In
the year ended March 31, 2022, we celebrated a significant
milestone on our sustainability journey – eliminating approximately
one million pounds of packaging waste since the inception of
"Project Unicorn". Project Unicorn was launched in 2019 to elevate
e.l.f. Cosmetics’ product assortment, presentation, and navigation
on-shelf, and resulted in a significant streamlining in our product
packaging footprint. The elimination of packaging waste was
achieved by removing secondary cartons, vacuum formed trays and
paper insert cards, slimming down secondary packaging, and
designing a patented approach to display product on
shelf.
Our Furry Friends
We are proud to be a 100% cruelty-free company. We do not conduct
or tolerate any tests on animals, nor do we use any ingredients
that are tested on animals in any of our products. Each of our
brands is certified by People for the Ethical Treatment of Animals
(PETA) as “Global Animal Test-Free”, a credential given to
companies and brands who have verified that their own facilities
and their suppliers do not conduct, commission, pay for, or allow
any tests on animals for their ingredients, formulations, or
finished products.
Seasonality
Our results of operations are subject to seasonal fluctuations,
with net sales in the third and fourth fiscal quarters typically
being higher than in the first and second fiscal quarters. The
higher net sales in our third and fourth fiscal quarters are
largely attributable to the increased levels of purchasing by
retailers for the holiday season and customer shelf reset activity,
respectively. Lower holiday purchases or shifts in customer shelf
reset activity could have a disproportionate effect on our results
of operations for the entire fiscal year. To support anticipated
higher sales during the third and fourth fiscal quarters, we make
investments in working capital to ensure inventory levels can
support demand. Fluctuations throughout the year are also driven by
the timing of product restocking or rearrangement by our major
retail customers as well as expansion into new retail customers.
Because a limited number of our retail customers account for a
large percentage of our net sales, a change in the order pattern of
one or more of our large retail customers could cause a significant
fluctuation of our quarterly results or impact our
liquidity.
Trademarks and Other Intellectual Property
We believe that our intellectual property has substantial value and
has contributed significantly to the success of our business. Our
primary trademarks include “e.l.f.,” “e.l.f. eyes lips face,” “Well
People,” and “Keys Soulcare” all of which are registered or have
registrations pending with the U.S. Patent and Trademark Office for
our goods and services of primary interest. These trademarks are
also registered or have registrations pending in various foreign
countries in which we operate. We also have other trademark
registrations and pending trademark applications for product names
and tag lines. Our trademarks are valuable assets that reinforce
the distinctiveness of our brands and our consumers’ perception of
our products. In addition to trademark protection, we own U.S.
Design Patents covering packaging, make-up tools and brush handle
shapes and we own numerous domain names, including the domain names
of our e-commerce websites. We also rely on and use commercially
reasonable measures to protect our unpatented proprietary
technology, which includes our expertise and product formulations,
continuing innovation and other know-how to develop and maintain
our competitive position.
Government Regulation
We and our products are subject to various federal, state and
international laws and regulations, including regulation in the
United States by the FDA, the Consumer Product Safety Commission
(the “CPSC”), the Federal Trade Commission (the “FTC”), and
regulations outside of the United States by Health Canada and the
European Commission, among others. These laws and regulations
principally relate to the ingredients, proper labeling,
advertising, packaging, marketing, manufacture, safety, shipment
and disposal of our products. Further, as the vast majority of our
products are imported from overseas manufacturers, we are subject
to Customs Border Patrol clearance regulations prior to goods being
released into the United States market.
In the Unites States, the Federal Food, Drug and Cosmetic Act
(“FDCA”), defines cosmetics as articles or components of articles
intended for application to the human body to cleanse, beautify,
promote attractiveness, or alter the appearance, with the exception
of soap. The labeling of cosmetic products is subject to the
requirements of the FDCA, the Fair Packaging and Labeling Act, the
Poison Prevention Packaging Act and other FDA regulations.
Cosmetics are not subject to pre-market approval by the FDA;
however, certain ingredients, such as color additives, must be
pre-approved for the specific intended use of the product and are
subject to certain restrictions on their use. If a company has not
adequately substantiated the safety of its products or ingredients
by, for example, performing appropriate toxicological tests or
relying on already available toxicological test data, then a
specific warning label is required. The FDA may, by regulation,
require other warning statements on certain cosmetic products for
specified hazards associated with such products. FDA regulations
also prohibit or otherwise restrict the use of certain types of
ingredients in cosmetic products.
In addition, the FDA requires that cosmetic labeling and claims be
truthful and not misleading. Moreover, cosmetics may not be
marketed or labeled for their use in treating, preventing,
mitigating, or curing disease or other conditions or in affecting
the structure or function of the body, as such claims would render
the products to be a drug and subject to regulation as a drug. The
FDA has issued warning letters to cosmetic companies alleging
improper drug claims regarding their cosmetic products. In addition
to FDA requirements, the FTC as well as state consumer protection
laws and regulations can subject a cosmetics company to a range of
requirements and theories of liability, including similar standards
regarding false and misleading product claims, under which FTC or
state enforcement or class-action lawsuits may be
brought.
In the U.S., the FDA has not promulgated regulations establishing
Good Manufacturing Practices (“GMPs”) for cosmetics. However, FDA’s
draft guidance on cosmetic GMPs, most recently updated in June
2013, provides recommendations related to process documentation,
recordkeeping, building and facility design, equipment maintenance
and personnel, and compliance with these recommendations can reduce
the risk that FDA finds such products have been rendered
adulterated or misbranded in violation of applicable law. FDA also
recommends that manufacturers maintain product complaint and recall
files and voluntarily report adverse events to the agency. The FDA
monitors compliance of cosmetic products through market
surveillance and inspection of cosmetic manufacturers and
distributors to ensure that the products are not manufactured under
unsanitary conditions, or labeled in a false or misleading manner.
Inspections also may arise from consumer or competitor complaints
filed with the FDA. In the event the FDA identifies unsanitary
conditions, false or misleading labeling, or any other violation of
FDA regulation, FDA may request or a manufacturer may
independently
decide
to conduct a recall or market withdrawal of products.
In addition to our cosmetic products, we also market certain
non-prescription drug products, including certain products that are
intended to treat acne or be used as sunscreens, which are
regulated as over-the-counter (“OTC”) drug products by the FDA.
Certain OTC drug products are subject to regulation pursuant to the
FDA’s “monographs,” which provide rules applicable to each
therapeutic category of non-prescription drug, and establishes
conditions, such as active ingredients, uses (indications), doses,
labeling, and testing procedures, under which an OTC drug within
that particular category may be generally recognized as a safe and
effective (“GRASE”), and therefore can be marketed without
obtaining pre-market approval of an new drug application (“NDA”) or
abbreviated new drug application (“ANDA”). To be legally marketed,
among other things, OTC drug products marketed under an OTC
monograph must be manufactured in compliance with the FDA’s GMP
requirements for drug products, and the failure to maintain
compliance with these requirements could lead to FDA enforcement
action. Moreover, a failure to comply with the OTC monograph
requirements could lead the FDA to determine that the drug is not
GRASE, and thus is a “new drug” requiring approval in accordance
with the NDA or ANDA processes, or to make changes to its
manufacturing processes or product formulations or
labels.
Moreover, the FTC regulates and can bring enforcement action
against cosmetic companies for deceptive advertising and lack of
adequate scientific substantiation for claims. The FTC requires
that companies have a reasonable basis to support marketing claims.
What constitutes a reasonable basis can vary depending on the
strength or type of claim made, or the market in which the claim is
made, but objective evidence substantiating the claim is generally
required.
In the E.U., the sale of cosmetic products is regulated under the
E.U. Cosmetics Regulation (EC) No 1223/2009 setting out the general
regulatory framework for finished cosmetic products placed on the
E.U. market. The overarching requirement is that a cosmetic product
made available on the E.U. market must be safe for human health
when used under normal or reasonably foreseeable conditions of use,
taking account, in particular, of the following: (a) presentation
including conformity with Directive 87/357/EEC regarding health and
safety of consumers; (b) labelling; (c) instructions for use and
disposal; (d) any other indication or information provided by the
responsible person.
Generally, there is no requirement for pre-market approval of
cosmetic products in the E.U. However, centralized notification of
all cosmetic products placed on the E.U. market is required.
Manufacturers are required to notify their products via the E.U.
cosmetic products notification portal. Manufacturers are
responsible for safety of their marketed finished cosmetic
products, and must ensure that they undergo an appropriate
scientific safety assessment before cosmetic products are sold. A
special database with information on cosmetic substances and
ingredients, known as CosIng, enables easy access to data on
cosmetic ingredients, including legal requirements and
restrictions. We rely on expert consultants for our E.U. product
registrations and review of our labelling for compliance with E.U.
regulation.
The E.U. Cosmetics Regulation requires the manufacture of cosmetic
products to comply with GMPs, which is presumed where the
manufacture is in accordance with the relevant harmonized
standards. In addition, in the labelling, making available on the
market and advertising of cosmetic products, text, names,
trademarks, pictures and figurative or other signs must not be used
to imply that these products have characteristics or functions they
do not have; any product claims in labelling must be capable of
being substantiated.
We are also subject to a number of federal, state and international
laws and regulations that affect companies conducting business on
the Internet, including regulations related to consumer protection,
the promotion and sale of merchandise, privacy, use and protection
of consumer and employee personal information and data (including
the collection of data from minors), behavioral tracking, and
advertising and marketing activities (including sweepstakes,
contests and giveaways).
Expenditures for Environmental Compliance
We are subject to numerous foreign, federal, provincial, state,
municipal and local environmental, health and safety laws and
regulations relating to, among other matters, safe working
conditions, product stewardship and environmental protection,
including those relating to emissions to the air, discharges to
land and surface waters, generation, handling, storage,
transportation, treatment and disposal of hazardous substances and
waste materials, and the registration and evaluation of chemicals.
We maintain policies and procedures to monitor and control
environmental, health and safety risks, and to monitor compliance
with applicable environmental, health and safety requirements.
Compliance with such laws and regulations pertaining to the
discharge of materials into the environment, or otherwise relating
to the protection of the environment, has not had a material effect
upon our capital expenditures, earnings or competitive
position.
Segments
We operate our business as a single operating and reportable
segment. For more information regarding segment reporting, see
Note 2 Summary of significant accounting policies to our
consolidated financial statements in Part IV, Item 15. “Exhibits,
financial statement schedules” under the heading “Segment
reporting.”
Geographic Information
For information regarding the geographic source of our net sales
and the location of our long-lived assets, see Note 2 Summary of
significant accounting policies to our consolidated financial
statements in Part IV, Item 15. “Exhibits, financial statement
schedules” under the heading “Segment reporting.” For information
regarding the risks related to our non-U.S. operations, see Part I,
Item 1A “Risk factors.”
Corporate Information
e.l.f. Beauty was formed as a Delaware corporation on December 20,
2013 under the name J.A. Cosmetics Holdings, Inc. and we changed
our name to e.l.f. Beauty, Inc. in April 2016. We completed the
initial public offering of our common stock in September 2016. Our
common stock is currently listed on the New York Stock Exchange
(“NYSE”) under the symbol “ELF." Our principal executive offices
are located at 570 10th Street, Oakland, California 94607. Our
telephone number is (510) 778-7787 and our investor relations
website can be found at www.elfbeauty.com. e.l.f Beauty operates
through its principal
subsidiaries, e.l.f. Cosmetics, Inc., which conducts business under
the name "e.l.f. Cosmetics" or "e.l.f.", "Keys Soulcare", and Well
People, Inc., which conducts business under the name “Well
People”.
Available Information
We make available on or through our website certain reports and
amendments to those reports that we file with, or furnish to, the
SEC in accordance with the Securities Exchange Act of 1934, as
amended (the “Exchange Act”). These include our Annual Reports on
Form 10-K, our Quarterly Reports on Form 10-Q and our Current
Reports on Form 8-K, and amendments to those reports filed or
furnished pursuant to Section 13(a) or 15(d) of the Exchange Act.
We make this information available on or through our website free
of charge as soon as reasonably practicable after we electronically
file the information with, or furnish it to, the SEC. The
information on, or that can be accessed through, our website is not
incorporated by reference into this Annual Report or any other
filings we make with the SEC.
Item 1A. Risk factors.
Certain risks may have a material and/or adverse effect on our
business, financial condition and results of operations. These
risks include those described below and may include additional
risks and uncertainties not presently known to us or that we
currently deem immaterial. These risks should be read in
conjunction with the other information in this Annual Report,
including our consolidated financial statements and related notes
thereto and Part II, Item 7 “Management’s discussion and analysis
of financial condition and results of operations”.
Risks factors related to the beauty industry
The beauty industry is highly competitive, and if we are unable to
compete effectively our results will suffer.
We face vigorous competition from companies throughout the world,
including large multinational consumer products companies that have
many beauty brands under ownership and independent beauty brands,
including those that may target the latest trends or specific
distribution channels. Competition in the beauty industry is based
on the introduction of new products, pricing of products, quality
of products and packaging, brand awareness, perceived value and
quality, innovation, in-store presence and visibility, promotional
activities, advertising, editorials, e-commerce and mobile-commerce
initiatives and other activities. We must compete with a high
volume of new product introductions and existing products by
diverse companies across several different distribution
channels.
Many multinational consumer companies have greater financial,
technical or marketing resources, longer operating histories,
greater brand recognition or larger customer bases than we do and
may be able to respond more effectively to changing business and
economic conditions than we can. Many of these competitors’
products are sold in a wider selection or greater number of retail
stores and possess a larger presence in these stores, typically
having significantly more inline shelf space than we do. Given the
finite space allocated to beauty products by retail stores, our
ability to grow the number of retail stores in which our products
are sold and expand our space allocation once in these retail
stores may require the removal or reduction of the shelf space of
these competitors. We may be unsuccessful in our growth strategy in
the event retailers do not reallocate shelf space from our
competitors to us. Increasing shelf space allocated to our products
may be especially challenging in instances when a retailer has its
own brand. In addition, our competitors may attempt to gain market
share by offering products at prices at or below the prices at
which our products are typically offered, including through the use
of large percentage discounts and “buy one and get one free”
offers. Competitive pricing may require us to reduce our prices,
which would decrease our profitability or result in lost sales. Our
competitors, many of whom have greater resources than we do, may be
better able to withstand these price reductions and lost
sales.
It is difficult for us to predict the timing and scale of our
competitors’ activities in these areas or whether new competitors
will emerge in the beauty industry. In recent years, numerous
online, “indie”, celebrity and influencer-backed beauty companies
have emerged and garnered significant followings. In addition,
further technological breakthroughs, including new and enhanced
technologies which increase competition in the online retail
market, new product offerings by competitors and the strength and
success of our competitors’ marketing programs may impede our
growth and the implementation of our business
strategy.
Our ability to compete also depends on the continued strength of
our brands and products, the success of our marketing, innovation
and execution strategies, the continued diversity of our product
offerings, the successful management of new product introductions
and innovations, strong operational execution, including in order
fulfillment, and our success in entering new markets and expanding
our business in existing geographies. If we are unable to continue
to compete effectively, it could have a material adverse effect on
our business, financial condition and results of
operations.
Our new product introductions may not be as successful as we
anticipate.
The beauty industry is driven in part by fashion and beauty trends,
which may shift quickly. Our continued success depends on our
ability to anticipate, gauge and react in a timely and
cost-effective manner to changes in consumer preferences for beauty
products, consumer attitudes toward our industry and brands and
where and how consumers shop for those products. We must
continually work to develop, produce and market new products,
maintain and enhance the recognition of our brands, maintain a
favorable mix of products and develop our approach as to how and
where we market and sell our products.
We have a process for the development, evaluation and validation of
our new product concepts. Nonetheless, each new product launch
involves risks, as well as the possibility of unexpected
consequences. For example, the acceptance of new product launches
and sales to our retail customers may not be as high as we
anticipate, due to lack of acceptance of the products themselves or
their price, or limited effectiveness of our marketing strategies.
In addition, our ability to launch new products may be limited by
delays or difficulties affecting the ability of our suppliers or
manufacturers to timely manufacture, distribute and ship new
products or displays for new products. Sales of new products may be
affected by inventory management by our retail customers, and we
may experience product shortages or limitations in retail display
space by our retail customers. We may also experience a decrease in
sales of certain existing products as a result of newly-launched
products, the impact of which could be exacerbated by shelf space
limitations or any shelf space loss. Any of these occurrences could
delay or impede our ability to achieve our sales objectives, which
could have a material adverse effect on our business, financial
condition and results of operations.
As part of our ongoing business strategy, we expect we will need to
continue to introduce new products in the color cosmetics and
skincare categories, while also expanding our product launches into
adjacent categories in which we may have little to no operating
experience. The success of product launches in adjacent product
categories could be hampered by our relative inexperience operating
in such categories, the strength of our competitors or any of the
other risks referred to above. Furthermore, any expansion into new
product categories may prove to be an operational and financial
constraint which inhibits our ability to successfully accomplish
such expansion. Our inability to introduce successful products in
our traditional categories or in adjacent categories could limit
our future growth and have a material adverse effect on our
business, financial condition and results of
operations.
Any damage to our reputation or brands may materially and adversely
affect our business, financial condition and results of
operations.
We believe that developing and maintaining our brands is critical
and that our financial success is directly dependent on consumer
perception of our brands. Furthermore, the importance of brand
recognition may become even greater as competitors offer more
products similar to ours.
We have relatively low brand awareness among consumers when
compared to other beauty brands and maintaining and enhancing the
recognition and reputation of our brands is critical to our
business and future growth. Many factors, some of which are beyond
our control, are important to maintaining our reputation and
brands. These factors include our ability to comply with ethical,
social, product, labor and environmental standards. Any actual or
perceived failure in compliance with such standards could damage
our reputation and brands.
The growth of our brands depends largely on our ability to provide
a high-quality consumer experience, which in turn depends on our
ability to bring innovative products to the market at competitive
prices that respond to consumer demands and preferences. Additional
factors affecting our consumer experience include our ability to
provide appealing store sets in retail stores, the maintenance and
stocking of those sets by our retail customers, the overall
shopping experience provided by our retail customers, a reliable
and user-friendly website interface and mobile applications for our
consumers to browse and purchase products on our e-commerce
websites and mobile applications. If we are unable to preserve our
reputation, enhance our brand recognition or increase positive
awareness of our products and in-store and Internet platforms, it
may be difficult for us to maintain and grow our consumer base, and
our business, financial condition and results of operations may be
materially and adversely affected.
The success of our brands may also suffer if our marketing plans or
product initiatives do not have the desired impact on our brands'
image or our ability to attract consumers. Further, our brand value
could diminish significantly due to a number of factors, including
consumer perception that we have acted in an irresponsible manner,
adverse publicity about our products, our failure to maintain the
quality of our products, product contamination, the failure of our
products to deliver consistently positive consumer experiences, or
the products becoming unavailable to consumers.
Our success depends, in part, on the quality, performance and
safety of our products.
Any loss of confidence on the part of consumers in the ingredients
used in our products, whether related to product contamination or
product safety or quality failures, actual or perceived, or
inclusion of prohibited ingredients, could tarnish the image of our
brands and could cause consumers to choose other products.
Allegations of contamination or other adverse effects on product
safety or suitability for use by a particular consumer, even if
untrue, may require us to expend significant time and resources
responding to such allegations and could, from time to time, result
in a recall of a product from any or all of the markets in which
the affected product was distributed. Any such issues or recalls
could negatively affect our profitability and image of our
brands.
If our products are found to be, or perceived to be, defective or
unsafe, or if they otherwise fail to meet our consumers’
expectations, our relationships with consumers could suffer, the
appeal of our brands could be diminished, we may need to recall
some of our products and/or become subject to regulatory action,
and we could lose sales or market share or become subject to
boycotts or liability claims. In addition, safety or other defects
in our competitors’ products could reduce consumer demand for our
own products if consumers view them to be similar. Any of these
outcomes could result in a material adverse effect on our business,
financial condition and results of operations.
Risks factors related to our growth and profitability
We may not be able to successfully implement our growth
strategy.
Our future growth, profitability and cash flows depend upon our
ability to successfully implement our business strategy, which, in
turn, is dependent upon a number of key initiatives, including our
ability to:
•drive
demand in our brands;
•invest
in digital capabilities;
•improve
productivity and drive space expansion with our
retailers;
•focus
on innovation by providing prestige quality products at an
extraordinary value;
•implement
the necessary cost savings to help fund our marketing and digital
investments; and
•pursue
strategic extensions that can leverage our strengths and bring new
capabilities.
There can be no assurance that we can successfully achieve any or
all of the above initiatives in the manner or time period that we
expect. Further, achieving these objectives will require
investments which may result in short-term cost increases with net
sales materializing on a longer-term horizon and therefore may be
dilutive to our earnings. We cannot provide any assurance that we
will realize, in full or in part, the anticipated benefits we
expect our strategy will achieve. The failure to realize those
benefits could have a material adverse effect on our business,
financial condition and results of operations.
Our growth and profitability are dependent on a number of factors,
and our historical growth may not be indicative of our future
growth.
Our historical growth should not be considered as indicative of our
future performance. We may not be successful in executing our
growth strategy, and even if we achieve our strategic plan, we may
not be able to sustain profitability. In future periods, our
revenue could decline, or grow more slowly than we expect. We also
may incur significant losses in the future for a number of reasons,
including the following risks and the other risks described in this
report, and we may encounter unforeseen expenses, difficulties,
complications, delays and other unknown factors:
•we
may lose one or more significant retail customers, or sales of our
products through these retail customers may decrease;
•the
ability of our third-party suppliers and manufacturers to produce
our products and of our distributors to distribute our products
could be disrupted;
•because
substantially all of our products are sourced and manufactured in
China, our operations are susceptible to risks inherent in doing
business there;
•our
products may be the subject of regulatory actions, including but
not limited to actions by the FDA, the FTC and the CPSC in the
United States;
•we
may be unable to introduce new products that appeal to consumers or
otherwise successfully compete with our competitors in the beauty
industry;
•we
may be unsuccessful in enhancing the recognition and reputation of
our brands, and our brands may be damaged as a result of, among
other reasons, our failure, or alleged failure, to comply with
applicable ethical, social, product, labor or environmental
standards;
•we
may experience service interruptions, data corruption, cyber-based
attacks or network security breaches which result in the disruption
of our operating systems or the loss of confidential information of
our consumers;
•we
may be unable to retain key members of our senior management team
or attract and retain other qualified personnel; and
•we
may be affected by any adverse economic conditions in the United
States or internationally.
We may be unable to grow our business effectively or efficiently,
which would harm our business, financial condition and results of
operations.
Growing our business will place a strain on our management team,
financial and information systems, supply chain and distribution
capacity and other resources. To manage growth effectively, we must
continue to enhance our operational, financial and management
systems, including our warehouse management and inventory control;
maintain and improve our internal controls and disclosure controls
and procedures; maintain and improve our information technology
systems and procedures; and expand, train and manage our employee
base.
We may not be able to effectively manage this expansion in any one
or more of these areas, and any failure to do so could
significantly harm our business, financial condition and results of
operations. Growing our business may make it difficult for us to
adequately predict the expenditures we will need to make in the
future. If we do not make the necessary overhead expenditures to
accommodate our future growth, we may not be successful in
executing our growth strategy, and our results of operations would
suffer.
Acquisitions or investments could disrupt our business and harm our
financial condition.
We frequently review acquisition and strategic investment
opportunities that would expand our current product offerings, our
distribution channels, increase the size and geographic scope of
our operations or otherwise offer growth and operating efficiency
opportunities. There can be no assurance that we will be able to
identify suitable candidates or consummate these transactions on
favorable terms. The process of integrating an acquired business,
product or technology can create unforeseen operating difficulties,
expenditures and other challenges such as:
•potentially
increased regulatory and compliance requirements;
•implementation
or remediation of controls, procedures and policies at the acquired
business;
•diversion
of management time and focus from operation of our then-existing
business to acquisition integration challenges;
•coordination
of product, sales, marketing and program and systems management
functions;
•transition
of the users and customers of the acquired business, product, or
technology onto our system;
•retention
of employees from the acquired business;
•integration
of employees from the acquired business into our
organization;
•integration
of the acquired business’ accounting, information management, human
resources and other administrative systems and operations into our
systems and operations;
•liability
for activities of the acquired business, product or technology
prior to the acquisition, including violations of law, commercial
disputes and tax and other known and unknown liabilities;
and
•litigation
or other claims in connection with the acquired business, product
or technology, including claims brought by terminated employees,
customers, former stockholders or other third parties.
If we are unable to address these difficulties and challenges or
other problems encountered in connection with any acquisition or
investment, we might not realize the anticipated benefits of that
acquisition or investment, and we might incur unanticipated
liabilities or otherwise suffer harm to our business
generally.
To the extent that we pay the consideration for any acquisitions or
investments in cash, it would reduce the amount of cash available
to us for other purposes. Acquisitions or investments could also
result in dilutive issuances of our equity securities or the
incurrence of debt, contingent liabilities, amortization expenses,
increased interest expenses or impairment charges against goodwill
on our consolidated balance sheet, any of which could have a
material adverse effect on our business, financial condition and
results of operations.
Risk factors related to our business operations
A disruption in our operations, including a disruption in the
supply chains for our products, could materially and adversely
affect our business.
As a company engaged in distribution on a global scale, our
operations, including those of our third-party manufacturers,
suppliers, brokers and delivery service providers, are subject to
the risks inherent in such activities, including industrial
accidents, environmental events, strikes and other labor disputes,
disruptions or delays in shipments, disruptions in information
systems, product quality control, safety, licensing requirements
and other regulatory issues, as well as natural disasters,
pandemics (such as the coronavirus pandemic), border disputes,
international conflict, acts of terrorism and other external
factors over which we and our third-party manufacturers, suppliers,
brokers and delivery service providers have no control. The loss
of, or damage to, the manufacturing facilities or distribution
centers of our third-party manufacturers, suppliers, brokers and
delivery service providers could materially and adversely affect
our business, financial condition and results of
operations.
We depend heavily on ocean container delivery to receive shipments
of our products from our third-party manufacturers located in China
and contracted third-party delivery service providers to deliver
our products to our distribution facilities and logistics
providers, and from there to our retail customers. Further, we rely
on postal and parcel carriers for the delivery of products sold
directly to consumers through our e-commerce websites and mobile
applications. Interruptions,
to or failures in, these delivery services could prevent the timely
or successful delivery of our products. These interruptions or
failures may be due to unforeseen events that are beyond our
control or the control of our third-party delivery service
providers, such as port congestion, container shortages, inclement
weather, natural disasters, international conflict, labor unrest or
other transportation disruptions. In addition, port congestion,
container shortages, inclement weather, natural disasters,
international conflict, labor unrest or other transportation
disruptions may increase the costs to supply or transport our
products or the components of our products. If our products are not
delivered on time or are delivered in a damaged state, retail
customers and consumers may refuse to accept our products and have
less confidence in our services. In addition, a vessel and
container shortage globally could delay future inventory receipts
and, in turn, could delay deliveries to our retailer customers and
availability of products in our direct-to-consumer e-commerce
channel. Such potential delays, additional transportation expenses
and shipping disruptions could negatively impact our results of
operations through higher inventory costs and reduced sales.
Furthermore, the delivery personnel of contracted third-party
delivery service providers act on our behalf and interact with our
consumers personally. Any failure to provide high-quality delivery
services to our consumers may negatively affect the shopping
experience of our consumers, damage our reputation and cause us to
lose consumers.
Our ability to meet the needs of our consumers and retail customers
depends on the proper operation of our distribution facilities,
where most of our inventory that is not in transit is housed.
Although we currently insure our inventory, our insurance coverage
may not be sufficient to cover the full extent of any loss or
damage to our inventory or distribution facilities, and any loss,
damage or disruption of the facilities, or loss or damage of the
inventory stored there, could materially and adversely affect our
business, financial condition and results of
operations.
Our success depends, in part, on our retention of key members of
our senior management team and ability to attract and retain
qualified personnel.
Our success depends, in part, on our ability to attract and retain
key employees, including our executive officers, senior management
team and operations, finance, sales and marketing personnel. The
labor market in the United States and China, where most of our
employees are located, is hyper competitive and attracting and
retaining top talent requires significant organizational costs and
attention.
We are a small company that relies on a few key employees, any one
of whom would be difficult to replace, and because we are a small
company, we believe that the loss of key employees may be more
disruptive to us than it would be to a larger company. Our success
also depends, in part, on our continuing ability to identify, hire,
train and retain other highly qualified personnel. In addition, we
may be unable to effectively plan for the succession of senior
management, including our Chief Executive Officer. The loss of key
personnel or the failure to attract and retain qualified personnel
may have a material adverse effect on our business, financial
condition and results of operations.
We rely on a number of third-party suppliers, manufacturers,
distributors and other vendors, and they may not continue to
produce products or provide services that are consistent with our
standards or applicable regulatory requirements, which could harm
our brands, cause consumer dissatisfaction, and require us to find
alternative suppliers of our products or services.
We use multiple third-party suppliers and manufacturers, primarily
based in China, to source and manufacture substantially all of our
products. We engage our third-party suppliers and manufacturers on
a purchase order basis and are not party to long-term contracts
with any of them. The ability of these third parties to supply and
manufacture our products may be affected by competing orders placed
by other persons and the demands of those persons. Further, we are
subject to risks associated with disruptions or delays in shipments
whether due to port congestion, container shortages, labor
disputes, product regulations and/or inspections or other factors,
natural disasters or health pandemics, or other transportation
disruptions. If we experience significant increases in demand or
need to replace a significant number of existing suppliers or
manufacturers, there can be no assurance that additional supply and
manufacturing capacity will be available when required on terms
that are acceptable to us, or at all, or that any supplier or
manufacturer will allocate sufficient capacity to us in order to
meet our requirements.
In addition, quality control problems, such as the use of
ingredients and delivery of products that do not meet our quality
control standards and specifications or comply with applicable laws
or regulations could harm our business. These quality control
problems could result in regulatory action, such as restrictions on
importation, products of inferior quality or product stock outages
or shortages, harming our sales and creating inventory write-downs
for unusable products.
We have also outsourced significant portions of our distribution
process, as well as certain technology-related functions, to
third-party service providers. Specifically, we rely on third-party
distributors to sell our products in a number of foreign countries,
our warehouses and distribution facilities are managed and staffed
by third-party service providers, we are dependent on a single
third-party vendor for credit card processing and we utilize a
third-party hosting and networking provider to host our e-commerce
websites and mobile applications. The failure of one or more of
these entities to provide the expected services on a timely basis,
or at all, or at the prices we expect, or the costs and disruption
incurred in changing these outsourced functions to being performed
under our management and direct control or that of a third-party,
may have a material adverse effect on our business, financial
condition and results of operations. We are not party to long-term
contracts with some of our distributors, and upon expiration of
these existing agreements, we may not be able to renegotiate the
terms on a commercially reasonable basis, or at all.
Further, our third-party manufacturers, suppliers and distributors
may:
•have
economic or business interests or goals that are inconsistent with
ours;
•take
actions contrary to our instructions, requests, policies or
objectives;
•be
unable or unwilling to fulfill their obligations under relevant
purchase orders, including obligations to meet our production
deadlines, quality standards, pricing guidelines and product
specifications, or to comply with applicable regulations, including
those regarding the safety and quality of products and ingredients
and good manufacturing practices;
•have
financial difficulties;
•encounter
raw material or labor shortages;
•encounter
increases in raw material or labor costs which may affect our
procurement costs;
•disclose
our confidential information or intellectual property to
competitors or third parties;
•engage
in activities or employment practices that may harm our reputation;
and
•work
with, be acquired by, or come under control of, our
competitors.
The occurrence of any of these events, alone or together, could
have a material adverse effect on our business, financial condition
and results of operations. In addition, such problems may require
us to find new third-party suppliers, manufacturers or
distributors, and there can be no assurance that we would be
successful in finding third-party suppliers, manufacturers or
distributors meeting our standards of innovation and
quality.
The management and oversight of the engagement and activities of
our third-party suppliers, manufacturers and distributors requires
substantial time, effort and expense of our employees, and we may
be unable to successfully manage and oversee the activities of our
third-party manufacturers, suppliers and distributors. If we
experience any supply chain disruptions caused by our manufacturing
process or by our inability to locate suitable third-party
manufacturers or suppliers, or if our manufacturers or raw material
suppliers experience problems with product quality or disruptions
or delays in the manufacturing process or delivery of the finished
products or the raw materials or components used to make such
products, our business, financial condition and results of
operations could be materially and adversely affected.
If we fail to manage our inventory effectively, our results of
operations, financial condition and liquidity may be materially and
adversely affected.
Our business requires us to manage a large volume of inventory
effectively. We depend on our forecasts of demand for, and
popularity of, various products to make purchase decisions and to
manage our inventory of stock-keeping units. Demand for products,
however, can change significantly between the time inventory or
components are ordered and the date of sale. Demand may be affected
by seasonality, new product launches, rapid changes in product
cycles and pricing, product defects, promotions, changes in
consumer spending patterns, changes in consumer tastes with respect
to our products and other factors, and our consumers may not
purchase products in the quantities that we expect. It may be
difficult to accurately forecast demand and determine appropriate
levels of product or components. We generally do not have the right
to return unsold products to our suppliers. If we fail to manage
our inventory effectively or negotiate favorable credit terms with
third-party suppliers, we may be subject to a heightened risk of
inventory obsolescence, a decline in inventory values, and
significant inventory write-downs or write-offs. In addition, if we
are required to lower sale prices in order to reduce inventory
level or to pay higher prices to our suppliers, our profit margins
might be negatively affected. Any of the above may materially and
adversely affect our business, financial condition and results of
operations. See also “—Our quarterly results of operations
fluctuate due to seasonality, order patterns from key retail
customers and other factors, and we may not have sufficient
liquidity to meet our seasonal working capital
requirements.”
The outbreak of the COVID-19 global pandemic and related
government, private sector and individual consumer responsive
actions have adversely affected, and will continue to adversely
affect, our business, financial condition and results of
operations.
The outbreak of the COVID-19 pandemic has been declared a pandemic
by the World Health Organization and continues to impact to the
United States and other countries. Related government and private
sector responsive actions, as well as changes in consumer shopping
behaviors, have adversely affected, and will continue to adversely
affect our business, financial condition and results of
operations.
In response to the spread of the COVID-19 pandemic, international,
federal, state and local governments have taken actions to, and
recommended precautions to, mitigate the spread of the COVID-19
pandemic, including enforcing quarantines and warning against
congregating in heavily populated areas, such as malls, shopping
centers, and other retailers and adopting shelter-in-place
regulations. In April 2022, for example, government officials in
Shanghai implemented a strict quarantine requirement that currently
remains in place and impacts our employees there, requiring them to
work exclusively at-home, as well as some of our suppliers. There
is significant uncertainty around the breadth and duration of
business disruptions related to the COVID-19 pandemic, as well as
its impact on the United States and global economy and our
consumers’ shopping habits. Decreased activity at our retailers
could result in a decrease in sales of our products, which in turn
could adversely affect our business, financial condition and
results of operations.
While our suppliers and distribution centers currently remain open,
there is risk that any of these facilities may become less
productive or encounter disruptions due to employees at the
facilities becoming infected with the COVID-19 pandemic and/or may
no longer be allowed to operate based on directives from public
health officials or government authorities in the United States,
China or other jurisdictions.
As a result of the COVID-19 pandemic, over 60% of our personnel
based in the United States are working under our hybrid model of
three days in the office and two days remote. It is possible with
nearly 40% of our personnel working remotely full time and the
remainder of our personnel working remotely two days a week that
the execution of our business plans and operations could be
negatively impacted. If a natural disaster, power outage,
connectivity issue, or other event occurs that impacts our
employees’ ability to work remotely, it may be difficult or, in
certain cases, impossible, for us to continue our business for a
substantial period of time. The increase in remote working may also
result in consumer privacy, IT security and fraud concerns as well
as increase our exposure to potential wage and hour
issues.
COVID-19 vaccines are now broadly distributed and administered, and
starting October 1, 2021 we required all U.S. employees to be fully
vaccinated and have the same requirement for any vendor and
contractors who engage in meetings or business activities in any of
our offices. Our vaccine mandate may cause us to have difficulty
retaining current employees and recruiting new employees, both of
which could adversely affect our business, financial condition and
results of operations. As the COVID-19 pandemic evolves, we
continue to evaluate and refine our work from home policy. Any
changes to our remote work policy could also cause us to have
difficulty retaining current employees and recruiting new
employees, both of which could adversely affect our business,
financial condition and results of operations.
The uncertainty around the duration of business disruptions and the
extent of the spread of the COVID-19 pandemic in the United States
and to other areas of the world will likely continue to adversely
impact the national or global economy and negatively impact
consumer spending and shopping behaviors. Any of these outcomes
could have an adverse impact on our business, financial condition
and results of operations.
The extent to which the COVID-19 pandemic impacts our results will
depend on future developments, which are highly uncertain and
cannot be predicted, including new information that may emerge
concerning the variants of SARS-CoV-2 and the actions taken to
contain it or treat its impact, including vaccination effectiveness
and rates.
Risk factors related to our financial condition
Our substantial indebtedness may have a material adverse effect on
our business, financial condition and results of
operations.
As of March 31, 2022, we had a total of $97.7 million of
indebtedness, consisting of amounts outstanding under our credit
facilities and finance lease obligations, and a total availability
of $100.0 million under our Amended Revolving Credit Facility (as
defined in Part II, Item 7 “Management’s discussion and analysis of
financial condition and results of operations” under the heading
“Description of indebtedness”). Our indebtedness could have
significant consequences, including:
•requiring
a substantial portion of our cash flows to be dedicated to debt
service payments instead of funding growth, working capital,
capital expenditures, investments or other cash
requirements;
•reducing
our flexibility to adjust to changing business conditions or obtain
additional financing;
•exposing
us to the risk of increased interest rates as our borrowings are at
variable rates;
•making
it more difficult for us to make payments on our
indebtedness;
•subjecting
us to restrictive covenants that may limit our flexibility in
operating our business, including our ability to take certain
actions with respect to indebtedness, liens, sales of assets,
consolidations and mergers, affiliate transactions, dividends and
other distributions and changes of control;
•subjecting
us to maintenance covenants which require us to maintain specific
financial ratios; and
•limiting
our ability to obtain additional financing for working capital,
capital expenditures, debt service requirements and general
corporate or other purposes.
If our cash from operations is not sufficient to meet our current
or future operating needs, expenditures and debt service
obligations, our business, financial condition and results of
operations may be materially and adversely affected.
We may require additional cash resources due to changed business
conditions or other future developments, including any marketing
initiatives, investments or acquisitions we may decide to pursue.
To the extent we are unable to generate sufficient cash flow, we
may be forced to cancel, reduce or delay these activities.
Alternatively, if our sources of funding are insufficient to
satisfy our cash requirements, we may seek to obtain an additional
credit facility or sell equity or debt securities. The sale of
equity securities would result in dilution of our existing
stockholders. The incurrence of additional indebtedness would
result in increased debt service obligations and operating and
financing covenants that could restrict our
operations.
Our ability to generate cash to meet our operating needs,
expenditures and debt service obligations will depend on our future
performance and financial condition, which will be affected by
financial, business, economic, legislative, regulatory and other
factors, including potential changes in costs, pricing, the success
of product innovation and marketing, competitive pressure and
consumer preferences. If our cash flows and capital resources are
insufficient to fund our debt service obligations and other cash
needs, we could face substantial liquidity problems and could be
forced to reduce or delay investments and capital expenditures or
to dispose of material assets or operations, seek additional debt
or equity capital or restructure or refinance our indebtedness. Our
credit facilities may restrict our ability to take these actions,
and we may not be able to affect any such alternative measures on
commercially reasonable terms, or at all. If we cannot make
scheduled payments on our debt, the lenders under the Amended
Credit Agreement (as defined in Part II, Item 7 “Management’s
discussion and analysis of financial condition and results of
operations” under the heading “Description of indebtedness”) can
terminate their commitments to loan money under the Amended
Revolving Credit Facility, and our lenders under the Amended Credit
Agreement can declare all outstanding principal and interest to be
due and payable and foreclose against the assets securing their
borrowings, and we could be forced into bankruptcy or
liquidation.
Furthermore, it is uncertain whether financing will be available in
amounts or on terms acceptable to us, if at all, which could
materially and adversely affect our business, financial condition
and results of operations.
Changes in tax law, in our tax rates or in exposure to additional
income tax liabilities or assessments could materially and
adversely affect our business, financial condition and results of
operations.
Changes in law and policy relating to taxes, including changes in
administrative interpretations and legal precedence, could
materially and adversely affect our business, financial condition
and results of operations. In addition, as we continue to expand
our business internationally, the application and implementation of
existing, new or future international laws, including the
introduction of non-traditional indirect taxes (such as the Plastic
Packaging Tax enacted by the United Kingdom), could materially and
adversely affect our business, financial condition and results of
operations.
Fluctuations in currency exchange rates may negatively affect our
financial condition and results of operations.
Exchange rate fluctuations may affect the costs that we incur in
our operations. The main currencies to which we are exposed are
Euro, British pound, Chinese Renminbi (RMB) and Canadian dollar.
The exchange rates between these currencies and the U.S. dollar in
recent years have fluctuated significantly and may continue to do
so in the future. A depreciation of these currencies against the
U.S. dollar will decrease the U.S. dollar equivalent of the amounts
derived from foreign operations reported in our consolidated
financial statements, and an appreciation of these currencies will
result in a corresponding increase in such amounts. The cost of
certain items, such as raw materials, manufacturing, employee
salaries and transportation and freight, required by our operations
may be affected by changes in the value of the relevant currencies.
To the extent that we are required to pay for goods or services in
foreign currencies, the appreciation of such currencies against the
U.S. dollar will tend to negatively affect our business. There can
be no assurance that foreign currency fluctuations will not have a
material adverse effect on our business, financial condition and
results of operations.
Risk factors related to our retail customers, consumers and the
seasonality of our business
We depend on a limited number of retailers for a large portion of
our net sales, and the loss of one or more of these retailers, or
business challenges at one or more of these retailers, could
adversely affect our results of operations.
A limited number of our retail customers account for a large
percentage of our net sales. We expect a small number of retailers
will, in the aggregate, continue to account for the majority of our
net sales for foreseeable future periods. Any changes in the
policies or our ability to meet the demands of our retail customers
relating to service levels, inventory de-stocking, pricing and
promotional strategies or limitations on access to display space
could have a material adverse effect on our business, financial
condition and results of operations.
As is typical in our industry, our business with retailers is based
primarily upon discrete sales orders, and we do not have contracts
requiring retailers to make firm purchases from us. Accordingly,
retailers could reduce their purchasing levels or cease buying
products from us at any time and for any reason. If we lose a
significant retail customer or if sales of our products to a
significant retailer materially decrease, it could have a material
adverse effect on our business, financial condition and results of
operations.
Because a high percentage of our sales are made through our retail
customers, our results are subject to risks relating to the general
business performance of our key retail customers. Factors that
adversely affect our retail customers’ businesses may also have a
material adverse effect on our business, financial condition and
results of operations. These factors may include:
•any
reduction in consumer traffic and demand at our retail customers as
a result of economic downturns, pandemics or other health crises,
changes in consumer preferences or reputational damage as a result
of, among other developments, data privacy breaches, regulatory
investigations or employee misconduct;
•any
credit risks associated with the financial condition of our retail
customers;
•the
effect of consolidation or weakness in the retail industry or at
certain retail customers, including store closures and the
resulting uncertainty; and
•inventory
reduction initiatives and other factors affecting retail customer
buying patterns, including any reduction in retail space committed
to beauty products and retailer practices used to control inventory
shrinkage.
Our quarterly results of operations fluctuate due to seasonality,
order patterns from key retail customers and other factors, and we
may not have sufficient liquidity to meet our seasonal working
capital requirements.
Our results of operations are subject to seasonal fluctuations,
with net sales in the third and fourth fiscal quarters typically
being higher than in the first and second fiscal quarters. The
higher net sales in our third and fourth fiscal quarters are
largely attributable to the increased levels of purchasing by
retailers for the holiday season and customer shelf reset activity,
respectively. Adverse events that occur during either the third or
fourth fiscal quarter could have a disproportionate effect on our
results of operations for the entire fiscal year. To support
anticipated higher sales during the third and fourth fiscal
quarters, we make investments in working capital to ensure
inventory levels can support demand. Fluctuations throughout the
year are also driven by the timing of product restocking or
rearrangement by our major customers as well as our expansion into
new customers. Because a limited number of our retail customers
account for a large percentage of our net sales, a change in the
order pattern of one or more of our large retail customers could
cause a significant fluctuation of our quarterly results or reduce
our liquidity.
Furthermore, product orders from our large retail customers may
vary over time due to changes in their inventory or out-of-stock
policies. If we were to experience a significant shortfall in sales
or profitability, we may not have sufficient liquidity to fund our
business. As a result of quarterly fluctuations caused by these and
other factors, comparisons of our operating results across
different fiscal quarters may not be accurate indicators of our
future performance. Any quarterly fluctuations that we report in
the future may differ from the expectations of market analysts and
investors, which could cause the price of our common stock to
fluctuate significantly.
Risk factors related to information technology and
cybersecurity
We are increasingly dependent on information technology, and if we
are unable to protect against service interruptions, data
corruption, cyber-based attacks or network security breaches, our
operations could be disrupted.
We rely on information technology networks and systems to market
and sell our products, to process electronic and financial
information, to manage a variety of business processes and
activities and to comply with regulatory, legal and tax
requirements. We are increasingly dependent on a variety of
information systems to effectively process retail customer orders
and fulfill consumer orders from our e-commerce business. We depend
on our information technology infrastructure for digital marketing
activities and for electronic communications among our personnel,
retail customers, consumers, manufacturers and suppliers around the
world. These information technology systems, some of which are
managed by third parties, may be susceptible to damage, disruptions
or shutdowns due to failures during the process of upgrading or
replacing software, databases or components, power outages,
hardware failures, computer viruses, attacks by computer hackers,
telecommunication failures, user errors or catastrophic events. Any
material disruption of our systems, or the systems of
our
third-party service providers, could disrupt our ability to track,
record and analyze the products that we sell and could negatively
impact our operations, shipment of goods, ability to process
financial information and transactions and our ability to receive
and process retail customer and e-commerce orders or engage in
normal business activities. If our information technology systems
suffer damage, disruption or shutdown, we may incur substantial
cost in repairing or replacing these systems, and if we do not
effectively resolve the issues in a timely manner, our business,
financial condition and results of operations may be materially and
adversely affected, and we could experience delays in reporting our
financial results.
Our e-commerce operations are important to our business. Our
e-commerce websites and mobile applications serve as an extension
of our marketing strategies by introducing potential new consumers
to our brand, product offerings and enhanced content. Due to the
importance of our e-commerce operations, we are vulnerable to
website downtime and other technical failures. Our failure to
successfully respond to these risks in a timely manner could reduce
e-commerce sales and damage our brands' reputation.
We must successfully maintain and upgrade our information
technology systems, and our failure to do so could have a material
adverse effect on our business, financial condition and results of
operations.
We have identified the need to significantly expand and improve our
information technology systems and personnel to support expected
future growth. As such, we are in process of implementing, and will
continue to invest in and implement, significant modifications and
upgrades to our information technology systems and procedures,
including replacing legacy systems with successor systems, making
changes to legacy systems or acquiring new systems with new
functionality, hiring employees with information technology
expertise and building new policies, procedures, training programs
and monitoring tools. These types of activities subject us to
inherent costs and risks associated with replacing and changing
these systems, including impairment of our ability to leverage our
e-commerce channels, fulfill customer orders, potential disruption
of our internal control structure, substantial capital
expenditures, additional administration and operating expenses,
acquisition and retention of sufficiently skilled personnel to
implement and operate the new systems, demands on management time
and other risks and costs of delays or difficulties in
transitioning to or integrating new systems into our current
systems. These implementations, modifications and upgrades may not
result in productivity improvements at a level that outweighs the
costs of implementation, or at all. In addition, difficulties with
implementing new technology systems, delays in our timeline for
planned improvements, significant system failures, or our inability
to successfully modify our information systems to respond to
changes in our business needs may cause disruptions in our business
operations and have a material adverse effect on our business,
financial condition and results of operations.
If we fail to adopt new technologies or adapt our e-commerce
websites and systems to changing consumer requirements or emerging
industry standards, our business may be materially and adversely
affected.
To remain competitive, we must continue to enhance and improve the
responsiveness, functionality and features of our information
technology, including our e-commerce websites and mobile
applications. Our competitors are continually innovating and
introducing new products to increase their consumer base and
enhance user experience. As a result, in order to attract and
retain consumers and compete against our competitors, we must
continue to invest resources to enhance our information technology
and improve our existing products and services for our consumers.
The Internet and the online retail industry are characterized by
rapid technological evolution, changes in consumer requirements and
preferences, frequent introductions of new products and services
embodying new technologies and the emergence of new industry
standards and practices, any of which could render our existing
technologies and systems obsolete. Our success will depend, in
part, on our ability to identify, develop, acquire or license
leading technologies useful in our business, and respond to
technological advances and emerging industry standards and
practices in a cost-effective and timely way. The development of
our e-commerce websites, mobile applications and other proprietary
technology entails significant technical and business risks. There
can be no assurance that we will be able to properly implement or
use new technologies effectively or adapt our e-commerce websites,
mobile applications and systems to meet consumer requirements or
emerging industry standards. If we are unable to adapt in a
cost-effective and timely manner in response to changing market
conditions or consumer requirements, whether for technical, legal,
financial or other reasons, our business, financial condition and
results of operations may be materially and adversely
affected.
Failure to protect sensitive information of our consumers and
information technology systems against security breaches could
damage our reputation and brand and substantially harm our
business, financial condition and results of
operations.
We collect, maintain, transmit and store data about our consumers,
suppliers and others, including personal data, financial
information, including consumer payment information, as well as
other confidential and proprietary information important to our
business. We also employ third-party service providers that
collect, store, process and transmit personal data, and
confidential, proprietary and financial information on our
behalf.
We have in place technical and organizational measures to maintain
the security and safety of critical proprietary, personal,
employee, customer and financial data which we continue to maintain
and upgrade to industry standards. However, advances in technology,
the pernicious ingenuity of criminals, new exposures via
cryptography, acts or omissions by our employees, contractors or
service providers or other events or developments could result in a
compromise or breach in the security of confidential or personal
data. We and our service providers may not be able to prevent third
parties, including criminals, competitors or others, from breaking
into or altering our systems, disrupting business operations or
communications infrastructure through denial-of-service attacks,
attempting to gain access to our systems, information or monetary
funds through phishing or social engineering campaigns, installing
viruses or malicious software on our e-commerce websites or mobile
applications or devices used by our employees or contractors, or
carrying out other activity intended to disrupt our systems or gain
access to confidential or sensitive information in our or our
service providers’ systems. We are not aware of any breach or
compromise of the personal data of consumers, but we have been
subject to attacks (e.g. phishing, denial of service) in the past
and cannot guarantee that our security measures will be sufficient
to prevent a material breach or compromise in the
future.
Furthermore, such third parties may engage in various other illegal
activities using such information, including credit card fraud or
identity theft, which may cause additional harm to us, our
consumers and our brands. We also may be vulnerable to error or
malfeasance by our own employees or other insiders. Third parties
may attempt to fraudulently induce our or our service providers’
employees to misdirect funds or to disclose information in order to
gain access to personal data we maintain about our consumers or
website users. In addition, we have limited control or influence
over the security policies or measures adopted by third-party
providers of online payment services through which some of our
consumers may elect to make payment for purchases at our e-commerce
websites and mobile applications. Contracted third-party delivery
service providers may also violate their confidentiality or data
processing obligations and disclose or use information about our
consumers inadvertently or illegally.
If a material security breach were to occur, our reputation and
brands could be damaged, and we could be required to expend
significant capital and other resources to alleviate problems
caused by such breaches including exposure of litigation or
regulatory action and a risk of loss and possible liability. Actual
or anticipated attacks may cause us to incur increasing costs,
including costs to deploy additional personnel and protection
technologies, train employees and engage third-party experts and
consultants. In addition, any party who is able to illicitly obtain
a subscriber’s password could access the subscriber’s financial,
transaction or personal information. Any compromise or breach of
our security measures, or those of our third-party service
providers, may violate applicable privacy, data security,
financial, cyber and other laws and cause significant legal and
financial exposure, adverse publicity, and a loss of confidence in
our security measures, all of which could have a material adverse
effect on our business, financial condition and results of
operations. We may be subject to post-breach review of the adequacy
of our privacy and security controls by regulators and other third
parties, which could result in post-breach regulatory
investigation, fines and consumer litigation as well as regulatory
oversight, at significant expense and risking reputational
harm.
Furthermore, we are subject to diverse laws and regulations in the
United States, the European Union, and other international
jurisdictions that require notification to affected individuals in
the event of a breach involving personal information. These
required notifications can be time-consuming and costly.
Furthermore, failure to comply with these laws and regulations
could subject us to regulatory scrutiny and additional liability.
Although we maintain relevant insurance, we cannot be certain that
our insurance coverage will be adequate for all breach related
liabilities, that insurance will continue to be available to us on
economically reasonable terms, or at all, or that the insurer will
not deny coverage as to any future claim. The successful assertion
of one or more large claims against us that exceed available
insurance coverage, or the occurrence of changes in our insurance
policies, including premium increases or the imposition of large
deductible or co-insurance requirements, could adversely affect our
reputation, business, financial condition and results of
operations. We may need to devote significant resources to protect
against security breaches or to address problems caused by
breaches, diverting resources from the growth and expansion of our
business.
Payment methods used on our e-commerce websites subject us to
third-party payment processing-related risks.
We accept payments from our consumers using a variety of methods,
including online payments with credit cards and debit cards issued
by major banks, payments made with gift cards processed by
third-party providers and payment through third-party online
payment platforms such as PayPal, Afterpay and Apple Pay. We also
rely on third parties to provide payment processing services. For
certain payment methods, including credit and debit cards, we pay
interchange and other fees, which may increase over time and raise
our operating costs and lower our profit margins. We may also be
subject to fraud and other illegal activities in connection with
the various payment methods we offer, including online payment
options and gift cards. Transactions on our e-commerce websites and
mobile applications are card-not-present transactions, so they
present a greater risk of fraud. Criminals are using increasingly
sophisticated methods to engage in illegal activities such as
unauthorized use of credit or debit cards and bank account
information. Requirements relating to consumer authentication and
fraud detection with respect to online sales are complex. We may
ultimately be held liable for the unauthorized use of a
cardholder’s card number in an illegal activity and be required by
card issuers to pay charge-back fees. Charge-backs result not only
in our loss of fees earned with respect to the payment, but also
leave us liable for the underlying money transfer amount. If our
charge-back rate becomes excessive, card associations also may
require us to pay fines or refuse to process our transactions. In
addition, we may be subject to additional fraud risk if third-party
service providers or our employees fraudulently use consumer
information for their own gain or facilitate the fraudulent use of
such information. Overall, we may have little recourse if we
process a criminally fraudulent transaction.
We are subject to payment card association operating rules,
certification requirements and various rules, regulations and
requirements governing electronic funds transfers, which could
change or be reinterpreted to make it difficult or impossible for
us to comply. As our business changes, we may also be subject to
different rules under existing standards, which may require new
assessments that involve costs above what we currently pay for
compliance. If we fail to comply with the rules or requirements of
any provider of a payment method we accept, or if the volume of
fraud in our transactions limits or terminates our rights to use
payment methods we currently accept, or if a data breach occurs
relating to our payment systems, among other things, we may be
subject to fines and higher transaction fees and lose our ability
to accept credit and debit card payments from our consumers,
process electronic funds transfers or facilitate other types of
online payments, and our reputation and our business, financial
condition and results of operations could be materially and
adversely affected.
Risk factors related to conducting business
internationally
We have significant operations in China, which exposes us to risks
inherent in doing business in that country.
We currently source and manufacture a substantial number
of our products from third-party suppliers and manufacturers in
China. As of March 31, 2022, we had 79 employees
in China. With the rapid development of the Chinese economy, the
cost of labor has increased and may continue to increase in the
future. Our results of operations will be materially and adversely
affected if our labor costs, or the labor costs of our suppliers
and manufacturers, increase significantly. In addition, we and our
manufacturers and suppliers may not be able to find a sufficient
number of qualified workers due to the intensely competitive and
fluid market for skilled labor in China. Furthermore, pursuant to
Chinese labor laws, employers in China are subject to various
requirements when signing labor contracts, paying remuneration,
determining the term of employees’ probation and unilaterally
terminating labor contracts. These labor laws and related
regulations impose liabilities on employers and may significantly
increase the costs of workforce reductions. If we decide to change
or reduce our workforce, these labor laws could limit or restrict
our ability to make such changes in a timely, favorable and
effective manner. Any of these events may materially and adversely
affect our business, financial condition and results of
operations.
Operating in China exposes us to political, legal and economic
risks. In particular, the political, legal and economic climate in
China, both nationally and regionally, is fluid and unpredictable.
Our ability to operate in China may be adversely affected by
changes in the United States and Chinese laws and regulations such
as those related to, among other things, taxation, import and
export tariffs, environmental regulations, land use rights,
intellectual property, currency controls, network security,
employee benefits, hygiene supervision and other matters. For
example, the U.S. Congress recently passed the Uyghur Forced Labor
Prevention Act in an effort to prevent what it views as forced
labor and human rights abuses in the Xinjiang Uyghur Autonomous
Region (XUAR). If it is determined that our third-party suppliers
and manufacturers mine, produce or manufacture our products wholly
or in part from the XUAR, then we could be prohibited from
importing such products into the U.S. In addition, we may not
obtain or retain the requisite legal permits to continue to operate
in China, and costs or operational limitations may be imposed in
connection with obtaining and complying with such permits. In
addition, Chinese trade regulations are in a state of flux, and we
may become subject to other forms of taxation, tariffs and duties
in China. Furthermore, the third parties we rely on in China may
disclose our confidential information or intellectual property to
competitors or third parties, which could result in the illegal
distribution and sale of counterfeit versions of our products.
If
any of these events occur, our business, financial condition and
results of operations could be materially and adversely
affected.
Adverse economic conditions in the United States, Europe or China
or any of the other countries in which we may conduct business
could negatively affect our business, financial condition and
results of operations.
Consumer spending on beauty products is influenced by general
economic conditions and the availability of discretionary income.
Adverse economic conditions in the United States, Europe, China or
any of the other countries in which we do significant business, or
periods of inflation or high energy prices may contribute to higher
unemployment levels, decreased consumer spending, reduced credit
availability and declining consumer confidence and demand, each of
which poses a risk to our business. A decrease in consumer spending
or in retailer and consumer confidence and demand for our products
could have a significant negative impact on our net sales and
profitability, including our operating margins and return on
invested capital. These economic conditions could cause some of our
retail customers or suppliers to experience cash flow or credit
problems and impair their financial condition, which could disrupt
our business and adversely affect product orders, payment patterns
and default rates and increase our bad debt expense.
We are subject to international business
uncertainties.
We sell some of our products to customers located outside the
United States. In addition, substantially all of our third-party
suppliers and manufacturers are located in China and certain other
foreign countries. We intend to continue to sell to customers
outside the United States and maintain our relationships in China
and other foreign countries where have suppliers and manufacturers.
Further, we may establish additional relationships in other
countries to grow our operations. The substantial up-front
investment required, the lack of consumer awareness of our products
in jurisdictions outside of the United States, differences in
consumer preferences and trends between the United States and other
jurisdictions, the risk of inadequate intellectual property
protections and differences in packaging, labeling and related
laws, rules and regulations are all substantial matters that need
to be evaluated prior to doing business in new territories. We
cannot be assured that our international efforts will be
successful. International sales and increased international
operations may be subject to risks such as:
•difficulties
in staffing and managing foreign operations;
•burdens
of complying with a wide variety of laws and regulations, including
more stringent regulations relating to data privacy and security,
particularly in the United Kingdom and the European
Union;
•adverse
tax effects and foreign exchange controls making it difficult to
repatriate earnings and cash;
•political
and economic instability;
•terrorist
activities and natural disasters;
•trade
restrictions;
•disruptions
or delays in shipments whether due to port congestion, container
shortages, labor disputes, product regulations and/or inspections
or other factors, natural disasters or health pandemics, or other
transportation disruptions;
•differing
employment practices and laws and labor disruptions;
•the
imposition of government controls;
•an
inability to use or to obtain adequate intellectual property
protection for our key brands and products;
•tariffs
and customs duties and the classifications of our goods by
applicable governmental bodies;
•a
legal system subject to undue influence or corruption;
•a
business culture in which illegal sales practices may be
prevalent;
•logistics
and sourcing; and
•military
conflicts.
The occurrence of any of these risks could negatively affect our
international business and consequently our overall business,
financial condition and results of operations.
The ongoing conflict between Russia and Ukraine could adversely
affect our business, financial condition and results of
operations.
On February 24, 2022, Russian military forces launched a military
action in Ukraine, and sustained conflict and disruption in the
region is likely. Although the length, impact and outcome of the
ongoing military conflict in Ukraine is highly unpredictable, this
conflict could lead to significant market and other disruptions,
including significant volatility in commodity prices and supply of
energy resources, instability in financial markets, supply chain
interruptions, political and social instability, changes in
consumer or purchaser preferences as well as increase in
cyberattacks and espionage.
Russia’s recognition of two separatist republics in the Donetsk and
Luhansk regions of Ukraine and subsequent military action against
Ukraine have led to an unprecedented expansion of sanction programs
imposed by the United States, the European Union, the United
Kingdom, Canada, Switzerland, Japan and other countries against
Russia, Belarus, the Crimea Region of Ukraine, the so-called
Donetsk People’s Republic and the so-called Luhansk People’s
Republic, including, among others:
•blocking
sanctions against some of the largest state-owned and private
Russian financial institutions (and their subsequent removal from
the Society for Worldwide Interbank Financial Telecommunication
SWIFT payment system) and certain Russian businesses, some of which
have significant financial and trade ties to the European
Union;
•blocking
sanctions against Russian and Belarusian individuals, including the
Russian President, other politicians and those with government
connections or involved in Russian military activities;
and
•blocking
of Russia’s foreign currency reserves as well as expansion of
sectoral sanctions and export and trade restrictions, limitations
on investments and access to capital markets and bans on various
Russian imports.
In retaliation against new international sanctions and as part of
measures to stabilize and support the volatile Russian financial
and currency markets, Russian authorities imposed significant
currency control measures aimed at restricting the outflow of
foreign currency and capital from Russia, imposed various
restrictions on transacting with non-Russian parties, banned
exports of various products and other economic and financial
restrictions. The situation is rapidly evolving as a result of the
conflict in Ukraine, and the United States, the European Union, the
United Kingdom and other countries may implement additional
sanctions, export controls or other measures against Russia,
Belarus and other countries, regions, officials, individuals or
industries in the respective territories. Such sanctions and other
measures, as well as the existing and potential further responses
from Russia or other countries to such sanctions, tensions and
military actions, could adversely affect the global economy and
financial markets and could adversely affect our business,
financial condition and results of operations.
We are actively monitoring the situation in Ukraine and assessing
its impact on our business, including our business partners and
customers. We do not sell our products in Russia and to date we
have not experienced any material interruptions in our
infrastructure, supplies, technology systems or networks needed to
support our operations. We have no way to predict the progress or
outcome of the conflict in Ukraine or its impacts in Ukraine,
Russia or Belarus as the conflict, and any resulting government
reactions, are rapidly developing and beyond our control. The
extent and duration of the military action, sanctions and resulting
market disruptions could be significant and could potentially have
substantial impact on the global economy and our business for an
unknown period of time. Any of the above mentioned factors could
affect our business, financial condition and results of
operations.
Risk factors related to evolving laws and regulations and
compliance with laws and regulations
New laws, regulations, enforcement trends or changes in existing
regulations governing the introduction, marketing and sale of our
products to consumers could harm our business.
There has been an increase in regulatory activity and activism in
the United States and abroad, and the regulatory landscape is
becoming more complex with increasingly strict requirements. If
this trend continues, we may find it necessary to alter
some
of the ways we have traditionally manufactured and marketed our
products in order to stay in compliance with a changing regulatory
landscape, and this could add to the costs of our operations and
have an adverse impact on our business. To the extent federal,
state, local or foreign regulatory changes regarding consumer
protection, or the ingredients, claims or safety of our products
occur in the future, they could require us to reformulate or
discontinue certain of our products, revise the product packaging
or labeling, or adjust operations and systems, any of which could
result in, among other things, increased costs, delays in product
launches, product returns or recalls and lower net sales, and
therefore could have a material adverse effect on our business,
financial condition and results of operations. Noncompliance with
applicable regulations could result in enforcement action by the
FDA or other regulatory authorities within or outside the United
States, including but not limited to product seizures, injunctions,
product recalls and criminal or civil monetary penalties, all of
which could have a material adverse effect on our business,
financial condition and results of operations.
In the United States, with the exception of color additives, the
FDA does not currently require pre-market approval for products
intended to be sold as cosmetics. However, the FDA may in the
future require pre-market approval, clearance or
registration/notification of cosmetic products, establishments or
manufacturing facilities. Moreover, such products could also be
regulated as both drugs and cosmetics simultaneously, as the
categories are not mutually exclusive. The statutory and regulatory
requirements applicable to drugs are extensive and require
significant resources and time to ensure compliance. For example,
if any of our products intended to be sold as cosmetics were to be
regulated as drugs, we might be required to conduct, among other
things, clinical trials to demonstrate the safety and efficacy of
these products. We may not have sufficient resources to conduct any
required clinical trials or to ensure compliance with the
manufacturing requirements applicable to drugs. If the FDA
determines that any of our products intended to be sold as
cosmetics should be classified and regulated as drug products and
we are unable to comply with applicable drug requirements, we may
be unable to continue to market those products. Any inquiry into
the regulatory status of our cosmetics and any related interruption
in the marketing and sale of these products could damage our
reputation and image in the marketplace.
In recent years, the FDA has issued warning letters to several
cosmetic companies alleging improper claims regarding their
cosmetic products. If the FDA determines that we have disseminated
inappropriate drug claims for our products intended to be sold as
cosmetics, we could receive a warning or untitled letter, be
required to modify our product claims or take other actions to
satisfy the FDA. In addition, plaintiffs’ lawyers have filed class
action lawsuits against cosmetic companies after receipt of these
types of FDA warning letters. There can be no assurance that we
will not be subject to state and federal government actions or
class action lawsuits, which could harm our business, financial
condition and results of operations.
Additional state and federal requirements may be imposed on
consumer products as well as cosmetics, cosmetic ingredients, or
the labeling and packaging of products intended for use as
cosmetics. For example, in recent years, certain lawmakers have
proposed giving the FDA additional authority to regulate cosmetics
and their ingredients. This increased authority could require the
FDA to impose increased testing and manufacturing requirements on
cosmetic manufacturers or cosmetics or their ingredients before
they may be marketed. We are unable to ascertain what, if any,
impact any increased statutory or regulatory requirements may have
on our business.
We sell a number of products as over-the-counter (“OTC”) drug
products, which are subject to the FDA OTC drug regulatory
requirements because they are intended to be used as sunscreen or
to treat acne. The FDA regulates the formulation, manufacturing,
packaging and labeling of OTC drug products. Our sunscreen and acne
drug products are regulated pursuant to FDA OTC drug monographs
that specify acceptable active drug ingredients and acceptable
product claims that are generally recognized as safe and effective
for particular uses. If any of these products that are marketed as
OTC drugs are not in compliance with the applicable FDA monograph,
we may be required to reformulate the product, stop making claims
relating to such product or stop selling the product until we are
able to obtain costly and time-consuming FDA approvals. We are also
required to submit adverse event reports to the FDA for our OTC
drug products, and failure to comply with this requirement may
subject us to FDA regulatory action.
We also sell a number of consumer products, which are subject to
regulation by the CPSC in the United States under the provisions of
the Consumer Product Safety Act, as amended by the Consumer Product
Safety Improvement Act of 2008. These statutes and the related
regulations ban from the market consumer products that fail to
comply with applicable product safety laws, regulations and
standards. The CPSC has the authority to require the recall,
repair, replacement or refund of any such banned products or
products that otherwise create a substantial risk of injury and may
seek penalties for regulatory noncompliance under certain
circumstances. The CPSC also requires manufacturers of consumer
products to report certain types of information to the CPSC
regarding products that fail to comply with applicable regulations.
Certain state laws also address the safety of consumer products,
and mandate reporting requirements, and noncompliance may result in
penalties or other regulatory action.
Our products are also subject to state laws and regulations, such
as the California Safe Drinking Water and Toxic Enforcement Act,
also known as “Prop 65,” and failure to comply with such laws may
also result in lawsuits and regulatory enforcement that could have
a material adverse effect on our business, financial condition and
results of operations.
Our facilities and those of our third-party manufacturers are
subject to regulation under the Federal Food, Drug and Cosmetic Act
(the “FDCA”) and FDA implementing regulations.
Our facilities and those of our third-party manufacturers are
subject to regulation under the FDCA and FDA implementing
regulations. The FDA may inspect all of our facilities and those of
our third-party manufacturers periodically to determine if we and
our third-party manufacturers are complying with provisions of the
FDCA and FDA regulations. In addition, third-party manufacturer’s
facilities for manufacturing OTC drug products must comply with the
FDA’s current good manufacturing practices (“cGMP”) requirements
for drug products that require us and our manufacturers to
maintain, among other things, good manufacturing processes,
including stringent vendor qualifications, ingredient
identification, manufacturing controls and record
keeping.
Our operations could be harmed if regulatory authorities make
determinations that we, or our vendors, are not in compliance with
these regulations. If the FDA finds a violation of cGMPs, it may
enjoin our manufacturer’s operations, seize product, restrict
importation of goods, and impose administrative, civil or criminal
penalties. If we or our third-party manufacturers fail to comply
with applicable regulatory requirements, we could be required to
take costly corrective actions, including suspending manufacturing
operations, changing product formulations, suspending sales, or
initiating product recalls. In addition, compliance with these
regulations has increased and may further increase the cost of
manufacturing certain of our products as we work with our vendors
to ensure they are qualified and in compliance. Any of these
outcomes could have a material adverse effect on our business,
financial condition and results of operations.
Government regulations and private party actions relating to the
marketing and advertising of our products and services may
restrict, inhibit or delay our ability to sell our products and
harm our business, financial condition and results of
operations.
Government authorities regulate advertising and product claims
regarding the performance and benefits of our products. These
regulatory authorities typically require a reasonable basis to
support any marketing claims. What constitutes a reasonable basis
for substantiation can vary widely from market to market, and there
is no assurance that the efforts that we undertake to support our
claims will be deemed adequate for any particular product or claim.
A significant area of risk for such activities relates to improper
or unsubstantiated claims about our products and their use or
safety. If we are unable to show adequate substantiation for our
product claims, or our promotional materials make claims that
exceed the scope of allowed claims for the classification of the
specific product, whether cosmetics, OTC drug products or other
consumer products that we offer, the FDA, the FTC or other
regulatory authorities could take enforcement action or impose
penalties, such as monetary consumer redress, requiring us to
revise our marketing materials, amend our claims or stop selling
certain products, all of which could harm our business, financial
condition and results of operations. Any regulatory action or
penalty could lead to private party actions, or private parties
could seek to challenge our claims even in the absence of formal
regulatory actions which could harm our business, financial
condition and results of operations.
Our business is subject to complex and evolving U.S. and foreign
laws and regulations regarding privacy and data protection. Many of
these laws and regulations are subject to change and uncertain
interpretation, and could result in claims, changes to our business
practices, monetary penalties, increased costs of operations or
otherwise harm our business, financial condition and results of
operations.
We are subject to a variety of laws and regulations in the United
States and abroad regarding privacy and data protection, some of
which can be enforced by private parties or government entities and
some of which provide for significant penalties for non-compliance.
Such laws and regulations restrict how personal information is
collected, processed, stored, used and disclosed, as well as set
standards for its security, implement notice requirements regarding
privacy practices, and provide individuals with certain rights
regarding the use, disclosure, and sale of their protected personal
information. For example, the UK General Data Protection Regulation
(the “UK GDPR”) and the European Union’s General Data Protection
Regulation (the “GDPR”) each allows for a private right of action,
imposes stringent data protection requirements on companies that
offer goods or services to, or monitor the behavior of, individuals
in the United Kingdom or the European Economic Area (the “EEA”), as
applicable. The UK GDPR and the GDPR establishes a robust framework
of data subjects’ rights and imposes onerous accountability
obligations on companies, with penalties for noncompliance of up to
the greater of 17.5 million British pounds or 20 million euros,
respectively, or 4% of annual global revenue.
Furthermore, the California Consumer Privacy Act (the “CCPA”)
requires new disclosures to California consumers, imposes new rules
for collecting or using information about minors, affords
California consumers new abilities to opt out of certain
disclosures of personal information and also establishes
significant penalties for noncompliance. Additionally, in November
2020, California voters passed the California Privacy Rights Act
(the “CPRA”). The CPRA, which is expected to take effect on January
1, 2023, significantly expands the CCPA, including by introducing
additional obligations such as data minimization and storage
limitations, granting additional rights to consumers such as
correction of personal information and additional opt-out rights,
and creates a new entity, the California Privacy Protection Agency,
to implement and enforce the law. The effects of the CPRA are
potentially significant and may require us to modify our data
collection or processing practices and policies and to incur
substantial costs and expenses in an effort to comply, and increase
our potential exposure to regulatory enforcement and/or
litigation.
We are also subject to European Union and United Kingdom ("UK")
rules with respect to cross-border transfers of personal data out
of the EEA and the UK. Recent legal developments in Europe have
created complexity and uncertainty regarding transfers of personal
data outside the EEA and the UK, including to the US. In addition,
on June 4, 2021, the European Commission published revised standard
contractual clauses for data transfers from the EEA: the revised
clauses must be used for relevant new data transfers from September
27, 2021; existing standard contractual clauses must be migrated to
the revised clauses by December 27, 2022. We may be required to
implement the revised standard contractual clauses in relation to
various business arrangements within the relevant time frames,
which could increase our compliance costs and adversely affect our
business. The United Kingdom’s Information Commissioner’s Office
has also published new data transfer standard contracts for
transfers from the UK under the UK GDPR. This new documentation
will be mandatory for relevant data transfers from September 21,
2022; existing standard contractual clauses arrangements must be
migrated to the new documentation by March 21, 2024. We will be
required to implement the latest UK data transfer documentation for
data transfers subject to the UK GDPR, in relation to relevant
existing contracts and certain additional contracts and vendor
and/or customer arrangements, within the relevant time frames.
These recent developments will require us to review and amend the
legal mechanisms by which we make and/ or receive personal data
transfers to the US. As supervisory authorities issue further
guidance on personal data export mechanisms, including
circumstances where the standard contractual clauses cannot be
used, and/or start taking enforcement action, we could suffer
additional costs, complaints and/or regulatory investigations or
fines, and/or if we are otherwise unable to transfer personal data
between and among countries and regions in which we operate, it
could affect the manner in which we operate our business and could
harm our business, financial condition and results of
operations.
In addition, on June 28, 2021, the European Commission adopted an
adequacy decision in favor of the UK, enabling data transfers from
EEA member states to the UK without additional safeguards. However,
the UK adequacy decision will automatically expire in June 2025
unless the European Commission re-assesses and renews/ extends that
decision, and remains under review by the Commission during this
period. The relationship between the UK and the EEA in relation to
certain aspects of data protection law remains unclear, and it is
unclear how UK data protection laws and regulations will develop in
the medium to longer term, and how data transfers to and from the
UK will be regulated in the long term. These changes may lead to
additional costs and increase our overall risk
exposure.
Data privacy continues to remain a matter of interest to lawmakers
and regulators. A number of proposals are pending before federal,
state and foreign legislative and regulatory bodies and additional
laws and regulations have been passed but are not yet effective,
all of which could significantly affect our business. Some U.S.
states have enacted or are considering enacting stricter data
privacy laws, some modeled on the GDPR, some modeled on the CCPA,
and others potentially imposing completely distinct requirements.
For example, on March 2, 2021, Virginia enacted the Virginia
Consumer Data Protection Act (“CDPA”), a comprehensive privacy
statute that shares similarities with the CCPA, CPRA, and
legislation proposed in other states. Additionally, the United
States is considering comprehensive federal privacy legislation,
such as the Consumer Online Privacy Rights Act, which would
significantly expand elements of the data protection rights and
obligations existing within the GDPR and the CCPA to all U.S.
consumers.
We are also subject to evolving EU and UK privacy laws on cookies,
tracking technologies and e-marketing. In the EU and the UK under
national laws derived from the ePrivacy Directive, informed consent
is required for the placement of a cookie or similar technologies
on a user’s device and for direct electronic marketing. Consent is
strictly defined, and includes a prohibition on pre-checked
consents and a requirement to ensure separate consents are sought
for each type of cookie or similar technology. The current national
laws that implement the ePrivacy Directive may be replaced across
the EU (but not directly in the UK) by an EU regulation known as
the ePrivacy Regulation which will significantly increase fines for
non-compliance. While the text of the ePrivacy Regulation is still
under development, a recent European court decision and regulators’
recent guidance are driving increased attention to cookies, web
beacons and similar technology. These decisions and guidance, as
well as the implementation of the ePrivacy Regulation, could affect
our ability to use our consumer’s data for
personalized advertising, and alter our ability to place
advertisements across social media and the web. Furthermore, the
current European Union member states’ and the UK local guidance has
significantly increased the risk of penalties for breach of the
GDPR, the UK GDPR, and law implementing the ePrivacy Directive. If
regulators start to enforce the strict approach outlined in recent
guidance, this could lead to substantial costs, require significant
systems changes, broader restrictions on the way we market our
products on a global basis and increase our risk of regulatory
oversight our ability to reach our consumers, and our capability to
provide our consumers with personalized services and
experiences.
Several countries in Europe have also recently issued guidance on
the use of cookies and similar tracking technologies which require
an additional layer of consent from, and disclosure to, website
users for third party advertising, social media advertising and
analytics. Regulation of cookies and similar technologies may lead
to broader restrictions on our marketing and personalization
activities and may negatively impact our efforts to understand
users’ Internet usage, online shopping and other relevant online
behaviors, as well as the effectiveness of our marketing and our
business generally. Such regulations, including uncertainties about
how well the advertising technology ecosystem can adapt to legal
changes around the use of tracking technologies, may have a
negative effect on businesses, including ours, that collect and use
online usage information for consumer acquisition and marketing.
The decline of cookies or other online tracking technologies as a
means to identify and target potential purchasers, may increase the
cost of operating our business and lead to a decline in revenues.
In addition, legal uncertainties about the legality of cookies and
other tracking technologies may increase regulatory scrutiny and
increase potential civil liability under data protection or
consumer protection laws.
Compliance with existing, not yet effective, and proposed privacy
and data protection laws and regulations can be costly and can
delay or impede our ability to market and sell our products, impede
our ability to conduct business through websites and mobile
applications we and our partners may operate, require us to modify
or amend our information practices and policies, change and limit
the way we use consumer information in operating our business,
cause us to have difficulty maintaining a single operating model,
result in negative publicity, increase our operating costs, require
significant management time and attention, or subject us to
inquiries or investigations, claims or other remedies, including
significant fines and penalties, or demands that we modify or cease
existing business practices. In addition, if our privacy or data
security measures fail to comply with applicable current or future
laws and regulations, we may be subject to litigation, regulatory
investigations, enforcement notices requiring us to change the way
we use personal data or our marketing practices, fines or other
liabilities, as well as negative publicity and a potential loss of
business. We may also face civil claims including representative
actions and other class action type litigation (where individuals
have suffered harm), potentially amounting to significant
compensation or damages liabilities, as well as associated costs,
and diversion of internal resources. Any of the foregoing could
have a material adverse effect on our business, financial condition
and results of operations.
Failure to comply with the U.S. Foreign Corrupt Practices Act,
other applicable anti-corruption and anti-bribery laws, and
applicable trade control laws could subject us to penalties and
other adverse consequences.
We currently source and manufacture a substantial number of our
products from third-party suppliers and manufacturers located
outside of the United States, and we have an office in China from
which we manage our international supply chain. We sell our
products in several countries outside of the United States,
including through distributors. Our operations are subject to the
U.S. Foreign Corrupt Practices Act (the “FCPA”), as well as the
anti-corruption and anti-bribery laws in the countries where we do
business. The FCPA prohibits covered parties from offering,
promising, authorizing or giving anything of value, directly or
indirectly, to a “foreign government official” with the intent of
improperly influencing the official’s act or decision, inducing the
official to act or refrain from acting in violation of lawful duty,
or obtaining or retaining an improper business advantage. The FCPA
also requires publicly traded companies to maintain records that
accurately and fairly represent their transactions, and to have an
adequate system of internal accounting controls. In addition, other
applicable anti-corruption laws prohibit bribery of domestic
government officials, and some laws that may apply to our
operations prohibit commercial bribery, including giving or
receiving improper payments to or from non-government parties, as
well as so-called “facilitation” payments. In addition, we are
subject to United States and other applicable trade control
regulations that restrict with whom we may transact business,
including the trade sanctions enforced by the U.S. Treasury, Office
of Foreign Assets Control.
While we have implemented policies, internal controls and other
measures reasonably designed to promote compliance with applicable
anti-corruption and anti-bribery laws and regulations, and certain
safeguards designed to ensure compliance with U.S. trade control
laws, our employees or agents may engage in improper conduct for
which we might be held responsible. Any violations of these
anti-corruption or trade controls laws, or even allegations of such
violations, can lead to an investigation and/or enforcement action,
which could disrupt our operations, involve significant management
distraction, and lead to significant costs and expenses, including
legal fees. If we, or our employees or agents acting on our behalf,
are found to have engaged in practices that violate these laws and
regulations, we could suffer severe fines and penalties,
profit
disgorgement, injunctions on future conduct, securities litigation,
bans on transacting government business, delisting from securities
exchanges and other consequences that may have a material adverse
effect on our business, financial condition and results of
operations. In addition, our brands and reputation, our sales
activities or our stock price could be adversely affected if we
become the subject of any negative publicity related to actual or
potential violations of anti-corruption, anti-bribery or trade
control laws and regulations.
Government regulation of the Internet and e-commerce is evolving,
and unfavorable changes or failure by us to comply with these
regulations could substantially harm our business, financial
condition and results of operations.
We are subject to general business regulations and laws as well as
regulations and laws specifically governing the Internet and
e-commerce. Existing and future regulations and laws could impede
the growth of the Internet, e-commerce or mobile commerce. These
regulations and laws may involve taxes, tariffs, privacy and data
security, anti-spam, content protection, electronic contracts and
communications, consumer protection, social media marketing,
third-party cookies, web beacons and similar technology for online
behavioral advertising and gift cards. It is not clear how existing
laws governing issues such as property ownership, sales taxes and
other taxes and consumer privacy apply to the Internet as the vast
majority of these laws were adopted prior to the advent of the
Internet and do not contemplate or address the unique issues raised
by the Internet or e-commerce. It is possible that general business
regulations and laws, or those specifically governing the Internet
or e-commerce, may be interpreted and applied in a manner that is
inconsistent from one jurisdiction to another and may conflict with
other rules or our practices. We cannot be sure that our practices
have complied, comply or will comply fully with all such laws and
regulations. Any failure, or perceived failure, by us to comply
with any of these laws or regulations could result in damage to our
reputation, a loss in business and proceedings or actions against
us by governmental entities or others. Any such proceeding or
action could hurt our reputation, force us to spend significant
amounts in defense of these proceedings, distract our management,
increase our costs of doing business and decrease the use of our
sites by consumers and suppliers and may result in the imposition
of monetary liability. We may also be contractually liable to
indemnify and hold harmless third parties from the costs or
consequences of non-compliance with any such laws or regulations.
In addition, it is possible that governments of one or more
countries may seek to censor content available on our sites or may
even attempt to completely block access to our sites. Adverse legal
or regulatory developments could substantially harm our business.
In particular, in the event that we are restricted, in whole or in
part, from operating in one or more countries, our ability to
retain or increase our consumer base may be adversely affected, and
we may not be able to maintain or grow our net sales and expand our
business as anticipated.
Risk factors related to legal and regulatory
proceedings
We are involved, and may become involved in the future, in disputes
and other legal or regulatory proceedings that, if adversely
decided or settled, could materially and adversely affect our
business, financial condition and results of
operations.
We are, and may in the future become, party to litigation,
regulatory proceedings or other disputes. In general, claims made
by or against us in disputes and other legal or regulatory
proceedings can be expensive and time consuming to bring or defend
against, requiring us to expend significant resources and divert
the efforts and attention of our management and other personnel
from our business operations. These potential claims include, but
are not limited to, personal injury claims, class action lawsuits,
intellectual property claims, employment litigation and regulatory
investigations and causes of action relating to the advertising and
promotional claims about our products. Any adverse determination
against us in these proceedings, or even the allegations contained
in the claims, regardless of whether they are ultimately found to
be without merit, may also result in settlements, injunctions or
damages that could have a material adverse effect on our business,
financial condition and results of operations.
We may be required to recall products and may face product
liability claims, either of which could result in unexpected costs
and damage our reputation.
We sell products for human use. Our products intended for use as
cosmetics or skincare are not generally subject to pre-market
approval or registration processes, so we cannot rely upon a
government safety panel to qualify or approve our products for use.
A product may be safe for the general population when used as
directed but could cause an adverse reaction for a person who has a
health condition or allergies, or who is taking a prescription
medication. While we include what we believe are adequate
instructions and warnings and we have historically had low numbers
of reported adverse reactions, previously unknown adverse reactions
could occur. If we discover that any of our products are causing
adverse reactions, we could suffer adverse publicity or
regulatory/government sanctions.
Potential product liability risks may arise from the testing,
manufacture and sale of our products, including that the products
fail to meet quality or manufacturing specifications, contain
contaminants, include inadequate instructions as to their proper
use, include inadequate warnings concerning side effects and
interactions with other substances or for persons with health
conditions or allergies, or cause adverse reactions or side
effects. Product liability claims could increase our costs, and
adversely affect our business, financial condition and results of
operations. As we continue to offer an increasing number of new
products, our product liability risk may increase. It may be
necessary for us to recall products that do not meet approved
specifications or because of the side effects resulting from the
use of our products, which would result in adverse publicity,
potentially significant costs in connection with the recall and
could have a material adverse effect on our business, financial
condition and results of operations.
In addition, plaintiffs in the past have received substantial
damage awards from other cosmetic and drug companies based upon
claims for injuries allegedly caused by the use of their products.
Although we currently maintain general liability insurance, any
claims brought against us may be subject to policy exclusions or
exceed our existing or future insurance policy coverage or limits.
Any judgment against us that is not covered or in excess of our
policy coverage or limits would have to be paid from our cash
reserves, which would reduce our capital resources. In addition, we
may be required to pay higher premiums and accept higher
deductibles in order to secure adequate insurance coverage in the
future. Further, we may not have sufficient capital resources to
pay a judgment, in which case our creditors could levy against our
assets. Any product liability claim or series of claims brought
against us could harm our business significantly, particularly if a
claim were to result in adverse publicity or damage awards outside
or in excess of our insurance policy limits.
Risk factors related to intellectual property
If we are unable to protect our intellectual property, the value of
our brands and other intangible assets may be diminished, and our
business may be adversely affected.
We rely on trademark, copyright, trade secret, patent and other
laws protecting proprietary rights, nondisclosure and
confidentiality agreements and other practices, to protect our
brands and proprietary information, technologies and processes. Our
primary trademarks include “e.l.f.,” “e.l.f. eyes lips face,” “Well
People,” and “Keys Soulcare” all of which are registered or have
registrations pending in the United States and in many other
countries or registries. Our trademarks are valuable assets that
support our brands and consumers’ perception of our products.
Although we have existing and pending trademark registrations for
our brands in the United States and in many of the foreign
countries in which we operate, we may not be successful in
asserting trademark or trade name protection in all jurisdictions.
We also have not applied for trademark protection in all relevant
foreign jurisdictions and cannot assure you that our pending
trademark applications will be approved. Third parties may also
attempt to register our trademarks abroad in jurisdictions where we
have not yet applied for trademark protection, oppose our trademark
applications domestically or abroad, or otherwise challenge our use
of the trademarks. In the event that our trademarks are
successfully challenged, we could be forced to rebrand our products
in some parts of the world, which could result in the loss of brand
recognition and could require us to devote resources to advertising
and marketing new brands.
We have limited patent protection, which limits our ability to
protect our products from competition. We primarily rely on
know-how to protect our products. It is possible that others will
independently develop the same or similar know-how, which may allow
them to sell products similar to ours. If others obtain access to
our know-how, our confidentiality agreements may not effectively
prevent disclosure of our proprietary information, technologies and
processes and may not provide an adequate remedy in the event of
unauthorized use of such information, which could harm our
competitive position.
The efforts we have taken to protect our proprietary rights may not
be sufficient or effective. In addition, effective trademark,
copyright, patent and trade secret protection may be unavailable or
limited for certain of our intellectual property in some foreign
countries. Other parties may infringe our intellectual property
rights and may dilute our brands in the marketplace. We may need to
engage in litigation or other activities to enforce our
intellectual property rights, to protect our trade secrets or to
determine the validity and scope of proprietary rights of others.
Any such activities could require us to expend significant
resources and divert the efforts and attention of our management
and other personnel from our business operations. If we fail to
protect our intellectual property or other proprietary rights, our
business, financial condition and results of operations may be
materially and adversely affected.
Our success depends on our ability to operate our business without
infringing, misappropriating or otherwise violating the trademarks,
patents, copyrights and other proprietary rights of third
parties.
Our commercial success depends in part on our ability to operate
without infringing, misappropriating or otherwise violating the
trademarks, patents, copyrights, trade secrets and other
proprietary rights of others. We cannot be certain that
the
conduct of our business does not and will not infringe,
misappropriate or otherwise violate such rights. From time to time
we receive allegations of intellectual property infringement and
third parties have filed claims against us with allegations of
intellectual property infringement. In addition, third parties may
involve us in intellectual property disputes as part of a business
model or strategy to gain competitive advantage.
To the extent we gain greater visibility and market exposure as a
public company or otherwise, we may also face a greater risk of
being the subject of such claims and litigation. For these and
other reasons, third parties may allege that our products or
activities infringe, misappropriate, dilute or otherwise violate
their trademark, patent, copyright or other proprietary rights.
Defending against allegations and litigation could be expensive,
occupy significant amounts of time, divert management’s attention
from other business concerns and have an adverse impact on our
ability to bring products to market. In addition, if we are found
to infringe, misappropriate, dilute or otherwise violate
third-party trademark, patent, copyright or other proprietary
rights, our ability to use brands to the fullest extent we plan may
be limited, we may need to obtain a license, which may not be
available on commercially reasonable terms, or at all, or we may
need to redesign or rebrand our marketing strategies or products,
which may not be possible.
We may also be required to pay substantial damages or be subject to
an order prohibiting us and our retail customers from importing or
selling certain products or engaging in certain activities. Our
inability to operate our business without infringing,
misappropriating or otherwise violating the trademarks, patents,
copyrights and proprietary rights of others could have a material
adverse effect on our business, financial condition and results of
operations.
Our agreement with Alicia Keys for our Keys Soulcare brand may be
terminated if specified conditions are not met.
We have an agreement with Alicia Keys regarding our Keys Soulcare
brand, which, among other things, includes a license for her
likeness and imposes various obligations on us. If we breach our
obligations, our rights under the agreement could be terminated by
Alicia Keys and we could, among other things, have to pay damages,
lose our ability to associate the Keys Soulcare brand with her,
lose our ability to sell products branded as Keys Soulcare, lose
any upfront investments made in connection with the Keys Soulcare
brand, and sustain reputational damage. Each of these risks could
have an adverse effect on our business, results of operations and
financial condition.
Risk factors related to marketing activities
Use of social media may materially and adversely affect our
reputation or subject us to fines or other penalties.
We rely to a large extent on our online presence to reach
consumers, and we offer consumers the opportunity to rate and
comment on our products on our e-commerce websites and mobile
applications. Negative commentary or false statements regarding us
or our products may be posted on our e-commerce websites, mobile
applications, or social media platforms and may be adverse to our
reputation or business. Our target consumers often value readily
available information and often act on such information without
further investigation and without regard to its accuracy. The harm
may be immediate without affording us an opportunity for redress or
correction. In addition, we may face claims relating to information
that is published or made available through the interactive
features of our e-commerce websites and mobile applications. For
example, we may receive third-party complaints that the comments or
other content posted by users on our platforms infringe third-party
intellectual property rights or otherwise infringe the legal rights
of others. While the Communications Decency Act ("CDA") and Digital
Millennium Copyright Act ("DMCA") generally protect online service
providers from claims of copyright infringement or other legal
liability for the self-directed activities of its users, if it were
determined that we did not meet the relevant safe harbor
requirements under either law, we could be exposed to claims
related to advertising practices, defamation, intellectual property
rights, rights of publicity and privacy, and personal injury torts.
We could incur significant costs investigating and defending such
claims and, if we are found liable, significant damages. If any of
these events occur, our business, financial condition and results
of operations could be materially and adversely
affected.
We also use third-party social media platforms as marketing tools.
For example, we maintain Snapchat, Facebook, TikTok, Twitter,
Pinterest, Instagram and YouTube accounts. As e-commerce and social
media platforms continue to rapidly evolve, we must continue to
maintain a presence on these platforms and establish presences on
new or emerging popular social media platforms. If we are unable to
cost-effectively use social media platforms as marketing tools, our
ability to acquire new consumers and our financial condition may
suffer. Furthermore, as laws and regulations rapidly evolve to
govern the use of these platforms and devices, the failure by us,
our employees or third parties acting at our direction to abide by
applicable laws and regulations in the use of these platforms and
devices could subject us to regulatory investigations, class action
lawsuits, liability, fines or other penalties and have a material
adverse effect on our business, financial condition and result of
operations.
In addition, an increase in the use of social media for product
promotion and marketing may cause an increase in the burden on us
to monitor compliance of such materials and increase the risk that
such materials could contain problematic product or marketing
claims in violation of applicable regulations.
Our business relies heavily on email and other messaging services,
and any restrictions on the sending of emails or messages or an
inability to timely deliver such communications could materially
adversely affect our net revenue and business.
Our business is highly dependent upon email and other messaging
services for promoting our brands, products and e-commerce
platforms. We provide emails and “push” communications to inform
consumers of new products, shipping specials and other promotions.
We believe these messages are an important part of our consumer
experience. If we are unable to successfully deliver emails or
other messages to our subscribers, or if subscribers decline to
open or read our messages, our business, financial condition and
results of operations may be materially adversely affected. Changes
in how web and mail services block, organize and prioritize email
may reduce the number of subscribers who receive or open our
emails. For example, Google’s Gmail service has a feature that
organizes incoming emails into categories (for example, primary,
social and promotions). Such categorization or similar inbox
organizational features may result in our emails being delivered in
a less prominent location in a subscriber’s inbox or viewed as
“spam” by our subscribers and may reduce the likelihood of that
subscriber reading our emails. Actions by third parties to block,
impose restrictions on or charge for the delivery of emails or
other messages could also adversely impact our business. From time
to time, Internet service providers or other third parties may
block bulk email transmissions or otherwise experience technical
difficulties that result in our inability to successfully deliver
emails or other messages to consumers.
Changes in the laws or regulations that limit our ability to send
such communications or impose additional requirements upon us in
connection with sending such communications would also materially
adversely impact our business. For example, electronic marketing
and privacy requirements in the European Union and the United
Kingdom are highly restrictive and differ greatly from those in the
United States, which could cause fewer of individuals in the
European Union or the United Kingdom to subscribe to our marketing
messages and drive up our costs and risk of regulatory oversight
and fines if we are found to be non-compliant.
Our use of email and other messaging services to send
communications to consumers may also result in legal claims against
us, which may cause us increased expenses, and if successful might
result in fines and orders with costly reporting and compliance
obligations or might limit or prohibit our ability to send emails
or other messages. We also rely on social networking messaging
services to send communications and to encourage consumers to send
communications. Changes to the terms of these social networking
services to limit promotional communications, any restrictions that
would limit our ability or our consumers’ ability to send
communications through their services, disruptions or downtime
experienced by these social networking services or decline in the
use of or engagement with social networking services by consumers
could materially and adversely affect our business, financial
condition and results of operations.
Risk factors relating to our stockholders and ownership of our
common stock
Our business could be negatively impacted by corporate citizenship
and sustainability matters.
There is an increased focus from certain investors, customers,
consumers, employees, and other stakeholders concerning corporate
citizenship and sustainability matters. From time to time, we may
announce certain initiatives, including goals, regarding our focus
areas, which include environmental matters, packaging, responsible
sourcing and social investments. We could fail, or be perceived to
fail, in our achievement of such initiatives or goals, or we could
fail in accurately reporting our progress on such initiatives and
goals. In addition, we could be criticized for the scope of such
initiatives or goals or perceived as not acting responsibly in
connection with these matters. Any such matters, or related
corporate citizenship and sustainability matters, could have a
material adverse effect on our business, financial condition and
results of operations.
In addition, a variety of organizations measure the performance of
companies on environmental, social, and governance (“ESG”) topics,
and the results of these assessments are widely publicized.
Investment in funds that specialize in companies that perform well
in such assessments are increasingly popular, and major
institutional investors have publicly emphasized the importance of
such ESG measures to their investment decisions. Topics taken into
account in such assessments include, among others, the company’s
efforts and impacts on climate change and human rights, ethics and
compliance with law, and the role of the company’s board of
directors in supervising various sustainability
issues.
Furthermore, climate change and other ESG-related legislation and
regulation is being implemented across the world, including in the
U.S., and any such legislation or regulation may impose additional
compliance burdens on us and on third parties in our value chain,
which could potentially result in increased administrative costs,
decreased demand in the marketplace for our products, and/or
increased costs for our supplies and products.
We take into consideration the expected impact of ESG matters on
the sustainability of our business over time and the potential
impact of our business on society and the environment. However, in
light of investors’ increased focus on ESG matters, and in light of
increased and evolving legislation and regulation regarding ESG
matters, there can be no certainty that we will manage such issues
successfully, or that we will successfully meet our customers’ or
society’s expectations as to our proper role. If we fail to meet
the ESG values, standards and metrics that we set for ourselves, or
our articulated public benefit purposes, or fail to align to
regulatory or market expectations or standards regarding such
matters, we may experience negative publicity and a loss of
customers as a result, which will adversely affect our business,
financial condition, and results of operations.
Actions of activist stockholders could be costly and
time-consuming, divert management’s attention and resources, and
have an adverse effect on our business.
While we value open dialogue and input from our stockholders,
activist stockholders could take actions that could be costly and
time-consuming to us, disrupt our operations, and divert the
attention of our board of directors, management, and employees,
such as public proposals and requests for potential nominations of
candidates for election to our board of directors, requests to
pursue a strategic combination or other transaction, or other
special requests. As a result, we have retained, and may in the
future retain additional services of various professionals to
advise us in these matters, including legal, financial and
communications advisers, the costs of which may negatively impact
our future financial results. In addition, perceived uncertainties
as to our future direction, strategy, or leadership created as a
consequence of activist stockholder initiatives may result in the
loss of potential business opportunities, harm our ability to
attract new or retain existing investors, customers, directors,
employees or other partners, and cause our stock price to
experience periods of volatility or stagnation.
Because we have no current plans to pay cash dividends on our
common stock, stockholders may not receive any return on investment
unless they sell our common stock for a price greater than that
which they paid for it.
We have no current plans to pay cash dividends on our common stock.
The declaration, amount and payment of any future dividends will be
at the sole discretion of our board of directors. Our board of
directors may take into account general and economic conditions,
our financial condition and results of operations, our available
cash and current and anticipated cash needs, capital requirements,
contractual, legal, tax and regulatory restrictions and
implications on the payment of dividends by us to our stockholders
or by our subsidiaries to us, including restrictions under the
Amended Credit Agreement and other indebtedness we may incur, and
such other factors as our board of directors may deem
relevant.
Stockholders may be diluted by the future issuance of additional
common stock in connection with our incentive plans, acquisitions
or otherwise.
We had approximately 197.7 million shares of common stock
authorized but unissued and 52,272,764 shares of common stock
outstanding as of May 18, 2022. Our amended and restated
certificate of incorporation authorizes us to issue these shares of
common stock and stock options exercisable for common stock (and
other equity awards) for the consideration and on the terms and
conditions established by our board of directors in its sole
discretion, whether in connection with acquisitions or otherwise.
Any common stock that we issue, including under our existing equity
incentive plans or any additional equity incentive plans that we
may adopt in the future, would dilute the percentage ownership held
by existing investors.
Anti-takeover provisions in our organizational documents and
Delaware law might discourage or delay acquisition attempts for us
that stockholders might consider favorable.
Our amended and restated certificate of incorporation and amended
and restated bylaws contain provisions that may make the
acquisition of our company more difficult without the approval of
our board of directors. Among other things:
•although
we do not have a stockholder rights plan, these provisions allow us
to authorize the issuance of undesignated preferred stock in
connection with a stockholder rights plan or otherwise, the terms
of which may be
established and the shares of which may be issued without
stockholder approval, and which may include super voting, special
approval, dividend or other rights or preferences superior to the
rights of the holders of common stock;
•these
provisions provide for a classified board of directors with
staggered three-year terms;
•these
provisions require advance notice for nominations of directors by
stockholders and for stockholders to include matters to be
considered at our annual meetings;
•these
provisions prohibit stockholder action by written
consent;
•these
provisions provide for the removal of directors only for cause and
only upon affirmative vote of holders of at least 75% of the shares
of common stock entitled to vote generally in the election of
directors; and
•these
provisions require the amendment of certain provisions only by the
affirmative vote of at least 75% of the shares of common stock
entitled to vote generally in the election of
directors.
Further, as a Delaware corporation, we are also subject to
provisions of Delaware law, which may impair a takeover attempt
that our stockholders may find beneficial. These anti-takeover
provisions and other provisions under Delaware law could
discourage, delay or prevent a transaction involving a change in
control of our company, including actions that our stockholders may
deem advantageous, or negatively affect the trading price of our
common stock. These provisions could also discourage proxy contests
and make it more difficult for other stockholders to elect
directors of their choosing and to cause us to take other corporate
actions they may desire.
Our board of directors is authorized to issue and designate shares
of our preferred stock in additional series without stockholder
approval.
Our amended and restated certificate of incorporation authorizes
our board of directors, without the approval of our stockholders,
to issue up to 30 million shares of our preferred stock, subject to
limitations prescribed by applicable law, rules and regulations and
the provisions of our amended and restated certificate of
incorporation, as shares of preferred stock in series, to establish
from time to time the number of shares to be included in each such
series and to fix the designation, powers, preferences and rights
of the shares of each such series and the qualifications,
limitations or restrictions thereof. The powers, preferences and
rights of these additional series of preferred stock may be senior
to or on parity with our common stock, which may reduce its
value.
Our amended and restated certificate of incorporation and amended
and restated bylaws provide that the Court of Chancery of the State
of Delaware will be the exclusive forum for substantially all
disputes between us and our stockholders, which could limit our
stockholders’ ability to obtain a favorable judicial forum for
disputes with us or our directors, officers or
employees.
Our amended and restated certificate of incorporation and amended
and restated bylaws provide that the Court of Chancery of the State
of Delaware is the exclusive forum for any derivative action or
proceeding brought on our behalf, any action asserting a breach of
fiduciary duty, any action asserting a claim against us arising
pursuant to the Delaware General Corporation Law, our amended and
restated certificate of incorporation or our amended and restated
bylaws, or any action asserting a claim against us that is governed
by the internal affairs doctrine. This provision may limit a
stockholder’s ability to bring a claim in a judicial forum that it
finds favorable for disputes with us or our directors, officers or
other employees, which may discourage such lawsuits against us and
our directors, officers and other employees. Alternatively, if a
court were to find this provision in our amended and restated
certificate of incorporation and amended and restated bylaws to be
inapplicable or unenforceable in an action, we may incur additional
costs associated with resolving such action in other jurisdictions,
which could adversely affect our business, financial condition and
results of operations.
General risk factors
Volatility in the financial markets could have a material adverse
effect on our business.
While we currently generate cash flows from our ongoing operations
and have had access to credit markets through our various financing
activities, credit markets may experience significant disruptions.
Deterioration in global financial markets could make future
financing difficult or more expensive. If any financial institution
party to our credit facilities or other
financing arrangements were to declare bankruptcy or become
insolvent, they may be unable to perform under their agreements
with us. This could leave us with reduced borrowing capacity, which
could have a material adverse effect on our business, financial
condition and results of operations.
An active trading market for our common stock may not be sustained,
and the market price of shares of our common stock may be volatile,
which could cause the value of your investment to
decline.
Although our common stock is listed on the NYSE, there can be no
assurances that an active trading market for our common stock will
be sustained. In the absence of an active trading market for our
common stock, stockholders may not be able to sell their common
stock at the time or price they would like to sell.
Even if an active trading market is sustained, the market price of
our common stock may be highly volatile and could be subject to
wide fluctuations. Securities markets often experience significant
price and volume fluctuations. This market volatility, as well as
general economic, market or political conditions, could reduce the
market price of shares of our common stock in spite of our
operating performance. In addition, our results of operations could
be below the expectations of public market analysts and investors
due to a number of potential factors, including variations in our
quarterly results of operations, additions or departures of key
management personnel, changes in consumer preferences or beauty
trends, announcements of new products or significant price
reductions by our competitors, failure to meet analysts’ earnings
estimates, publication of research reports about our industry,
litigation and government investigations, changes or proposed
changes in laws or regulations or differing interpretations or
enforcement thereof affecting our business, adverse market reaction
to any indebtedness we may incur or securities we may issue in the
future, changes in market valuations of similar companies or
speculation in the press or investment community, announcements by
our competitors of significant contracts, acquisitions,
dispositions, strategic partnerships, joint ventures or capital
commitments, adverse publicity about our industry, the level of
success of releases of new products and in response the market
price of shares of our common stock could decrease
significantly.
In addition, in May 2019, we announced that our board of directors
authorized a share repurchase program allowing us to repurchase up
to $25 million of our outstanding shares of common stock (“Share
Repurchase Program”). Purchases under the Share Repurchase Program
may be made from time to time in the open market, in privately
negotiated transactions or otherwise. The timing and amount of any
repurchases pursuant to the Share Repurchase Program will be
determined based on market conditions, share price and other
factors. The Share Repurchase Program may be suspended or
discontinued at any time and there is no guarantee that any shares
will be purchased under the Share Repurchase Program.
In the past, following periods of volatility in the overall market
and the market price of a company’s securities, securities class
action litigation has often been instituted against these
companies. This litigation, if instituted against us, could result
in substantial costs and a diversion of our management’s attention
and resources.
Future sales, or the perception of future sales, by us or our
stockholders in the public market could cause the market price for
our common stock to decline.
The sale of substantial amounts of shares of our common stock in
the public market, or the perception that such sales could occur
could harm the prevailing market price of shares of our common
stock. These sales, or the possibility that these sales may occur,
also might make it more difficult for us to sell equity securities
in the future at a time and at a price that we deem
appropriate.
The holders of up to 3,656,711 shares of our common stock, or
approximately 7% of our outstanding common stock based on shares
outstanding as of May 18, 2022, are entitled to rights with
respect to registration of such shares under the Securities Act
pursuant to a registration rights agreement. In addition, certain
family trusts of our Chairman and Chief Executive Officer, Tarang
Amin, have the right, subject to certain conditions, to require us
to file registration statements covering its or their
shares.
In addition, all the shares of common stock subject to stock
options and restricted stock units and shares of restricted stock
awards outstanding and reserved under our 2014 Equity Incentive
Plan, our 2016 Equity Incentive Award Plan and our 2016 Employee
Stock Purchase Plan have been registered on Form S-8 under the
Securities Act and such shares, once the underlying equity award
vests, will be eligible for sale in the public markets, subject to
Rule 144 limitations applicable to affiliates. We intend to file
one or more registration statements on Form S-8 to cover additional
shares of our common stock or securities convertible into or
exchangeable for shares of our common stock pursuant to automatic
increases in the number
of shares reserved under our 2016 Equity Incentive Award Plan and
our 2016 Employee Stock Purchase Plan. Accordingly, shares
registered under these registration statements on Form S-8 will be
available for sale in the open market.
As restrictions on resale end, the market price of shares of our
common stock could drop significantly if the holders of these
restricted shares sell them or are perceived by the market as
intending to sell them. These factors could also make it more
difficult for us to raise additional funds through future offerings
of shares of our common stock or other securities.
If securities analysts do not publish research or publish
inaccurate or unfavorable research about our business, our stock
price and trading volume could decline.
The trading market for our common stock depends in part on the
research and reports that securities or industry analysts publish
about us or our business. If one or more of the analysts who cover
us downgrade our stock or publish inaccurate or unfavorable
research about our business, our stock price would likely decline.
If one or more of these analysts cease coverage of our company or
fail to publish reports on us regularly, demand for our stock could
decrease, which might cause our stock price and trading volume to
decline.
Item 1B. Unresolved staff comments.
None.
Item 2. Properties.
Our principal executive offices are located in Oakland, California.
We also occupy offices and distribution centers in the United
States and abroad, as indicated blow.
|
|
|
|
|
|
|
|
|
Location/Facility |
Leased/Owned |
Use |
Oakland, California |
Leased |
Corporate headquarters |
New York, New York |
Leased |
Corporate offices |
Los Angeles, California |
Leased |
Corporate offices |
Fairfield, New Jersey |
Leased |
Corporate offices |
Shanghai, China |
Leased |
Corporate offices |
Ontario, California |
Leased |
Distribution |
Rancho Cucamonga, California |
Leased |
Manufacturing
(1)
|
|
|
|
|
|
|
(1)
|
The Company closed its manufacturing plant during the fourth
quarter of the year ended March 31, 2021. See Note 15 Restructuring
and other related costs to consolidated financial statements in
Part IV, Item 13. “Exhibits, financial statement schedules” under
the heading “2021 Restructuring Plan.”
|
We also use a distribution center located in Columbus, Ohio that is
operated by a third-party.
Our properties total an aggregate of approximately 39,894 square
feet of commercial space, approximately 25,350 square feet for
manufacturing and approximately 257,515 square feet of commercial
space for our distribution center.
All of our properties are leased. The leases expire at various
times through 2030, subject to renewal options. We consider our
properties to be generally in good condition and believe that our
existing facilities are adequate to support our existing
operations.
Item 3. Legal proceedings.
We are from time to time subject to, and are presently involved in,
litigation and other proceedings. We believe that there are no
pending lawsuits or claims that, individually or in the aggregate,
may have a material adverse effect on our business, financial
condition or results of operations.
Item 4. Mine safety disclosures.
None.
PART II
Item 5. Market for registrant’s common equity, related stockholder
matters and issuer purchases of equity securities.
Market information for common stock.
Our common stock began trading on the NYSE under the symbol “ELF”
on September 22, 2016. Prior to that date, there was no public
trading market for our common stock. On May 18, 2022, the
closing price for our common stock as reported by the NYSE was
$21.62.
Holders of record
As of May 18, 2022, the approximate number of common
stockholders of record was 15. This number does not include
beneficial owners whose shares are held by nominees in street
name.
Dividends
There were no dividends declared or paid during the year ended
March 31, 2022. Since our initial public offering on September 21,
2016, we have never declared or paid cash dividends on our capital
stock. We intend to retain all available funds and future earnings,
if any, to fund the development and expansion of our business and
we do not anticipate paying any cash dividends in the foreseeable
future. In addition, the Amended Credit Agreement limits our
ability to pay dividends to our stockholders.
Any future determination related to dividend policy will be made at
the discretion of our board of directors and will depend on a
number of factors, including future earnings, capital requirements,
financial conditions, future prospects, contractual restrictions
and covenants and other factors that our board of directors may
deem relevant.
Stock performance graph
The following performance graph and related information shall not
be deemed “soliciting material” or to be “filed” with the SEC, nor
shall such information be incorporated by reference into any future
filing under the Securities Act of 1933 or the Exchange Act, each
as amended, whether made before or after the date hereof and
irrespective of any general incorporation language in any such
filing, or otherwise subject to the liabilities under the
Securities Act of 1933 or Exchange Act, each as amended, except to
the extent that we specifically incorporate it by reference into
such filing.
The following graph compares the total cumulative stockholder
return on our common stock with the S&P 500 Stock Index and the
S&P Consumer Discretionary Index for the 5-year period covering
March 31, 2017, through March 31, 2022. The graph assumes an
investment of $100 made at the closing of trading on March 31,
2017 in (i) our common stock, (ii) the stocks comprising the
S&P 500 Index and (iii) the stocks comprising the S&P 500
Consumer Discretionary Index. All values assume reinvestment of the
full amount of all dividends. The performance shown on the graph
below is not intended to forecast or be indicative of possible
future performance of our common stock.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$100 investment in stock or index |
3/31/17 |
6/30/17 |
9/30/17 |
12/31/17 |
3/31/18 |
6/30/18 |
9/30/18 |
e.l.f. Beauty, Inc. (ELF) |
$ |
100.00 |
|
$ |
96.32 |
|
$ |
79.82 |
|
$ |
78.97 |
|
$ |
68.57 |
|
$ |
53.95 |
|
$ |
45.06 |
|
S&P 500 Index (GSPC) |
$ |
100.00 |
|
$ |
102.74 |
|
$ |
106.81 |
|
$ |
113.34 |
|
$ |
111.96 |
|
$ |
115.24 |
|
$ |
123.53 |
|
S&P 500 Consumer Discretionary Index (S5COND) |
$ |
100.00 |
|
$ |
102.78 |
|
$ |
103.65 |
|
$ |
113.88 |
|
$ |
117.40 |
|
$ |
126.99 |
|
$ |
137.38 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$100 investment in stock or index |
12/31/18 |
3/31/19 |
6/30/19 |
9/30/19 |
12/31/19 |
3/31/20 |
6/30/20 |
e.l.f. Beauty, Inc. (ELF) |
$ |
30.65 |
|
$ |
37.52 |
|
$ |
49.91 |
|
$ |
61.98 |
|
$ |
57.10 |
|
$ |
34.83 |
|
$ |
67.50 |
|
S&P 500 Index (GSPC) |
$ |
106.27 |
|
$ |
120.16 |
|
$ |
124.71 |
|
$ |
126.20 |
|
$ |
136.96 |
|
$ |
109.57 |
|
$ |
131.43 |
|
S&P 500 Consumer Discretionary Index (S5COND) |
$ |
114.83 |
|
$ |
132.88 |
|
$ |
139.90 |
|
$ |
140.62 |
|
$ |
146.91 |
|
$ |
118.57 |
|
$ |
157.52 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$100 investment in stock or index |
9/30/20 |
12/31/20 |
3/31/21 |
6/30/21 |
9/30/21 |
12/31/21 |
3/31/22 |
e.l.f. Beauty, Inc. (ELF) |
$ |
65.03 |
|
$ |
89.17 |
|
$ |
94.97 |
|
$ |
96.07 |
|
$ |
102.83 |
|
$ |
117.56 |
|
$ |
91.43 |
|
S&P 500 Index (GSPC) |
$ |
142.57 |
|
$ |
159.23 |
|
$ |
168.43 |
|
$ |
182.19 |
|
$ |
182.61 |
|
$ |
202.06 |
|
$ |
192.06 |
|
S&P 500 Consumer Discretionary Index (S5COND) |
$ |
181.25 |
|
$ |
195.83 |
|
$ |
201.91 |
|
$ |
215.94 |
|
$ |
215.95 |
|
$ |
243.67 |
|
$ |
221.67 |
|
Recent sales of unregistered securities
None
Purchases of equity securities by the issuer and affiliated
purchasers
In May 2019, we announced that our board of directors authorized
the Share Repurchase Program, which authorizes us to repurchase up
to $25 million of our outstanding shares of common stock. The Share
Repurchase Plan remains in effect through the earlier of (i) the
date that $25 million of our outstanding common stock has been
purchased under the Share Repurchase Plan or (ii) the date that our
board of directors cancels the Share Repurchase Plan.
On April 30, 2021, the Company amended and restated its prior
credit agreement. Subject to certain exceptions, the covenants in
the Amended Credit Agreement require the Company to be in
compliance with certain leverage ratios to make repurchases under
the Share Repurchase Program.
We did not repurchase any shares during the three months ended
March 31, 2022, including pursuant to the Share Repurchase Program.
A total of $17.1 million remains available for purchase under the
Share Repurchase Program as of March 31, 2022.
Item 6. [Reserved]
Item 7. Management’s discussion and analysis of financial condition
and results of operations.
You should read the following discussion and analysis of our
financial condition and results of operations and our consolidated
financial statements and related notes thereto included elsewhere
in this Annual Report.
Overview and Business Trends
We are a multi-brand beauty company that offers inclusive,
accessible, cruelty-free cosmetics and skincare products. Our
mission is to make the best of beauty accessible to every eye, lip
and face.
We believe our ability to deliver 100% cruelty-free,
premium-quality products at accessible prices with broad appeal
differentiates us in the beauty industry. We believe the
combination of our fundamental value equation, digitally-led
strategy, as well as our world-class team’s ability to execute with
speed, has positioned us well to navigate a rapidly changing
landscape in beauty.
Our family of brands includes e.l.f. Cosmetics, e.l.f. SKIN, Well
People and Keys Soulcare. Our brands are available online and
across leading beauty, mass-market, and clean-beauty specialty
retailers. We have strong relationships with our retail partners
such as Walmart, Target, Ulta Beauty and other leading retailers
that have enabled us to expand distribution both domestically and
internationally.
For additional information regarding our business, see Part I, Item
1, “Business.”
COVID-19 Pandemic
The beauty industry and our business were impacted in the years
ended March 31, 2022 and March 31, 2021 by the COVID-19 pandemic.
There could be continued impact on the industry and our business
results until consumers return to normal shopping patterns and
quarantine and/or social gathering restrictions are removed. In
addition, a current vessel and container shortage globally could
delay future inventory receipts and, in turn, could delay
deliveries to our retailers and availability of products in our
direct-to-consumer e-commerce channel or could increase our
shipping costs. Such potential delays and shipping disruptions
could negatively impact our results of operations through higher
inventory costs and reduced sales. Throughout the COVID-19 pandemic
we have focused on the following areas to address the impact on our
business: supporting the health and safety of our employees and
community; minimizing disruption to the supply chain; and keeping
adequate levels of liquidity and flexibility within our credit
facility.
Tariffs
Tariffs have impacted the majority of products that we import from
China to the United States. We have taken various steps to help
mitigate the impact of tariffs including price increases,
negotiating lower prices with our suppliers in China, and exploring
potential new suppliers outside of China.
Components of our results of operations and trends affecting our
business
Net sales
We develop, market and sell beauty products under the e.l.f.
Cosmetics, e.l.f. SKIN, Well People and Keys Soulcare brands. Our
net sales are derived from sales of these beauty products, net of
provisions for sales discounts and allowances, product returns,
markdowns and price adjustments.
Year over year changes in net sales is driven by a number of
factors, including color cosmetics and skincare category
performance, levels of consumer spending, and our ability to drive
awareness of and demand for our products. Within our existing
retailer accounts, we are able to drive growth by increasing sales
per linear foot supported by marketing investments and continued
innovation, as well as through expanding space and door
penetration. While we have distribution with a number of key retail
accounts, we expect to continue to grow through improved sales per
linear foot in our existing space, expanded space allocation with
our current retail accounts, as well as adding new retail
customers.
Our business faces challenges and uncertainties, including our
ability to introduce new products that will appeal to a broad
consumer base, our ability to service demand, the ability of our
major retail customers to drive traffic and keep products in stock,
our ability to continue to grow our customer base and competitive
threats from other beauty companies.
Our largest three customers, Walmart, Target and Ulta Beauty,
accounted for 26%, 23% and 12%, respectively, of our net sales in
the year ended March 31, 2022. No other individual customer
accounted for 10% or more of our net sales in the year ended March
31, 2022. National and international retailers comprised 90% of our
net sales. The remaining 10% came from our direct-to-consumer
e-commerce channels in the year ended March 31, 2022.
The primary market for our products is in the United States, which
accounted for 89% of our net sales in the year ended March 31,
2022. The remaining 11% was attributable to international markets,
primarily Canada and the United Kingdom.
Gross profit
Gross profit is our net sales less cost of sales. Cost of sales
includes the aggregate costs to procure our products, including the
amounts invoiced by our third-party contract manufacturers for
finished goods as well as costs related to transportation to our
distribution center, customs and duties. Cost of sales also
includes the effect of changes in the balance of reserves for
excess and obsolete inventory. Gross margin measures our gross
profit as a percentage of net sales.
We have an extensive network of third-party manufacturers
(primarily in China) from whom we purchase substantially all of our
finished goods. We have worked to evolve our supply chain to
increase capacity and technical capabilities while maintaining or
reducing overall costs as a percentage of sales.
Historically, we have improved our gross margin largely through
changes in our product mix, pricing, purchasing efficiencies and
cost reductions in our supply chain. Other drivers of changes in
gross margin include fluctuations in exchange rates, changes in
customer mix, and changes in the balance of reserves for excess and
obsolete inventory, among other things, which may offset the
benefit of changes in product mix, pricing, purchasing efficiencies
and cost reductions.
Selling, general and administrative
Our selling, general and administrative (“SG&A”) expenses
primarily consist of personnel-related expenses, including
salaries, bonuses, fringe benefits and stock based compensation,
marketing and digital expenses, warehousing and distribution costs,
costs related to merchandising, depreciation of property and
equipment, amortization of retail product displays and amortization
of intangible assets. See “Critical Accounting Policies and
Estimates stock based Compensation” below for more detail regarding
stock based compensation.
Interest expense, net
Interest expense primarily consists of cash interest and fees on
our outstanding indebtedness. See “Financial condition, liquidity
and capital resources” below and a description of our indebtedness
in Note 8 to the Notes to consolidated financial statements in Part
IV, Item 15. “Exhibits, financial statement
schedules”.
Other income (expense), net
We are exposed to periodic currency fluctuations given our
purchasing and selling activities in various countries. Other
income (expense), net is primarily related to foreign exchange rate
movements.
Income tax (provision) benefit
The provision for income taxes represents federal, foreign, state
and local income taxes. The effective rate differs from statutory
rates due to the effect of state and local income taxes and certain
permanent tax adjustments. Our effective tax rate will change from
period to period based on recurring and nonrecurring factors
including, but not limited to, the geographical mix of earnings,
enacted tax legislation, state and local income taxes, tax audit
settlements, the interaction of various tax strategies and the
impact of permanent tax adjustments, such as those related to stock
based compensation.
Net income
Our net income for future periods will be affected by the various
factors described above.
Results of operations
The following table sets forth our consolidated statements of
operations data in dollars and as a percentage of net sales for the
periods presented.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended March 31, |
|
2022 |
|
2021 |
|
2020 |
Net sales |
$ |
392,155 |
|
|
$ |
318,110 |
|
|
$ |
282,851 |
|
Cost of sales |
140,423 |
|
|
111,912 |
|
|
101,728 |
|
Gross profit |
251,732 |
|
|
206,198 |
|
|
181,123 |
|
Selling, general and administrative expenses |
221,912 |
|
|
194,157 |
|
|
157,155 |
|
Restructuring expense (income) |
50 |
|
|
2,641 |
|
|
(5,982) |
|
Operating income |
29,770 |
|
|
9,400 |
|
|
29,950 |
|
Other (expense) income, net |
(1,438) |
|
|
(1,620) |
|
|
426 |
|
Interest expense, net |
(2,441) |
|
|
(4,090) |
|
|
(6,307) |
|
Loss on extinguishment of debt |
(460) |
|
|
— |
|
|
— |
|
Income before provision for income taxes |
25,431 |
|
|
3,690 |
|
|
24,069 |
|
Income tax (provision) benefit |
(3,661) |
|
|
2,542 |
|
|
(6,185) |
|
Net income |
$ |
21,770 |
|
|
$ |
6,232 |
|
|
$ |
17,884 |
|
Comprehensive income |
$ |
21,770 |
|
|
$ |
6,232 |
|
|
$ |
17,884 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended March 31, |
(percentage of net sales) |
2022 |
|
2021 |
|
2020 |
Net sales |
100 |
% |
|
100 |
% |
|
100 |
% |
Cost of sales |
36 |
% |
|
35 |
% |
|
36 |
% |
Gross profit |
64 |
% |
|
65 |
% |
|
64 |
% |
Selling, general and administrative expenses |
57 |
% |
|
61 |
% |
|
56 |
% |
Restructuring expense (income) |
— |
% |
|
1 |
% |
|
(2) |
% |
Operating income |
8 |
% |
|
3 |
% |
|
11 |
% |
Other (expense) income, net |
— |
% |
|
(1) |
% |
|
— |
% |
Interest expense, net |
(1) |
% |
|
(1) |
% |
|
(2) |
% |
Loss on extinguishment of debt |
— |
% |
|
— |
% |
|
— |
% |
Income before provision for income taxes |
6 |
% |
|
1 |
% |
|
9 |
% |
Income tax (provision) benefit |
(1) |
% |
|
1 |
% |
|
(2) |
% |
Net income |
6 |
% |
|
2 |
% |
|
6 |
% |
Comprehensive income |
6 |
% |
|
2 |
% |
|
6 |
% |
Comparison of the year ended March 31, 2022 to the year ended
March 31, 2021
Net sales
Net sales increased $74.0 million, or 23%, to
$392.2 million in the year ended March 31, 2022, from
$318.1 million in the year ended March 31, 2021. The
increase was driven primarily by strength in our national and
international retailers. Net sales increased $76.8 million, or 28%,
in our retailer channels, offset by a decrease of $2.8 million, or
6%, in our e-commerce channels. From a price and volume
perspective, a higher volume of units sold drove $59.4 million
of the increase in net sales and a higher average item price within
retailer and e-commerce orders drove the remaining
$14.6 million increase in net sales as compared to the year
ended March 31, 2021.
Gross profit
Gross profit increased $45.5 million, or 22%, to
$251.7 million in the year ended March 31, 2022, compared to
$206.2 million in the year ended March 31, 2021. Gross
margin decreased from 65% in the year ended March 31, 2021 to
64% in the year ended March 31, 2022. Increased volume accounted
for approximately $48.0 million of the increase in gross profit,
offset by a $2.5 million decline related to the decrease in gross
margin rate. The decrease in gross margin rate was primarily driven
by unfavorable foreign exchange rates and elevated transportation
costs. These items were partially offset by price increases, cost
savings and margin accretive mix.
Selling, general and administrative expenses
SG&A expenses were $221.9 million in the year ended March
31, 2022, an increase of $27.8 million, or 14%, from
$194.2 million in the year ended March 31, 2021. SG&A
expenses as a percentage of net sales decreased to 57% for the year
ended March 31, 2022 from 61% in the year ended March 31,
2021. The increase on a dollar basis was primarily related to
increased marketing and digital spend of $15.1 million along
with increased compensation and benefits of $5.7 million and
increased software subscription costs of
$2.8 million.
Restructuring expense
Restructuring expenses were $50 thousand in the year ended March
31, 2022. See Note 13 Restructuring and other related costs to
consolidated financial statements in Part IV, Item 15. “Exhibits,
financial statement schedules” for further details.
Other expense, net
Other expense, net was $1.4 million of expense in the year
ended March 31, 2022, as compared to $1.6 million of expense
in the year ended March 31, 2021. The change was primarily
related to foreign exchange rate movements.
Interest expense, net
Interest expense decreased $1.6 million, or 40%, to
$2.4 million in the year ended March 31, 2022, as compared to
$4.1 million in the year ended March 31, 2021. This
decrease was due to a reduction in our long-term debt as well as a
decline in interest rates.
Income tax (provision) benefit
The provision for income taxes increased from a benefit of $2.5
million, or an effective tax rate of (69)%, for the year ended
March 31, 2021, to an expense of $3.7 million, or an effective
tax rate of 14%, for the year ended March 31, 2022. The change in
the provision for income taxes was primarily driven by an increase
in income before taxes of $21.7 million. One-time tax benefits
related to stock based compensation were consistent between
periods.
Comparison of the year ended March 31, 2021 to the year ended
March 31, 2020
Net sales
Net sales increased $35.3 million, or 12%, to $318.1 million in the
year ended March 31, 2021, from $282.9 million in the year ended
March 31, 2020. The increase was driven by strength in e-commerce,
international, and our national retailers. Net sales increased
$18.1 million, or 7% in our retailer channels and $17.0 million, or
64% in our e-commerce channels. From a price and volume
perspective, a higher average item price within retailer and
e-commerce orders substantially drove the $35.3 million dollar
increase in net sales while volume remained flat as compared to the
year ended March 31, 2020.
Gross profit
Gross profit increased $25.1 million, or 14%, to $206.2 million in
the year ended March 31, 2021, compared to $181.1 million in the
year ended March 31, 2020. Increased volume accounted for
approximately $22.6 million of the increase in gross profit, with
the remaining $2.5 million driven by an increase in gross margin
rate. The increase in gross margin rate was driven by benefits from
margin accretive innovation, cost savings, a mix shift to
elfcosmetics.com, and price increases partially offset by certain
costs related to retailer activity and space expansion, an increase
in inventory adjustments, and the impact of tariffs on goods
imported from China in the year ended March 31, 2021. The net of
these drivers resulted in an 80 basis point increase in gross
margin, which increased from 64% in the year ended March 31, 2020
to 65% in the year ended March 31, 2021.
Selling, general and administrative expenses
SG&A expenses were $194.2 million in the year ended March 31,
2021, an increase of $37.0 million, or 24%, from $157.2 million in
the year ended March 31, 2020. SG&A expenses as a percentage of
net sales increased to 61% for the year ended March 31, 2021 from
56% in the year ended March 31, 2020. The increase was primarily
related to marketing and digital, including costs related to
advertising, digital, and organizational costs related to building
out our marketing, digital and innovation capabilities of $22.0
million. Additionally, we experienced increased operational costs
mainly driven by the increase in e-commerce sales of $6.9
million.
Restructuring expense
Restructuring expenses were $2.6 million in the year ended March
31, 2021, consisting of charges related to the closure of our
manufacturing facility in California.
Other expense, net
Other expense, net was $1.6 million of expense in the year ended
March 31, 2021, as compared to $0.4 million of income in the year
ended March 31, 2020. The change was primarily related to foreign
exchange rate movements.
Interest expense, net
Interest expense decreased $2.2 million, or 35%, to $4.1 million in
the year ended March 31, 2021, as compared to $6.3 million in the
year ended March 31, 2020. This decrease was due to a reduction in
our long-term debt as well as a decline in interest
rates.
Income tax benefit (provision)
The provision for income taxes decreased from an expense of $6.2
million, or an effective tax rate of 26%, for the year ended March
31, 2020, to a benefit of $2.5 million, or an effective tax rate of
(69)%, for the year ended March 31, 2021. The change in the
provision for income taxes was primarily driven by a decrease in
income before taxes of $20.4 million and an increase in one-time
tax benefits of $3.7 million, primarily related to stock based
compensation.
Financial condition, liquidity and capital resources
Overview
As of March 31, 2022, we held $43.4 million of cash and cash
equivalents. In addition, as of March 31, 2022, we had borrowing
capacity of $100.0 million under the Amended Revolving Credit
Facility.
Our primary cash needs are for capital expenditures, retail product
displays and working capital. Capital expenditures typically vary
depending on strategic initiatives selected for the fiscal year,
including investments in infrastructure, digital capabilities, and
expansion within or to additional retailer store locations. We
expect to fund ongoing capital expenditures from existing cash on
hand, cash generated from operations and, if necessary, draws on
the Amended Revolving Credit Facility.
Our primary working capital requirements are for product and
product-related costs, payroll, rent, distribution costs and
advertising and marketing. Fluctuations in working capital are
primarily driven by the timing of when a retailer rearranges or
restocks its products, expansion of space within our existing
retailer base and the general seasonality of our business. As of
March 31, 2022, we had working capital, excluding cash, of
$84.7 million, compared to $39.0 million as of March 31,
2021. Working capital, excluding cash and debt, was
$90.4 million and $55.3 million as of March 31, 2022 and
March 31, 2021, respectively.
We believe that our operating cash flow, cash on hand and available
financing under the Amended Revolving Credit Facility will be
adequate to meet our planned operating, investing and financing
needs for the next twelve months. If necessary, we can borrow funds
under the Amended Revolving Credit Facility to finance our
liquidity requirements, subject to customary borrowing conditions.
To the extent additional funds are necessary to meet our long-term
liquidity needs as we continue to execute our business strategy, we
anticipate that they will be obtained through the incurrence of
additional indebtedness, additional equity financings or a
combination of these potential sources of funds; however, such
financing may not be available on favorable terms, or at all. Our
ability to meet our operating, investing and financing needs
depends to a significant extent on our future financial
performance, which will be subject in part to general economic,
competitive, financial, regulatory and other factors that are
beyond our control, including those described elsewhere in Part I,
Item 1A “Risk factors”. In addition to these general economic and
industry factors, the principal factors in determining whether
our
cash flows will be sufficient to meet our liquidity requirements
will be our ability to provide innovative products to our consumers
and manage production and our supply chain.
Cash flows
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended March 31, |
(in thousands) |
2022 |
|
2021 |
|
2020 |
Net cash provided by (used in): |
|
|
|
|
|
Operating activities |
$ |
19,513 |
|
|
$ |
29,475 |
|
|
$ |
44,313 |
|
Investing activities |
(4,818) |
|
|
(6,474) |
|
|
(35,345) |
|
Financing activities |
(29,110) |
|
|
(11,400) |
|
|
(16,675) |
|
Net (decrease) increase in cash: |
$ |
(14,415) |
|
|
$ |
11,601 |
|
|
$ |
(7,707) |
|
Cash provided by operating activities
For the year ended March 31, 2022, net cash provided by operating
activities was $19.5 million. This included net income, before
deducting depreciation, amortization and other non-cash items, of
$66.2 million and an increase in net working capital of
$46.7 million. The increase in net working capital was driven
by a $5.6 million increase in accounts receivable, a
$27.7 million increase in inventory, a $10.6 million
increase in prepaid and other assets and a $1.5 million increase of
accounts payable and accrued expenses, partially offset by a
$4.4 million decrease of other liabilities.
For the year ended March 31, 2021, net cash provided by operating
activities was $29.5 million. This included net income, before
deducting depreciation, amortization and other non-cash items, of
$46.4 million and an increase in net working capital of
$16.9 million. The increase in net working capital was driven
by a $10.5 million increase in accounts receivable, a
$10.9 million increase in inventory and a $9.7 million
increase in prepaid and other assets, partially offset by a $17.5
million increase of accounts payable and accrued
expenses.
For the year ended March 31, 2020, net cash provided by operating
activities was $44.3 million. This included net income, before
deducting depreciation, amortization and other non-cash items, of
$54.3 million and an increase in net working capital of
$10.0 million. The increase in net working capital was driven
by an $11.5 million decrease in other liabilities primarily related
to termination payments on store leases, partially offset by the
timing of cash payments related to accounts payable and accrued
expenses.
Cash used in investing activities
For the year ended March 31, 2022, net cash used in investing
activities was $4.8 million, which was primarily driven by capital
expenditures related to new customer fixture programs.
For the year ended March 31, 2021, net cash used in investing
activities was $6.5 million, which was primarily driven by capital
expenditures related to new customer fixture programs.
For the year ended March 31, 2020, net cash used in investing
activities was $35.3 million.
This includes $25.9 million paid for the acquisition of Well
People, Inc. and capital expenditures of $9.4 million.
Cash used in financing activities
For the year ended March 31, 2022, net cash used in financing
activities was $29.1 million, driven by $54.5 million of repayment
of the revolving line of credit and the term loan facility, and
$25.6 million of cash received from net of proceeds from the
amended revolving line of credit and the Amended term loan
facility.
For the year ended March 31, 2021, net cash used in financing
activities was $11.4 million, driven by $11.8 million in mandatory
principal payments under the prior term loan facility. This was
partially offset by $1.5 million of proceeds from the exercise of
options to purchase common stock.
For the year ended March 31, 2020, net cash used in financing
activities was $16.7 million, driven by $9.5 million in mandatory
principal payments under the prior term loan facility and
repurchase of common stock of $7.9 million. This was partially
offset by $1.5 million of proceeds from the exercise of options to
purchase common stock.
Description of indebtedness
Amended credit agreement
On April 30, 2021, we amended and restated the prior credit
agreement (the "Amended Credit Agreement"), amended and restated
the prior term loan facility and the prior revolving credit
facility, and refinanced all loans under the prior credit
agreement.
The Amended Credit Agreement has a five year term and consists of
(i) a $100 million revolving credit facility (the “Amended
Revolving Credit Facility”) and (ii) a $100 million term loan
facility (the "Amended Term Loan Facility").
All amounts under the Amended Revolving Credit Facility are
available for draw until the maturity date on April 30, 2026. The
Amended Revolving Credit Facility is collateralized by
substantially all of our assets and requires payment of an unused
fee ranging from 0.10% to 0.30% (based on our consolidated total
net leverage ratio (as defined in the Amended Credit Agreement))
times the average daily amount of unutilized commitments under the
Amended Revolving Credit Facility. The Amended Revolving Credit
Facility also provides for sub-facilities in the form of a $7
million letter of credit and a $5 million swing line loan; however,
all amounts under the Amended Revolving Credit Facility cannot
exceed $100 million. The unused balance of the Amended Revolving
Credit Facility as of March 31, 2022 was $100.0
million.
Both the Amended Revolving Credit Facility and the Amended Term
Loan Facility bear interest, at borrowers’ option, at either (i) a
rate per annum equal to an adjusted LIBOR rate determined by
reference to the cost of funds for the United States dollar
deposits for the applicable interest period (subject to a minimum
floor of 0%) plus an applicable margin ranging from 1.25% to 2.125%
based on our consolidated total net leverage ratio or (ii) a
floating base rate plus an applicable margin ranging from 0.25% to
1.125% based on our consolidated total net leverage ratio. The
interest rate as of December 31, 2021 for the Amended Term Loan
Facility was approximately 2.3%.
The Amended Credit Agreement contains a number of covenants that,
among other things, restrict our ability to (subject to certain
exceptions) pay dividends and distributions or repurchase our
capital stock, incur additional indebtedness, create liens on
assets, engage in mergers or consolidations and sell or otherwise
dispose of assets. The Amended Credit Agreement also includes
reporting, financial and maintenance covenants that require us to,
among other things, comply with certain consolidated total net
leverage ratios and consolidated fixed charge coverage ratios. As
of March 31, 2022, we were in compliance with all financial
covenants under the Amended Credit Agreement.
Off-balance sheet arrangements
We are not party to any off-balance sheet
arrangements.
Critical accounting policies and estimates
Our consolidated financial statements included elsewhere in this
Annual Report have been prepared in accordance with U.S. generally
accepted accounting principles. The preparation of our financial
statements requires us to make estimates and judgments that affect
the reported amounts of assets, liabilities, revenues and expenses.
We base our estimates on historical experience and on various other
assumptions that we believe are reasonable under the circumstances.
Actual results may differ from these estimates under different
assumptions or conditions. While our significant accounting
policies are more fully described in the Note 2 to consolidated
financial statements in Part IV, Item 15. “Exhibits, financial
statement schedules”, we believe that the following accounting
policies and estimates are critical to our business operations and
understanding of our financial results.
Revenue recognition
We recognize revenue when control of promised goods or services is
transferred to a customer in an amount that reflects the
consideration that we expect to receive in exchange for those goods
or services. Control of the substantial majority of the products
that we sell is transferred at a point in time. Factors that
determine the specific point in time a customer obtains control and
a performance obligation is satisfied are when we have a present
right to payment for the goods, whether the customer has physical
possession and title to the goods, and whether significant risks
and rewards of ownership have transferred. Delivery is typically
considered to have occurred at the time the title and risk of loss
passes to the customer.
In the normal course of business, we offer various incentives to
customers such as sales discounts, markdown support and other
incentives and allowances, which give rise to variable
consideration. The amount of variable consideration is estimated at
the time of sale based on either the expected value method or the
most likely amount, depending on the nature of the
variability. We regularly review and revise, when deemed necessary,
our estimates of variable consideration based on both
customer-specific expectations as well as historical rates of
realization. A provision for unclaimed customer incentives and
allowances is included on the consolidated balance sheet, net
against accounts receivable.
Impairment of long-lived assets, including goodwill and intangible
assets
We assess potential impairments to our long-lived assets, which
include property and equipment, retail product displays, and
amortizable intangible assets, whenever events or circumstances
indicate that the carrying amount of an asset may not be
recoverable. Recoverability of an asset is measured by a comparison
of the carrying amount of an asset group to the estimated
undiscounted future cash flows expected to be generated by the
asset. If the carrying amount of the asset group exceeds its
estimated undiscounted future cash flows, an impairment charge is
recognized as the amount by which the carrying amount of the asset
exceeds the fair value of the asset. There were no impairment
charges recorded on long-lived assets during the years ended March
31, 2022 or March 31, 2021.
We evaluate our indefinite-lived intangible asset to determine
whether current events and circumstances continue to support an
indefinite useful life. In addition, our indefinite-lived
intangible asset is tested for impairment annually. The
indefinite-lived intangible asset impairment test consists of a
comparison of the fair value of each asset with its carrying value,
with any excess of carrying value over fair value being recognized
as an impairment loss. We are also permitted to make a qualitative
assessment of whether it is more likely than not that an
indefinite-lived intangible asset’s fair value is less than its
carrying value prior to applying the quantitative assessment. If
based on our qualitative assessment it is more likely than not that
the carrying value of the asset is less than its fair value, then a
quantitative assessment may be required.
The goodwill impairment test consists of a comparison of each
reporting unit’s fair value to its carrying value. The fair value
of a reporting unit is an estimate of the amount for which the unit
as a whole could be sold in a current transaction between willing
parties. If the carrying value of a reporting unit exceeds its fair
value, goodwill is written down to its implied fair value. We are
also permitted to make a qualitative assessment of whether it is
more likely than not that the fair value of a reporting unit is
less than its carrying value prior to applying the quantitative
assessment. If based on our qualitative assessment it is more
likely than not that the carrying value of the reporting unit is
less than its fair value, then a quantitative assessment may be
required. We have identified a single reporting unit for purposes
of impairment testing.
We have selected October 1 as the date on which to perform our
annual impairment tests. We also test for impairment whenever
events or circumstances indicate that the fair value of goodwill or
indefinite-lived intangible assets has been impaired. No impairment
of goodwill or our indefinite-lived intangible asset was recorded
during the years ended March 31, 2022 or March 31,
2021.
Stock based compensation
Stock based compensation cost is measured at grant date, based on
the fair value of the award, and is recognized on a straight-line
basis over the requisite service period for all awards that vest.
We estimate the fair value of employee stock based payment awards
subject to only a service condition on the date of grant using the
Black-Scholes valuation model. The Black-Scholes model requires the
use of highly subjective and complex assumptions, including the
option’s expected term and the price volatility of the underlying
stock. We estimate the fair value of employee stock based payment
awards subject to market conditions on the date of grant using a
Monte Carlo simulation model.
We recognize compensation expense for awards with only a service
condition on a straight-line basis over the requisite service
period, which is generally the award’s vesting period. Compensation
expense for employee stock based awards whose vesting is subject to
the fulfillment of both a market condition and the occurrence of a
performance condition is recognized on a graded-vesting basis at
the time the achievement of the performance condition becomes
probable. We account for forfeitures as they occur.
The expected stock price volatility for common stock was estimated
by taking the average historic price volatility for industry peers
based on daily price observations over a period equivalent to the
expected term of the stock option grants. Industry peers consist of
several public companies in our industry which are of similar size,
complexity and stage of development. The risk-free interest rate
for the expected term of the option is based on the U.S. Treasury
implied yield at the date of grant. The weighted-average expected
term is determined with reference to historical exercise and
post-vesting cancellation experience and the vesting period and
contractual term of the awards.
We have no current plans to pay a regular dividend.
New accounting pronouncements
See Note 2 Summary of significant accounting policies to the Notes
to consolidated financial statements in Part IV, Item 15.
“Exhibits, Financial Statement Schedules” for information regarding
new accounting pronouncements.
We comply with any new or revised accounting standards on the
relevant dates on which adoption of such standards is required for
publicly traded companies that are not emerging growth
companies.
Item 7A. Quantitative and qualitative disclosures about market
risk.
We are exposed to certain market risks arising from transactions in
the normal course of our business. Such risk is principally
associated with interest rates and foreign exchange.
Interest rate risk
We had cash, cash equivalents of $43.4 million and $57.8 million as
of March 31, 2022 and March 31, 2021, respectively. Our cash and
cash equivalents consist of cash and money market funds, which are
highly liquid and, as such, are not sensitive to interest rate
risk.
We are exposed to changes in interest rates because the
indebtedness incurred under the Amended Credit Agreement is
variable rate debt. Interest rate changes generally do not affect
the market value of our Amended Credit Facility; however, they do
affect the amount of our interest payments. A hypothetical 1%
increase or decrease of interest rates would result in a decrease
or increase, respectively, in interest expense on an annualized
basis of approximately $1.0 million as of March 31,
2022.
Foreign exchange risk
We are exposed to foreign exchange risk as we sell product into
Canada, the United Kingdom, Europe and other smaller international
markets. We also have exposure to the Chinese Renminbi as we source
nearly all our products from China. We do not have an active
hedging program, and all of our legacy exchange rate forward
contracts matured in 2016. We neither used these foreign currency
forward contracts for trading purposes nor did we follow hedge
accounting, and therefore the periodic impact of these legacy
hedging activities was calculated on a mark-to-market basis.
Accordingly, the foreign currency forward contracts were carried at
their fair value either as an asset or liability on the
consolidated balance sheet with changes in fair value being
recorded in other income (expense), net in our consolidated
statements of operations.
Foreign currency transaction exposure from a 10% movement of
currency exchange rates would have a material impact on our
reported cost of sales and net income. Based on a hypothetical 10%
adverse movement in RMB as compared to the US dollar, our cost of
sales and net income would be adversely affected by approximately
$14.5 million for the year ended March 31, 2022.
Item 8. Financial statements and supplementary data.
The following consolidated financial statements are incorporated by
reference herein:
|
|
|
|
|
|
e.l.f. Beauty, Inc. and subsidiaries |
Index to consolidated financial statements |
|
Page |
|
|
|
|
|
|
|
|
|
|
|
|
Item 9. Changes in and disagreements with accountants on accounting
and financial disclosure.
None.
Item 9A. Controls and procedures.
Evaluation of Disclosure Controls and Procedures
As of March 31, 2022, our management conducted an evaluation, under
the supervision and with the participation of our Chief Executive
Officer and Chief Financial Officer, of the effectiveness of the
design and operation of our disclosure controls and procedures, as
defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act.
Based upon that evaluation, our Chief Executive Officer and Chief
Financial Officer concluded that, as of March 31, 2022, our
disclosure controls and procedures were effective to provide
reasonable assurance that the information required to be disclosed
by the Company in the reports that it files or submits under the
Exchange Act is recorded, processed, summarized and reported within
the time periods specified in SEC rules and forms and that such
information is accumulated and communicated to the officers who
certify our financial reports and to the members of the Company’s
senior management and board of directors as appropriate to allow
timely decisions regarding required disclosure.
Management’s Annual Report on Internal Control over Financial
Reporting
Our management is responsible for establishing and maintaining
adequate internal control over financial reporting, as such term is
defined in the Exchange Act. Internal control over financial
reporting is designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial
statements prepared for external purposes in accordance with
generally accepted accounting principles. Because of its inherent
limitations, internal control over financial reporting may not
prevent or detect misstatements.
Under the supervision and with the participation of our Chief
Executive Officer and Chief Financial Officer, our management
conducted an evaluation of the effectiveness of our internal
control over financial reporting based upon the framework in
“Internal Control - Integrated Framework (2013)” issued by the
Committee of Sponsoring Organizations of the Treadway Commission.
Based on that evaluation, management concluded that our internal
control over financial reporting was effective as of March 31,
2022.
Deloitte & Touche LLP, an independent registered public
accounting firm, was retained to audit our Consolidated Financial
Statements and the effectiveness of our internal control over
financial reporting. They have issued an attestation report on our
internal control over financial reporting as of March 31, 2022,
which is included herein.
Changes in Internal Control over Financial Reporting
There were no changes to our internal control over financial
reporting that occurred during the quarter ended March 31, 2022
that have materially affected, or are reasonably likely to
materially affect, our internal control over financial reporting.
We have not experienced any material impact to our internal
controls over financial reporting despite the fact that many of our
employees are working remotely due to the COVID-19 pandemic. We are
continually monitoring and assessing the impact of
the COVID-19 pandemic on our internal controls to minimize the
impact on the design and operating effectiveness of our
controls.
Section 302 and 906 Certification
The required certification of our Chief Executive Officer and Chief
Financial Officer under Sections 302 and 906 of the Sarbanes-Oxley
Act of 2002 are included as exhibits to this Annual Report (See
Exhibits 31 and 32 under Part IV, Item 15. "Exhibits, Financial
Statement Schedules").
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM
To the stockholders and the Board of Directors of e.l.f. Beauty,
Inc.
Opinion on Internal Control over Financial Reporting
We have audited the internal control over financial reporting of
e.l.f. Beauty, Inc. and subsidiaries (the “Company”) as of March
31, 2022, based on criteria established in
Internal Control — Integrated Framework (2013)
issued by the Committee of Sponsoring Organizations of the Treadway
Commission (COSO). In our opinion, the Company maintained, in all
material respects, effective internal control over financial
reporting as of March 31, 2022, based on criteria established
in
Internal Control — Integrated Framework (2013)
issued by COSO.
We have also audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States) (PCAOB),
the consolidated financial statements as of and for the year ended
March 31, 2022, of the Company and our report dated May 26, 2022,
expressed an unqualified opinion on those financial
statements.
Basis for Opinion
The Company’s management is responsible for maintaining effective
internal control over financial reporting and for its assessment of
the effectiveness of internal control over financial reporting,
included in the accompanying Management’s Annual Report on Internal
Control over Financial Reporting. Our responsibility is to express
an opinion on the Company’s internal control over financial
reporting based on our audit. We are a public accounting firm
registered with the PCAOB and are required to be independent with
respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the
Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the
PCAOB. Those standards require that we plan and perform the audit
to obtain reasonable assurance about whether effective internal
control over financial reporting was maintained in all material
respects. Our audit included obtaining an understanding of internal
control over financial reporting, assessing the risk that a
material weakness exists, testing and evaluating the design and
operating effectiveness of internal control based on the assessed
risk, and performing such other procedures as we considered
necessary in the circumstances. We believe that our audit provides
a reasonable basis for our opinion.
Definition and Limitations of Internal Control over Financial
Reporting
A company’s internal control over financial reporting is a process
designed to provide reasonable assurance regarding the reliability
of financial reporting and the preparation of financial statements
for external purposes in accordance with generally accepted
accounting principles. A company’s internal control over financial
reporting includes those policies and procedures that (1) pertain
to the maintenance of records that, in reasonable detail,
accurately and fairly reflect the transactions and dispositions of
the assets of the company; (2) provide reasonable assurance that
transactions are recorded as necessary to permit preparation of
financial statements in accordance with generally accepted
accounting principles, and that receipts and expenditures of the
company are being made only in accordance with authorizations of
management and directors of the company; and (3) provide reasonable
assurance regarding prevention or timely detection of unauthorized
acquisition, use, or disposition of the company’s assets that could
have a material effect on the financial statements.
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements. Also,
projections of any evaluation of effectiveness to future periods
are subject to the risk that controls may become inadequate because
of changes in conditions, or that the degree of compliance with the
policies or procedures may deteriorate.
/s/ Deloitte & Touche LLP
San Francisco, California
May 26, 2022
Item 9B. Other information.
None.
Item 9C. Disclosure regarding foreign jurisdictions that prevent
inspections.
None.
PART III
Item 10. Directors, executive officers and corporate
governance.
The information required by this Part III, Item 10 is incorporated
by reference to the sections entitled “Our Board of Directors”,
“Our Executive Officers", and “Corporate Governance Materials (or
similar titles) that will be contained in our Definitive Proxy
Statement relating to our 2022 annual meeting of stockholders (our
“Proxy Statement”). Our Proxy Statement will be filed with the SEC
within 120 days of March 31, 2022.
Item 11. Executive compensation.
The information required by this Part III, Item 11 is incorporated
by reference to the sections entitled “Our Board of Directors” and
“Executive Compensation” (or similar titles) that will be contained
in the Proxy Statement.
Item 12. Security ownership of certain beneficial owners and
management and related stockholder matters.
The information required by this Part III, Item 12 is incorporated
by reference to the sections entitled “Equity Compensation Plan
Information” and “Beneficial Ownership of Common Stock” (or similar
titles) that will be contained in the Proxy Statement.
Item 13. Certain relationships and related transactions, and
director independence.
The information required by this Part III, Item 13 is incorporated
by reference to the sections entitled “Certain Relationships and
Related Party Transactions” and “Our Board of Director” (or similar
titles) that will be contained in the Proxy Statement.
Item 14. Principal accounting fees and services.
The information required by this Part III, Item 14 is incorporated
by reference to the section entitled “Audit Matters” (or a similar
title) that will be contained in the Proxy Statement.
PART IV
Item 15. Exhibits, financial statement schedules.
(a) The following documents are filed as part of this Annual
Report:
1.Consolidated
financial statements:
Reference is made to the Index to Consolidated Financial Statements
on page
60
hereof, which is incorporated by reference herein.
2.Financial
statement schedules:
All schedules are omitted because the required information is
either not present, not present in material amounts or presented
within our consolidated financial statements and notes thereto
beginning on page
68
hereof and are incorporated herein by reference.
3.Exhibits
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incorporated by Reference |
Exhibit Number |
Exhibit Description |
Provided
Herewith |
Form |
Exhibit
Number |
File Number |
Filing Date |
|
|
|
|
|
|
|
3.1 |
|
|
8-K |
3.1 |
001-37873 |
9/27/2016 |
|
|
|
|
|
|
|
3.2 |
|
|
8-K |
3.2 |
001-37873 |
9/27/2016 |
|
|
|
|
|
|
|
4.1 |
Reference is made to Exhibits 3.1 and 3.2. |
|
|
|
|
|
|
|
|
|
|
|
|
4.2 |
|
|
S-1 |
4.2 |
333-213333 |
8/26/2016 |
|
|
|
|
|
|
|
4.3 |
|
|
S-1/A |
4.4 |
333-213333 |
9/12/2016 |
|
|
|
|
|
|
|
4.4 |
|
|
10-K |
4.4 |
001-37873 |
5/27/2021 |
|
|
|
|
|
|
|
10.1 (a) |
|
|
S-1 |
10.1 |
333-213333 |
8/26/2016 |
|
|
|
|
|
|
|
10.1 (b) |
|
|
S-1 |
10.2 |
333-213333 |
8/26/2016 |
|
|
|
|
|
|
|
10.1 (c) |
|
|
S-1 |
10.3 |
333-213333 |
8/26/2016 |
|
|
|
|
|
|
|
10.1 (d) |
|
|
S-1 |
10.4 |
333-213333 |
8/26/2016 |
|
|
|
|
|
|
|
10.1 (e) |
|
|
10-Q |
10.1 |
001-37873
|
8/8/2019 |
|
|
|
|
|
|
|
10.2(a) |
|
|
S-1 |
10.5 |
333-213333 |
8/26/2016 |
|
|
|
|
|
|
|
10.2(b) |
|
|
10-Q |
10.1 |
001-37873 |
2/4/2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incorporated by Reference |
Exhibit Number |
Exhibit Description |
Provided
Herewith |
Form |
Exhibit
Number |
File Number |
Filing Date |
10.3 (a) |
Senior Secured Credit Agreement, dated as of December 23,
2016, by and among e.l.f. Beauty, Inc., as parent guarantor, e.l.f.
Cosmetics, Inc., J.A. 139 Fulton Street Corp., J.A. 741 Retail
Corp., J.A. Cosmetics Retail, Inc., J.A. RF, LLC and J.A. Cherry
Hill, LLC, each as a borrower, and Bank of Montreal, as the
administrative agent, swingline lender and l/c
issuer.
|
|
8-K |
10.1 |
001-37873 |
12/28/2016 |
|
|
|
|
|
|
|
10.3 (b) |
First Amendment to Credit Agreement, dated as of August 25, 2017,
by and among e.l.f. Beauty, Inc., as parent guarantor, e.l.f.
Cosmetics, Inc., J.A. 139 Fulton Street Corp., J.A. 741 Retail
Corp., J.A. Cosmetics Retail, Inc., J.A. RF, LLC and J.A. Cherry
Hill, LLC, each as a borrower, Bank of Montreal, as the
administrative agent, swingline lender and l/c issuer, and the
lenders from time to time party thereto.
|
|
8-K |
10.1 |
001-37873 |
8/28/2017 |
|
|
|
|
|
|
|
10.3 (c) |
Second Amendment to Credit Agreement, dated as of December 7, 2018,
by and among e.l.f. Beauty, Inc., as parent guarantor, e.l.f.
Cosmetics, Inc., J.A. 139 Fulton Street Corp., J.A. 741 Retail
Corp., J.A. Cosmetics Retail, Inc., J.A. RF, LLC and J.A. Cherry
Hill, LLC, each as a borrower, Bank of Montreal, as the
administrative agent, swingline lender and l/c issuer, and the
lenders from time to time party thereto
|
|
10-K |
10.8(b) |
001-37873 |
5/28/2020 |
|
|
|
|
|
|
|
10.3(d) |
Third Amendment to Credit Agreement, dated as of April 8, 2020, by
and among e.l.f. Beauty, Inc., as parent guarantor, e.l.f.
Cosmetics, Inc., W3ll People, Inc., J.A. RF, LLC, each as a
borrower, Bank of Montreal, as the administrative agent, swingline
lender and l/c issuer, and the lenders from time to time party
thereto.
|
|
8-K |
10.1 |
001-37873 |
4/9/2020 |
|
|
|
|
|
|
|
10.4 |
Amended and Restated Credit Agreement, dated April 30, 2021, by and
among the Company as parent guarantor, e.l.f. Cosmetics, Inc., W3LL
People, Inc. and J.A. RF, LLC, each as a borrower, Bank of
Montreal, as the administrative agent, swingline lender and l/c
issuer, U.S. Bank, as syndication agent and a joint lead arranger,
BMO Capital Markets Corp., as a joint lead arranger and bookrunner,
and the lenders from time to time party thereto.
|
|
8-K |
10.1 |
001-37873 |
5/4/2020 |
|
|
|
|
|
|
|
10.5 (a)# |
|
|
S-1 |
10.12 |
333-213333 |
8/26/2016 |
|
|
|
|
|
|
|
10.5 (b)# |
|
|
10-K |
10.7(b) |
001-37873 |
3/15/2017 |
|
|
|
|
|
|
|
10.5 (c)# |
|
|
S-1 |
10.13 |
333-213333 |
8/26/2016 |
|
|
|
|
|
|
|
10.6 (a)# |
|
|
S-1/A |
10.16 |
333-213333 |
9/12/2016 |
|
|
|
|
|
|
|
10.6 (b)# |
|
|
8-K |
10.2 |
001-37873 |
7/2/2020 |
|
|
|
|
|
|
|
10.6 (c)# |
|
|
S-1/A |
10.17 |
333-213333 |
9/12/2016 |
|
|
|
|
|
|
|
10.6 (d)# |
|
|
S-1/A |
10.27 |
333-213333 |
9/12/2016 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incorporated by Reference |
Exhibit Number |
Exhibit Description |
Provided
Herewith |
Form |
Exhibit
Number |
File Number |
Filing Date |
10.6 (e)# |
|
|
10-K |
10.12(d) |
001-37873 |
3/15/2017 |
|
|
|
|
|
|
|
10.6 (f)# |
|
|
10-K |
10.12(e) |
001-37873 |
3/15/2017 |
|
|
|
|
|
|
|
10.6 (g)# |
|
|
10-K |
10.1 |
001-37873 |
5/27/2021 |
|
|
|
|
|
|
|
10.6 (h)# |
|
|
10-K |
10.2 |
001-37873 |
5/27/2021 |
|
|
|
|
|
|
|
10.7# |
|
|
S-1/A |
10.18 |
333-213333 |
9/12/2016 |
|
|
|
|
|
|
|
10.8# |
|
|
10-K |
10.16 |
001-37873 |
2/28/2019 |
|
|
|
|
|
|
|
10.9# |
|
|
10-K |
10.17 |
001-37873 |
2/28/2019 |
|
|
|
|
|
|
|
10.10# |
|
|
10-K |
10.18 |
001-37873 |
2/28/2019 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.11#
|
|
|
10-Q |
10.1 |
001-37873 |
5/9/2019 |
|
|
|
|
|
|
|
10.12# |
|
|
8-K |
10.1 |
001-37873 |
3/21/2019 |
|
|
|
|
|
|
|
10.13# |
|
|
10-Q
|
10.1 |
001-37873 |
2/6/2020 |
|
|
|
|
|
|
|
10.14# |
|
|
S-1 |
10.25 |
333-213333 |
8/26/2016 |
|
|
|
|
|
|
|
10.15# |
|
|
10-Q
|
10.1 |
001-37873 |
11/7/2019 |
|
|
|
|
|
|
|
10.16# |
Cooperation Agreement, dated as of July 1, 2020, by and between
e.l.f. Beauty, Inc., Marathon Partners Equity Management, LLC,
Marathon Partners L.P., Marathon Focus Fund L.P., Marathon Partners
LUX Fund, L.P., Cibelli Research & Management, LLC and Mario
Cibelli.
|
|
8-K |
10.1 |
001-37873 |
7/2/2020 |
|
|
|
|
|
|
|
10.17 |
|
|
10-K |
21.1 |
001-37873 |
5/27/2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incorporated by Reference |
Exhibit Number |
Exhibit Description |
Provided
Herewith |
Form |
Exhibit
Number |
File Number |
Filing Date |
23.1 |
|
X |
|
|
|
|
|
|
|
|
|
|
|
24.1 |
|
X |
|
|
|
|
|
|
|
|
|
|
|
31.1 |
|
X |
|
|
|
|
|
|
|
|
|
|
|
31.2 |
|
X |
|
|
|
|
|
|
|
|
|
|
|
32.1* |
|
X |
|
|
|
|
|
|
|
|
|
|
|
101.INS
|
XBRL Instance Document - Instance document does not appear in the
Interactive Data File because its XBRL tags are embedded within the
Inline XBRL document.
|
X
|
|
|
|
|
101.SCH |
Inline XBRL Taxonomy Extension Schema Document. |
X |
|
|
|
|
101.CAL |
Inline XBRL Taxonomy Extension Calculation Linkbase
Document. |
X |
|
|
|
|
101.DEF |
Inline XBRL Taxonomy Extension Definition Linkbase
Document. |
X |
|
|
|
|
101.LAB |
Inline XBRL Taxonomy Extension Label Linkbase Document. |
X |
|
|
|
|
101.PRE |
Inline XBRL Taxonomy Extension Presentation Linkbase
Document. |
X |
|
|
|
|
104 |
Cover Page Interactive Data File (formatted as Inline XBRL and
contained in Exhibit 101). |
X |
|
|
|
|
# Indicates management contract or
compensatory plan
* This certification is deemed furnished,
and not filed, with the Securities and Exchange Commission and is
not to be incorporated by reference into any filing of e.l.f.
Beauty, Inc. under the Securities Act of 1933, as amended, or the
Securities Exchange Act of 1934, as amended, whether made before or
after the date of this Annual Report on Form 10-K, irrespective of
any general incorporation language contained in such
filing.
Item 16. Form 10-K Summary.
None.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, as amended, the Registrant has
duly caused this Report to be signed on its behalf by the
undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
e.l.f. Beauty, Inc. |
|
|
|
|
May 26, 2022 |
|
By: |
/s/ Tarang P. Amin |
Date |
|
|
Tarang P. Amin
Chief Executive Officer
(Principal Executive Officer) |
|
|
|
|
May 26, 2022 |
|
By: |
/s/ Mandy Fields |
Date |
|
|
Mandy Fields
Chief Financial Officer
(Principal Financial and Accounting Officer) |
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose
signature appears below hereby constitutes and appoints Tarang P.
Amin, Mandy Fields and Scott K. Milsten and each of them acting
individually, as his or her true and lawful attorneys-in-fact and
agents, each with full power of substitution, for him or her in any
and all capacities, to sign any and all amendments to this Annual
Report on Form 10-K and to file the same, with all exhibits thereto
and other documents in connection therewith, with the Securities
and Exchange Commission, granting unto said attorneys-in-fact and
agents, with full power of each to act alone, full power and
authority to do and perform each and every act and thing requisite
and necessary to be done in connection therewith, as fully for all
intents and purposes as he might or could do in person, hereby
ratifying and confirming all that said attorneys-in-fact and
agents, or his or their substitute or substitutes, may lawfully do
or cause to be done by virtue hereof.
IN WITNESS WHEREOF, each of the undersigned has executed this Power
of Attorney as of the date indicated opposite his or her
name.
Pursuant to the requirements of the Securities Exchange Act of
1934, as amended, this Annual Report on Form 10-K has been signed
below by the following persons in the capacities and on the dates
indicated.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name |
|
Title |
|
Date |
|
|
|
|
|
/s/ Tarang P. Amin |
|
Chairman, Chief Executive Officer and Director
(Principal Executive Officer) |
|
May 26, 2022 |
Tarang P. Amin |
|
|
|
|
|
|
|
|
|
/s/ Mandy Fields |
|
Senior Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer) |
|
May 26, 2022 |
Mandy Fields |
|
|
|
|
|
|
|
|
|
/s/ Lori A. Keith |
|
Director |
|
May 26, 2022 |
Lori A. Keith |
|
|
|
|
|
|
|
|
|
/s/ Lauren Cooks Levitan |
|
Director |
|
May 26, 2022 |
Lauren Cooks Levitan |
|
|
|
|
|
|
|
|
|
/s/ Kenny Mitchell |
|
Director |
|
May 26, 2022 |
Kenny Mitchell |
|
|
|
|
|
|
|
|
|
/s/ Richelle P. Parham |
|
Director |
|
May 26, 2022 |
Richelle P. Parham |
|
|
|
|
|
|
|
|
|
/s/ Kirk L. Perry |
|
Director |
|
May 26, 2022 |
Kirk L. Perry |
|
|
|
|
|
|
|
|
|
/s/ Beth M. Pritchard |
|
Director |
|
May 26, 2022 |
Beth M. Pritchard |
|
|
|
|
|
|
|
|
|
/s/ Maureen C. Watson |
|
Director |
|
May 26, 2022 |
Maureen C. Watson |
|
|
|
|
|
|
|
|
|
/s/ Richard G. Wolford |
|
Director |
|
May 26, 2022 |
Richard G. Wolford |
|
|
|
|
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM
To the stockholders and the Board of Directors of e.l.f. Beauty,
Inc.
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of
e.l.f. Beauty, Inc. and subsidiaries (the "Company") as of March
31, 2022 and 2021, the related consolidated statements of
operations and comprehensive income, stockholders' equity, and cash
flows, for the three years in the period ended March 31, 2022, and
the related notes (collectively referred to as the "financial
statements"). In our opinion, the financial statements present
fairly, in all material respects, the financial position of the
Company as of March 31, 2022 and 2021, and the results of its
operations and its cash flows for each of the three years in the
period ended March 31, 2022, in conformity with accounting
principles generally accepted in the United States of
America.
We have also audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States) (PCAOB),
the Company's internal control over financial reporting as of March
31, 2022, based on criteria established in
Internal Control — Integrated Framework (2013)
issued by the Committee of Sponsoring Organizations of the Treadway
Commission and our report dated May 26, 2022, expressed an
unqualified opinion on the Company's internal control over
financial reporting.
Basis for Opinion
These financial statements are the responsibility of the Company's
management. Our responsibility is to express an opinion on the
Company's financial statements based on our audits. We are a public
accounting firm registered with the PCAOB and are required to be
independent with respect to the Company in accordance with the U.S.
federal securities laws and the applicable rules and regulations of
the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the
PCAOB. Those standards require that we plan and perform the audit
to obtain reasonable assurance about whether the financial
statements are free of material misstatement, whether due to error
or fraud. Our audits included performing procedures to assess the
risks of material misstatement of the financial statements, whether
due to error or fraud, and performing procedures that respond to
those risks. Such procedures included examining, on a test basis,
evidence regarding the amounts and disclosures in the financial
statements. Our audits also included evaluating the accounting
principles used and significant estimates made by management, as
well as evaluating the overall presentation of the financial
statements. We believe that our audits provide a reasonable basis
for our opinion.
Critical Audit Matter
The critical audit matter communicated below is a matter arising
from the current-period audit of the financial statements that was
communicated or required to be communicated to the audit committee
and that (1) relates to accounts or disclosures that are material
to the financial statements and (2) involved our especially
challenging, subjective, or complex judgments. The communication of
critical audit matters does not alter in any way our opinion on the
financial statements, taken as a whole, and we are not, by
communicating the critical audit matter below, providing a separate
opinion on the critical audit matter or on the accounts or
disclosures to which it relates.
Revenue Recognition—Provision for Customer Incentives and
Allowances— Refer to Note 2 to the financial
statements
Critical Audit Matter Description
The Company offers various incentives to customers such as sales
discounts, markdown support and other incentives and allowances,
which give rise to variable consideration. The amount of variable
consideration is estimated at the time of sale based on either the
expected amount or the most likely amount, depending on the nature
of the variability. The Company regularly reviews and revises, when
deemed necessary, its estimates of variable consideration based on
both customer-specific expectations as well as historical rates of
realization. A provision for customer incentives and allowances is
included on the consolidated balance sheet, net against accounts
receivable. The provision for customer incentives and allowances
was $16.3 million and $11.9 million as of March 31, 2022 and March
31, 2021, respectively.
Auditing the Company’s provision for customer incentives and
allowances was complex and judgmental as the provision for customer
incentives and allowances is determined based on significant
management estimates. Changes in these estimates
can have a material impact on revenue recognized. Additionally,
given the subjectivity of estimating the provision for customer
incentives and allowances, performing audit procedures to evaluate
whether the provision for customer incentives and allowances is
appropriately recorded required a high degree of auditor
judgment.
How the Critical Audit Matter Was Addressed in the
Audit
Our audit procedures related to the Company’s provision of
unclaimed customer incentives and allowances included the
following, among others:
· We obtained an understanding, evaluated the design, and tested
the operating effectiveness of controls over the Company’s
provision of unclaimed customer incentives and allowances,
including controls over management’s review of the significant
assumptions, such as the historical rate of customer deductions and
management’s review of the completeness and accuracy of the data
used.
· We tested customer deduction data underlying the estimate to
validate the nature, timing, and amount of deductions
taken.
· We evaluated the Company’s historical ability to accurately
estimate its provision by performing a retrospective analysis on
the prior period reserve, based on current period
deductions.
· We evaluated period-over-period comparisons of the Company’s
provision for customer incentives and allowances and deductions
claimed by customers by allowance type to identify unusual
trends.
· We evaluated management’s methodologies and tested the
significant assumptions used by the Company to calculate the
provision for customer incentives and allowances and verified they
were in agreement with the terms of underlying customer
contracts.
/s/ Deloitte & Touche LLP
San Francisco, California
May 26, 2022
We have served as the Company's auditor since 2014.
e.l.f. Beauty, Inc. and subsidiaries
Consolidated balance sheets
(in thousands, except share and per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2022 |
|
March 31, 2021 |
|
|
Assets |
|
|
|
|
|
Current assets: |
|
|
|
|
|
Cash and cash equivalents |
$ |
43,353 |
|
|
$ |
57,768 |
|
|
|
Accounts receivable, net |
45,567 |
|
|
40,185 |
|
|
|
Inventory, net |
84,498 |
|
|
56,810 |
|
|
|
Prepaid expenses and other current assets |
19,611 |
|
|
15,381 |
|
|
|
Total current assets |
193,029 |
|
|
170,144 |
|
|
|
Property and equipment, net |
10,577 |
|
|
13,770 |
|
|
|
Intangible assets, net |
86,163 |
|
|
94,286 |
|
|
|
Goodwill |
171,620 |
|
|
171,620 |
|
|
|
Investments |
2,875 |
|
|
2,875 |
|
|
|
Other assets |
30,368 |
|
|
34,698 |
|
|
|
Total assets |
$ |
494,632 |
|
|
$ |
487,393 |
|
|
|
|
|
|
|
|
|
Liabilities and stockholders' equity |
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
Current portion of long-term debt and finance lease
obligations |
$ |
5,786 |
|
|
$ |
16,281 |
|
|
|
Accounts payable |
19,227 |
|
|
15,699 |
|
|
|
Accrued expenses and other current liabilities |
40,004 |
|
|
41,351 |
|
|
|
|
|
|
|
|
|
Total current liabilities |
65,017 |
|
|
73,331 |
|
|
|
Long-term debt and finance lease obligations |
91,080 |
|
|
110,255 |
|
|
|
Deferred tax liabilities |
9,593 |
|
|
13,479 |
|
|
|
Long-term operating lease obligations |
15,744 |
|
|
20,084 |
|
|
|
Other long-term liabilities |
769 |
|
|
598 |
|
|
|
Total liabilities |
182,203 |
|
|
217,747 |
|
|
|
|
|
|
|
|
|
Commitments and contingencies (Note 9) |
|
|
|
|
|
|
|
|
|
|
|
Stockholders' equity: |
|
|
|
|
|
|
|
|
|
|
|
Common stock, par value of $0.01 per
share;
250,000,000 shares authorized as of March 31, 2022 and
March 31, 2021; 52,243,764 and 51,590,830 shares issued and
outstanding as of March 31, 2022 and March 31, 2021,
respectively
|
515 |
|
|
504 |
|
|
|
Additional paid-in capital |
795,443 |
|
|
774,441 |
|
|
|
Accumulated deficit |
(483,529) |
|
|
(505,299) |
|
|
|
Total stockholders' equity |
312,429 |
|
|
269,646 |
|
|
|
Total liabilities and stockholders' equity |
$ |
494,632 |
|
|
$ |
487,393 |
|
|
|
The accompanying notes are an integral part of these consolidated
financial statements.
e.l.f. Beauty, Inc. and subsidiaries
Consolidated statements of operations and comprehensive
income
(in thousands, except share and per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended March 31, |
|
2022 |
|
2021 |
|
|
|
2020 |
|
|
Net sales |
$ |
392,155 |
|
|
$ |
318,110 |
|
|
|
|
$ |
282,851 |
|
|
|
Cost of sales |
140,423 |
|
|
111,912 |
|
|
|
|
101,728 |
|
|
|
Gross profit |
251,732 |
|
|
206,198 |
|
|
|
|
181,123 |
|
|
|
Selling, general and administrative expenses |
221,912 |
|
|
194,157 |
|
|
|
|
157,155 |
|
|
|
Restructuring expense (income) |
50 |
|
|
2,641 |
|
|
|
|
(5,982) |
|
|
|
Operating income |
29,770 |
|
|
9,400 |
|
|
|
|
29,950 |
|
|
|
Other (expense) income, net |
(1,438) |
|
|
(1,620) |
|
|
|
|
426 |
|
|
|
Interest expense, net |
(2,441) |
|
|
(4,090) |
|
|
|
|
(6,307) |
|
|
|
Loss on extinguishment of debt |
(460) |
|
|
— |
|
|
|
|
— |
|
|
|
Income before provision for income taxes |
25,431 |
|
|
3,690 |
|
|
|
|
24,069 |
|
|
|
Income tax (provision) benefit |
(3,661) |
|
|
2,542 |
|
|
|
|
(6,185) |
|
|
|
Net income |
$ |
21,770 |
|
|
$ |
6,232 |
|
|
|
|
$ |
17,884 |
|
|
|
Comprehensive income |
$ |
21,770 |
|
|
$ |
6,232 |
|
|
|
|
$ |
17,884 |
|
|
|
Net income per share: |
|
|
|
|
|
|
|
|
|
Basic |
$ |
0.43 |
|
|
$ |
0.13 |
|
|
|
|
$ |
0.37 |
|
|
|
Diluted |
$ |
0.41 |
|
|
$ |
0.12 |
|
|
|
|
$ |
0.35 |
|
|
|
Weighted average shares outstanding: |
|
|
|
|
|
|
|
|
|
Basic |
50,940,808 |
|
|
49,377,410 |
|
|
|
|
48,498,813 |
|
|
|
Diluted |
53,654,303 |
|
|
51,994,145 |
|
|
|
|
50,817,143 |
|
|
|
The accompanying notes are an integral part of these consolidated
financial statements.
e.l.f. Beauty, Inc. and subsidiaries
Consolidated statements of stockholders’ equity
(in thousands, except share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock |
|
Additional
paid-in
capital |
|
Accumulated deficit |
|
Total
stockholders'
equity |
|
|
|
|
|
|
Shares |
|
Amount |
|
|
|
Balance as of March 31, 2019 |
|
|
|
|
|
48,288,720 |
|
|
$ |
483 |
|
|
$ |
744,147 |
|
|
$ |
(529,415) |
|
|
$ |
215,215 |
|
Net income |
|
|
|
|
|
— |
|
|
— |
|
|
— |
|
|
17,884 |
|
|
17,884 |
|
Stock based compensation |
|
|
|
|
|
— |
|
|
— |
|
|
15,488 |
|
|
— |
|
|
15,488 |
|
Exercise of stock options and vesting of restricted
stock |
|
|
|
|
|
1,150,490 |
|
|
12 |
|
|
1,476 |
|
|
— |
|
|
1,488 |
|
Repurchase of common stock |
|
|
|
|
|
(564,468) |
|
|
(6) |
|
|
(7,898) |
|
|
— |
|
|
(7,904) |
|
Balance as of March 31, 2020 |
|
|
|
|
|
48,874,742 |
|
|
489 |
|
|
753,213 |
|
|
(511,531) |
|
|
242,171 |
|
Net income |
|
|
|
|
|
— |
|
|
— |
|
|
— |
|
|
6,232 |
|
|
6,232 |
|
Stock based compensation |
|
|
|
|
|
— |
|
|
— |
|
|
19,493 |
|
|
— |
|
|
19,493 |
|
Exercise of stock options and vesting of restricted
stock |
|
|
|
|
|
1,525,768 |
|
|
15 |
|
|
1,735 |
|
|
— |
|
|
1,750 |
|
Balance as of March 31, 2021 |
|
|
|
|
|
50,400,510 |
|
|
504 |
|
|
774,441 |
|
|
(505,299) |
|
|
269,646 |
|
Net income |
|
|
|
|
|
— |
|
|
— |
|
|
— |
|
|
21,770 |
|
|
21,770 |
|
Stock based compensation |
|
|
|
|
|
— |
|
|
— |
|
|
19,336 |
|
|
— |
|
|
19,336 |
|
Exercise of stock options and vesting of restricted
stock |
|
|
|
|
|
1,123,797 |
|
|
11 |
|
|
1,666 |
|
|
— |
|
|
1,677 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of March 31, 2022 |
|
|
|
|
|
51,524,307 |
|
|
$ |
515 |
|
|
$ |
795,443 |
|
|
$ |
(483,529) |
|
|
$ |
312,429 |
|
The accompanying notes are an integral part of these consolidated
financial statements.
e.l.f. Beauty, Inc. and subsidiaries
Consolidated statements of cash flows
(in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended March 31, |
|
2022 |
|
2021 |
|
2020 |
Cash flows from operating activities: |
|
|
|
|
|
Net income |
$ |
21,770 |
|
|
$ |
6,232 |
|
|
$ |
17,884 |
|
Adjustments to reconcile net income to net cash provided by
operating activities: |
|
|
|
|
|
Depreciation and amortization |
27,083 |
|
|
25,179 |
|
|
22,843 |
|
Restructuring expense (income) |
50 |
|
|
2,641 |
|
|
(5,982) |
|
Stock based compensation expense |
19,646 |
|
|
19,682 |
|
|
15,488 |
|
Amortization of debt issuance costs and discount on
debt |
394 |
|
|
847 |
|
|
747 |
|
Deferred income taxes |
(3,701) |
|
|
(8,584) |
|
|
2,443 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss on extinguishment of debt |
460 |
|
|
— |
|
|
— |
|
Other, net |
496 |
|
|
383 |
|
|
873 |
|
Changes in operating assets and liabilities: |
|
|
|
|
|
Accounts receivable |
(5,597) |
|
|
(10,529) |
|
|
2,504 |
|
Inventories |
(27,655) |
|
|
(10,937) |
|
|
(435) |
|
Prepaid expenses and other assets |
(10,555) |
|
|
(9,659) |
|
|
(6,500) |
|
Accounts payable and accrued expenses |
1,498 |
|
|
17,472 |
|
|
5,962 |
|
Other liabilities |
(4,376) |
|
|
(3,252) |
|
|
(11,514) |
|
Net cash provided by operating activities |
19,513 |
|
|
29,475 |
|
|
44,313 |
|
|
|
|
|
|
|
Cash flows from investing activities: |
|
|
|
|
|
Acquisition, net of cash acquired |
— |
|
|
— |
|
|
(25,923) |
|
Purchase of property and equipment |
(4,818) |
|
|
(6,474) |
|
|
(9,422) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities |
(4,818) |
|
|
(6,474) |
|
|
(35,345) |
|
|
|
|
|
|
|
Cash flows from financing activities: |
|
|
|
|
|
Proceeds from revolving line of credit |
26,480 |
|
|
20,000 |
|
|
— |
|
Repayment of revolving line of credit |
(26,480) |
|
|
(20,000) |
|
|
— |
|
Proceeds from long-term debt |
25,581 |
|
|
— |
|
|
— |
|
Repayment of long-term debt |
(54,525) |
|
|
(11,756) |
|
|
(9,488) |
|
Debt issuance costs paid |
(1,064) |
|
|
(334) |
|
|
— |
|
Repurchase of common stock |
— |
|
|
— |
|
|
(7,904) |
|
Cash received from issuance of common stock |
1,677 |
|
|
1,503 |
|
|
1,488 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other, net |
(779) |
|
|
(813) |
|
|
(771) |
|
Net cash used in financing activities |
(29,110) |
|
|
(11,400) |
|
|
(16,675) |
|
|
|
|
|
|
|
Net (decrease) increase in cash and cash equivalents |
(14,415) |
|
|
11,601 |
|
|
(7,707) |
|
Cash and cash equivalents - beginning of period |
57,768 |
|
|
46,167 |
|
|
53,874 |
|
Cash and cash equivalents - end of period |
$ |
43,353 |
|
|
$ |
57,768 |
|
|
$ |
46,167 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended March 31, |
|
2022 |
|
2021 |
|
2020 |
Supplemental disclosure of cash flow information: |
|
|
|
|
|
Cash paid for interest |
$ |
1,762 |
|
|
$ |
3,018 |
|
|
$ |
6,302 |
|
Cash paid for income taxes, net of refunds |
7,573 |
|
|
2,301 |
|
|
5,604 |
|
Cash paid for interest on finance leases |
63 |
|
|
137 |
|
|
179 |
|
Supplemental disclosure of noncash investing and financing
activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property and equipment purchases included in accounts payable and
accrued expenses |
$ |
390 |
|
|
$ |
359 |
|
|
$ |
1,132 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these consolidated
financial statements.
e.l.f. Beauty, Inc. and subsidiaries
Notes to consolidated financial statements
Note 1—Nature of operations
e.l.f. Beauty, Inc., a Delaware corporation, (“e.l.f. Beauty” and
together with its subsidiaries, the “Company,” or “we”) is a
multi-brand beauty company that offers inclusive, accessible,
cruelty-free cosmetics and skincare products. Our mission is to
make the best of beauty accessible to every eye, lip and
face.
We believe our ability to deliver 100% cruelty-free,
premium-quality products at accessible prices with broad appeal
differentiates us in the beauty industry. We believe the
combination of our fundamental value equation, digitally-led
strategy, as well as our world-class team’s ability to execute with
speed has positioned us well to navigate a rapidly changing
landscape in beauty.
Our family of brands includes e.l.f. Cosmetics, e.l.f. SKIN, Well
People and Keys Soulcare. Our brands are available online and
across leading beauty, mass-market and clean-beauty specialty
retailers. We have strong relationships with our retail partners
such as Walmart, Target, Ulta Beauty and other leading retailers
that have enabled us to expand distribution both domestically and
internationally.
Note 2—Summary of significant accounting policies
Basis of presentation and fiscal year end change
The consolidated financial statements and related notes have been
prepared in accordance with U.S. generally accepted accounting
principles (“U.S. GAAP”) and all intercompany balances and
transactions have been eliminated in consolidation.
Use of estimates
The preparation of financial statements in conformity with U.S.
GAAP requires management make estimates and assumptions that affect
the reported amounts of assets and liabilities at the date of the
financial statements and reported amounts of revenues and expenses
during the reporting period. Actual results could differ from these
estimates.
Cash and cash equivalents
Cash and cash equivalents include all cash balances and highly
liquid investments purchased with maturities of three months or
less.
Accounts receivable
Trade receivables consist of uncollateralized, non-interest bearing
customer obligations from transactions with retail customers,
reduced by an allowance for doubtful accounts for estimated losses
resulting from the inability of customers to make payments. The
allowance is based on the evaluation and aging of past due
balances, specific exposures, historical trends and economic
conditions.
The Company maintains allowances for doubtful accounts for
uncollectible accounts receivable. Management estimates anticipated
losses from doubtful accounts based on days past due, collection
history and the financial health of customers. The Company writes
off accounts receivable against the allowance when a balance is
determined to be uncollectible. Recoveries of receivables
previously written off are recorded when received. The Company
recorded an allowance for doubtful accounts of $0.1 million and
$0.2 million as of March 31, 2022 and March 31, 2021,
respectively. The Company recorded a reserve for sales adjustments
of $16.3 million and $11.9 million as of March 31, 2022
and March 31, 2021, respectively, which is also presented as a
reduction to accounts receivable. The Company grants credit terms
in the normal course of business to its customers. Trade credit is
extended based upon an evaluation of each customer’s ability to
perform its payment obligations.
Concentrations of credit risk
Financial instruments, which potentially subject the Company to
concentrations of credit risk, consist principally of cash and cash
equivalents including money market funds. Although the Company
deposits its cash with creditworthy financial institutions, its
deposits, at times, may exceed federally insured limits. To date,
the Company has not experienced any losses on its cash deposits.
The Company performs credit evaluations of its customers and the
risk with respect to trade receivables is further mitigated by the
short duration of customer payment terms and the pedigree of the
customer base.
e.l.f. Beauty, Inc. and subsidiaries
Notes to consolidated financial statements
During the years ended March 31, 2022, March 31, 2021 and March 31,
2020, three customers individually accounted for greater than 10%
of the Company’s net sales as disclosed below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended March 31, |
|
2022 |
|
2021 |
|
|
|
2020 |
Walmart |
26 |
% |
|
26 |
% |
|
|
|
31 |
% |
Target |
23 |
% |
|
22 |
% |
|
|
|
22 |
% |
Ulta Beauty |
12 |
% |
|
* |
|
|
|
* |
* Net sales from customer comprised less than 10% of net sales in
the periods indicated.
Customers that individually accounted for greater than 10% of the
Company’s accounts receivable at the end of the periods as of March
31, 2022 and March 31, 2021, respectively, are as
presented:
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2022 |
|
March 31, 2021 |
Walmart |
31 |
% |
|
33 |
% |
Target |
18 |
% |
|
17 |
% |
Ulta Beauty |
* |
|
11 |
% |
* Customer comprised less than 10% accounts receivable in the
period indicated.
Inventory
Inventory, consisting principally of finished goods, is stated at
the lower of cost or market. Cost is principally determined by the
first-in, first-out method. The Company also records a reserve for
excess and obsolete inventory, which represents the excess of the
cost of the inventory over its estimated market value. This reserve
is based upon an assessment of historical trends, current market
conditions and forecasted product demand. The Company recorded an
adjustment for excess and obsolete inventory, which is presented as
a reduction to inventory of $4.5 million and $3.6 million as of
March 31, 2022 and March 31, 2021, respectively.
Property and equipment and other assets
Property and equipment is stated at cost and is depreciated on a
straight-line basis over the estimated useful lives of the assets.
Leasehold improvements are amortized on a straight-line basis over
the shorter of the lease term or the useful lives of the assets.
Repairs and maintenance expenditures are expensed as
incurred.
Useful lives by major asset class are as follows:
|
|
|
|
|
|
|
Estimated
useful lives |
Machinery, equipment and software |
3 - 5 years
|
Leasehold improvements |
up to 5 years
|
Furniture and fixtures |
2 - 5 years
|
Store fixtures |
1 - 3 years
|
As of March 31, 2022 and March 31, 2021, included in other assets
are retail product displays, net, of $10.1 million and
$9.7 million, respectively, that are generally amortized over
a period of three years. Amortization expense for retail product
displays was $5.9 million, $5.2 million and
$6.0 million for the years ended March 31, 2022, March 31,
2021 and March 31, 2020, respectively.
The Company evaluates events and changes in circumstances that
could indicate carrying amounts of long-lived assets, including
property and equipment, may not be recoverable. When such events or
changes in circumstances occur, the Company assesses the
recoverability of long-lived assets by determining whether or not
the carrying value of such assets will be recovered through
undiscounted future cash flows derived from their use and eventual
disposition. For purposes of this assessment, long-lived assets are
grouped with other assets and liabilities at the lowest level for
which identifiable cash flows
e.l.f. Beauty, Inc. and subsidiaries
Notes to consolidated financial statements
are largely independent of the cash flows of other assets and
liabilities. The Company’s long-lived assets are grouped on an
entity-wide basis. This is due, in part, to the integrated nature
of the Company’s various distribution channels and the extent of
shared costs across those channels. If the sum of the undiscounted
future cash flows is less than the carrying amount of an asset, the
Company records an impairment loss for the amount by which the
carrying amount of the assets exceeds its fair value. There were no
impairment charges recorded on long-lived assets during the years
ended March 31, 2022, March 31, 2021 and March 31, 2020,
respectively.
Goodwill and intangible assets
Goodwill represents the excess of the purchase price for an
acquisition over the fair value of the net assets acquired. In
addition, the Company has acquired finite-lived intangible assets
and an indefinite-lived intangible asset.
Goodwill is not amortized but rather is reviewed annually for
impairment, at the reporting unit level, or when there is evidence
that events or changes in circumstances indicate that the Company’s
carrying amount may not be recovered. When testing goodwill for
impairment, the Company first performs an assessment of qualitative
factors. If qualitative factors indicate that it is more likely
than not that the fair value of the relevant reporting unit is less
than its carrying amount, the Company tests goodwill for impairment
at the reporting unit level using a two-step approach. In step one,
the Company determines if the fair value of the reporting unit
exceeds the unit’s carrying value. If step one indicates that the
fair value of the reporting unit is less than its carrying value,
the Company performs step two, determining the fair value of
goodwill and, if the carrying value of goodwill exceeds its implied
fair value, an impairment charge is recorded. The Company has
identified a single reporting unit for purposes of impairment
testing due, in part, to the integrated nature of the Company’s
various distribution channels and the extent of shared costs across
those channels.
Indefinite-lived intangible assets are not amortized but rather are
tested for impairment annually and impairment is recognized if the
carrying amount exceeds the fair value of the intangible asset. The
Company evaluates its indefinite-lived intangible asset to
determine whether current events and circumstances continue to
support an indefinite useful life. Amortization of intangible
assets with finite useful lives is computed on a straight-line
basis over periods of 3 years to 10 years. The determination of the
estimated period of benefit is dependent upon the use and
underlying characteristics of the intangible asset. The Company
evaluates the recoverability of its intangible assets subject to
amortization when facts and circumstances indicate that the
carrying value of the asset may not be recoverable. If the carrying
value of an intangible asset is not recoverable, impairment loss is
measured as the amount by which the carrying value exceeds its
estimated fair value.
Debt issuance costs
Debt issuance costs and lender fees were incurred for arranging the
credit facilities from various financial institutions. For credit
facilities consisting of both term and revolving debt, such costs
are allocated to each sub-facility based upon the total borrowing
capacity. For term debt, issuance costs are presented within the
related long-term debt liability on the consolidated balance sheet
and lender fees are presented as a direct deduction from the
carrying amount. Both debt issuance costs and lender fees are
amortized over the term of the related debt using the effective
interest rate method. For revolving debt, issuance costs and lender
fees are presented as a noncurrent asset and amortized over the
term of the related debt on a straight-line basis.
Fair value of financial instruments
The carrying amounts of cash and cash equivalents, accounts
receivable and accounts payable and accrued expenses approximate
their fair values due to the short-term nature of these items. The
carrying amounts of bank debt approximate their fair values as the
stated interest rates approximate market rates currently available
to the Company for loans with similar terms. See Note 7 Fair value
of financial instruments to consolidated financial statements in
Part IV, Item 15.“Exhibits, financial statement
schedules”.
Segment reporting
Operating segments are components of an enterprise for which
separate financial information is available that is evaluated by
the chief operating decision maker in deciding how to allocate
resources and in assessing performance. Utilizing these criteria,
the Company manages its business on the basis of one operating
segment and one reportable segment. It is impracticable for the
Company to provide revenue by product line.
e.l.f. Beauty, Inc. and subsidiaries
Notes to consolidated financial statements
During the years ended March 31, 2022, March 31, 2021 and
March 31, 2020, net sales in the United States and outside of the
United States were as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended March 31, |
|
2022 |
|
2021 |
|
2020 |
United States |
$ |
347,484 |
|
|
$ |
282,273 |
|
|
$ |
255,284 |
|
International |
44,671 |
|
|
35,837 |
|
|
27,567 |
|
Total net sales |
$ |
392,155 |
|
|
$ |
318,110 |
|
|
$ |
282,851 |
|
As of March 31, 2022 and March 31, 2021, the Company had property
and equipment in the United States and outside of the United States
as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2022 |
|
March 31, 2021 |
|
|
United States |
$ |
10,363 |
|
|
$ |
13,524 |
|
|
|
International |
214 |
|
|
246 |
|
|
|
Total property and equipment, net |
$ |
10,577 |
|
|
$ |
13,770 |
|
|
|
Revenue recognition
Revenue is recognized when control of promised goods or services is
transferred to a customer in an amount that reflects the
consideration that the Company expects to receive in exchange for
those goods or services.
For the Company's retail customer transactions, a contract exists
when a written purchase order is received and control transfers at
the time of shipment or the time of delivery, depending upon the
specific terms of the customer arrangement. For the Company's
direct-to-consumer transactions, a contract exists when an order is
placed online and control transfers at the time of delivery of
merchandise to the consumer. Nearly all of the Company’s
transactions with its customers and consumers include a single
performance obligation delivered at a point in time.
The transaction price can include both fixed and variable
consideration. In most cases, it is entirely comprised of variable
consideration with the variability driven by expected sales
discounts, markdown support and other incentives and allowances
offered to customers. These incentives may be explicit or implied
by the Company's historical business practices. Generally, these
commitments represent cash consideration paid to a customer and do
not constitute a promised good or service.
The amount of variable consideration is estimated at the time of
sale based on either the expected amount or the most likely amount,
depending on the nature of the variability. The Company regularly
reviews and revises, when deemed necessary, its estimates of
variable consideration, based on both customer-specific
expectations as well as historical rates of realization. A
provision for customer incentives and allowances is included on the
consolidated balance sheet, net against accounts
receivable.
Disaggregated revenue
The Company distributes product both through national and
international retailers as well as direct-to-consumers through its
e-commerce channels. The marketing and consumer engagement benefits
that the direct channels provide are integral to the Company’s
brand and product development strategy and drive sales across
channels. As such, the Company views its two primary distribution
channels as components of one integrated business, as opposed to
discrete revenue streams.